© 2000-2021 QIAGEN. All rights reserved.

Analysis Details for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Workspace	My Projects
Project	Adult_WM_vs_GM
Analysis	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Date	Wed Dec 23 14:29:42 PST 2020
Analysis ID	24400012

Analysis Settings
Cutoff before duplicate resolution	true
Resolve duplicate on	Expression logfoldchange
Color using	Expression logfoldchange
Cutoff for Expression logfoldchange	--
Cutoff for Expression pvalue	--
Reference set	Ingenuity Knowledge Base (Genes Only)
Relationship to include	Direct and Indirect
Includes Endogenous Chemicals	Yes
Optional Analyses	My Pathways My List
Filter Summary	
Consider only molecules and/or relationships where
(confidence = Experimentally Observed) AND
(tissues/cell lines = Nervous System not otherwise specified OR Purkinje cells OR Striatum OR Other Stem cells OR Caudate Nucleus OR SF-539 OR Cerebral Cortex OR Stem cells not otherwise specified OR CNS Cell Lines not otherwise specified OR Dorsal Root Ganglion OR Ventricular Zone OR Hypothalamus OR SNB-75 OR Cerebellum OR Embryonic stem cells OR Granule Cell Layer OR Amygdala OR Spinal Cord OR SF-295 OR Subventricular Zone OR Granule cells OR Parietal Lobe OR Other Neurons OR Gray Matter OR U251 OR U87MG OR Trigeminal Ganglion OR Hippocampus OR Other Nervous System OR Brain OR Mesenchymal stem cells OR Thalamus OR Other CNS Cell Lines OR Substantia Nigra OR Nucleus Accumbens OR White Matter OR Medulla Oblongata OR Putamen OR Pyramidal neurons OR Sciatic Nerve OR Corpus Callosum OR SF-268 OR Choroid Plexus OR Cortical neurons OR Astrocytes OR Olfactory Bulb OR Cerebral Ventricles OR Neurons not otherwise specified OR Pituitary Gland OR Brainstem) AND
(mol. types = biologic drug OR canonical pathway OR chemical - endogenous mammalian OR chemical - endogenous non-mammalian OR chemical - kinase inhibitor OR chemical - other OR chemical - protease inhibitor OR chemical drug OR chemical reagent OR chemical toxicant OR complex OR cytokine OR disease OR enzyme OR function OR fusion gene/product OR G-protein coupled receptor OR group OR growth factor OR ion channel OR kinase OR ligand-dependent nuclear receptor OR mature microRNA OR microRNA OR other OR peptidase OR phosphatase OR transcription regulator OR translation regulator OR transmembrane receptor OR transporter)

Canonical Pathways for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Ingenuity Canonical Pathways	 -log(p-value)	zScore	Ratio	Molecules
Adipogenesis pathway	-0E00		7.69E-03	CEBPB	
Aldosterone Signaling in Epithelial Cells	-0E00		1.43E-02	PDIA3,PIK3C2B	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00		1.59E-02	IL6	
Androgen Signaling	-0E00		1.53E-02	EP300,JUN	
Basal Cell Carcinoma Signaling	-0E00		1.49E-02	LEF1	
CCR5 Signaling in Macrophages	-0E00		1.18E-02	JUN	
Cellular Effects of Sildenafil (Viagra)	-0E00		1.75E-02	MYLK,PDIA3	
Cyclins and Cell Cycle Regulation	-0E00		1.27E-02	CCNA2	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	-0E00		1.61E-02	MTMR9,TNS3	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	-0E00		1.61E-02	MTMR9,TNS3	
D-myo-inositol-5-phosphate Metabolism	-0E00		1.46E-02	MTMR9,TNS3	
Dopamine-DARPP32 Feedback in cAMP Signaling	-0E00		1.32E-02	ATF1,PDIA3	
G Beta Gamma Signaling	-0E00		8.55E-03	RRAS2	
G-Protein Coupled Receptor Signaling	-0E00		1.89E-02	CNR1,GPR17,PIK3C2B,RRAS2,STAT3	
GNRH Signaling	-0E00		1.81E-02	JUN,PAK2,RRAS2	
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	-0E00		1.52E-02	PDIA3	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	-0E00		9.90E-03	PDIA3	
Gap Junction Signaling	-0E00		1.68E-02	PDIA3,PIK3C2B,RRAS2	
Glioma Signaling	-0E00		1.83E-02	PIK3C2B,RRAS2	
Gustation Pathway	-0E00		8.33E-03	PANX1	
Gαq Signaling	-0E00		1.34E-02	NFATC3,PIK3C2B	
Gαs Signaling	-0E00		9.52E-03	CNR1	
Inhibition of ARE-Mediated mRNA Degradation Pathway	-0E00		1.75E-02	TIA1,ZFP36L2	
Melatonin Signaling	-0E00		1.49E-02	PDIA3	
Mitochondrial Dysfunction	-0E00		1.86E-02	MT-CO2,MT-ND4,NDUFV2	
Mitotic Roles of Polo-Like Kinase	-0E00		1.64E-02	SLK	
NGF Signaling	-0E00		1.82E-02	PIK3C2B,RRAS2	
Netrin Signaling	-0E00		1.64E-02	NFATC3	
Neuroprotective Role of THOP1 in Alzheimer's Disease	-0E00		1.27E-02	HLA-E	
Nur77 Signaling in T Lymphocytes	-0E00		1.72E-02	EP300	
Opioid Signaling Pathway	-0E00		8.58E-03	EP300,RRAS2	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	-0E00		1.20E-02	JUN,PIK3C2B	
Pyridoxal 5'-phosphate Salvage Pathway	-0E00		1.61E-02	PAK2	
RAR Activation	-0E00		1.69E-02	EP300,JUN,MMP1	
Relaxin Signaling	-0E00		1.44E-02	JUN,PIK3C2B	
Role of BRCA1 in DNA Damage Response	-0E00		1.33E-02	ATF1	
Salvage Pathways of Pyrimidine Ribonucleotides	-0E00		1.18E-02	PAK2	
Sperm Motility	-0E00		1.06E-02	FLT1,PDIA3	
Synaptic Long Term Depression	-0E00		1.20E-02	PDIA3,RRAS2	
White Adipose Tissue Browning Pathway	-0E00		1.68E-02	CEBPB,THRA	
Xenobiotic Metabolism CAR Signaling Pathway	-0E00		1.39E-02	EP300,GSTO1	
Xenobiotic Metabolism PXR Signaling Pathway	-0E00		1.40E-02	EP300,GSTO1	
cAMP-mediated signaling	-0E00		1.38E-02	CNR1,GPR17,STAT3	
α-Adrenergic Signaling	-0E00		1.09E-02	RRAS2	
Calcium-induced T Lymphocyte Apoptosis	2E-01		1.92E-02	EP300	
Cell Cycle Control of Chromosomal Replication	2E-01		1.92E-02	CDK16	
Eicosanoid Signaling	2E-01		1.92E-02	PTGS2	
PXR/RXR Activation	2E-01		1.92E-02	IL6	
Heparan Sulfate Biosynthesis	2.1E-01		2.00E-02	XYLT2	
MSP-RON Signaling Pathway	2.1E-01		2.00E-02	PIK3C2B	
CD27 Signaling in Lymphocytes	2.15E-01		2.04E-02	JUN	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	2.21E-01		2.08E-02	EP300	
IL-15 Production	2.26E-01		1.90E-02	FLT1,IL6	
Spliceosomal Cycle	2.26E-01		2.13E-02	ZNF830	
Phospholipases	2.32E-01		2.17E-02	PDIA3	
Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency	2.32E-01		2.17E-02	ETS2	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	2.32E-01		2.17E-02	PIK3C2B	
Ephrin A Signaling	2.38E-01		2.22E-02	PIK3C2B	
Dermatan Sulfate Biosynthesis	2.44E-01		2.27E-02	XYLT2	
Transcriptional Regulatory Network in Embryonic Stem Cells	2.44E-01		2.27E-02	STAT3	
Sumoylation Pathway	2.5E-01		2.02E-02	EP300,JUN	
PFKFB4 Signaling Pathway	2.51E-01		2.33E-02	NCOA3	
Apelin Pancreas Signaling Pathway	2.57E-01		2.38E-02	PIK3C2B	
Sirtuin Signaling Pathway	2.63E-01	0.4472135954999579	1.93E-02	JUN,MT-ND4,NDUFV2,STAT3,ZIC2	
Type I Diabetes Mellitus Signaling	2.63E-01		2.08E-02	HLA-E,IL1R1	
Chondroitin Sulfate Biosynthesis	2.64E-01		2.44E-02	XYLT2	
Neuropathic Pain Signaling In Dorsal Horn Neurons	2.67E-01		2.11E-02	PDIA3,PIK3C2B	
iCOS-iCOSL Signaling in T Helper Cells	2.67E-01		2.11E-02	NFATC3,PIK3C2B	
Nicotine Degradation II	2.71E-01		2.50E-02	CYP1B1	
Kinetochore Metaphase Signaling Pathway	2.72E-01		2.13E-02	BOD1,MACROH2A1	
NER Pathway	2.72E-01		2.13E-02	COPS2,EP300	
3-phosphoinositide Biosynthesis	2.76E-01		2.04E-02	MTMR9,PIK3C2B,TNS3	
Role of IL-17F in Allergic Inflammatory Airway Diseases	2.79E-01		2.56E-02	IL6	
SPINK1 Pancreatic Cancer Pathway	2.79E-01		2.56E-02	TGFBR2	
Stearate Biosynthesis I (Animals)	2.79E-01		2.56E-02	ACSL5	
Superpathway of Melatonin Degradation	2.79E-01		2.56E-02	CYP1B1	
ATM Signaling	2.86E-01		2.20E-02	ATF1,JUN	
Triacylglycerol Biosynthesis	2.94E-01		2.70E-02	GPAT3	
Thrombin Signaling	3.09E-01		2.09E-02	MYLK,PDIA3,PIK3C2B,RRAS2	
Allograft Rejection Signaling	3.11E-01		2.86E-02	HLA-E	
Docosahexaenoic Acid (DHA) Signaling	3.11E-01		2.86E-02	PIK3C2B	
Melatonin Degradation I	3.11E-01		2.86E-02	CYP1B1	
TWEAK Signaling	3.11E-01		2.86E-02	CASP7	
3-phosphoinositide Degradation	3.12E-01		2.17E-02	MTMR9,SYNJ2,TNS3	
Factors Promoting Cardiogenesis in Vertebrates	3.16E-01		2.19E-02	LEF1,PDIA3,TGFBR2	
Calcium Signaling	3.2E-01		2.13E-02	ASPH,EP300,NFATC3,TPM3	
Nicotine Degradation III	3.2E-01		2.94E-02	CYP1B1	
RANK Signaling in Osteoclasts	3.23E-01		2.38E-02	JUN,PIK3C2B	
Corticotropin Releasing Hormone Signaling	3.25E-01		2.22E-02	CNR1,JUN,PTGS2	
Hereditary Breast Cancer Signaling	3.3E-01		2.24E-02	EP300,PIK3C2B,RRAS2	
Airway Pathology in Chronic Obstructive Pulmonary Disease	3.35E-01		2.44E-02	IL6,MMP1	
Type II Diabetes Mellitus Signaling	3.39E-01		2.27E-02	ACSL5,CEBPB,PIK3C2B	
4-1BB Signaling in T Lymphocytes	3.39E-01		3.12E-02	JUN	
Circadian Rhythm Signaling	3.39E-01		3.12E-02	CRY1	
Interferon Signaling	3.39E-01		3.12E-02	IFNAR2	
Role of JAK2 in Hormone-like Cytokine Signaling	3.39E-01		3.12E-02	STAT3	
BMP signaling pathway	3.47E-01		2.50E-02	JUN,RRAS2	
Regulation Of The Epithelial Mesenchymal Transition In Development Pathway	3.47E-01		2.50E-02	ADAM17,LEF1	
Phagosome Maturation	3.48E-01		2.31E-02	ATP6V0E1,HLA-E,PRDX1	
Autoimmune Thyroid Disease Signaling	3.49E-01		3.23E-02	HLA-E	
Estrogen Biosynthesis	3.49E-01		3.23E-02	CYP1B1	
FGF Signaling	3.53E-01		2.53E-02	PIK3C2B,STAT3	
Role of RIG1-like Receptors in Antiviral Innate Immunity	3.59E-01		3.33E-02	EP300	
TNFR2 Signaling	3.59E-01		3.33E-02	JUN	
Triacylglycerol Degradation	3.59E-01		3.33E-02	ABHD12	
Human Embryonic Stem Cell Pluripotency	3.68E-01		2.38E-02	LEF1,PIK3C2B,TGFBR2	
Chemokine Signaling	3.8E-01		2.67E-02	JUN,RRAS2	
MIF-mediated Glucocorticoid Regulation	3.82E-01		3.57E-02	PTGS2	
Role of Cytokines in Mediating Communication between Immune Cells	3.82E-01		3.57E-02	IL6	
Superpathway of Cholesterol Biosynthesis	3.82E-01		3.57E-02	NSDHL	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	3.84E-01		2.44E-02	CASP1,IL6,PIK3C2B	
p70S6K Signaling	3.89E-01		2.46E-02	PDIA3,PIK3C2B,RRAS2	
CTLA4 Signaling in Cytotoxic T Lymphocytes	3.94E-01		2.74E-02	HLA-E,PIK3C2B	
Complement System	3.94E-01		3.70E-02	CD55	
Synaptic Long Term Potentiation	3.94E-01		2.48E-02	EP300,PDIA3,RRAS2	
Antiproliferative Role of Somatostatin Receptor 2	4.01E-01		2.78E-02	PIK3C2B,RRAS2	
Non-Small Cell Lung Cancer Signaling	4.01E-01		2.78E-02	PIK3C2B,RRAS2	
Endocannabinoid Neuronal Synapse Pathway	4.06E-01		2.52E-02	CNR1,PDIA3,PTGS2	
Estrogen-mediated S-phase Entry	4.07E-01		3.85E-02	CCNA2	
Fatty Acid β-oxidation I	4.07E-01		3.85E-02	ACSL5	
Role of p14/p19ARF in Tumor Suppression	4.07E-01		3.85E-02	PIK3C2B	
FcγRIIB Signaling in B Lymphocytes	4.08E-01		2.82E-02	PIK3C2B,RRAS2	
ERK5 Signaling	4.16E-01		2.86E-02	IL6ST,RRAS2	
Small Cell Lung Cancer Signaling	4.16E-01		2.86E-02	PIK3C2B,PTGS2	
Hematopoiesis from Pluripotent Stem Cells	4.2E-01		4.00E-02	IL6	
Glioma Invasiveness Signaling	4.23E-01		2.90E-02	PIK3C2B,RRAS2	
Toll-like Receptor Signaling	4.23E-01		2.90E-02	IRAK2,JUN	
Role of MAPK Signaling in the Pathogenesis of Influenza	4.31E-01		2.94E-02	PTGS2,RRAS2	
Acetone Degradation I (to Methylglyoxal)	4.34E-01		4.17E-02	CYP1B1	
IL-7 Signaling Pathway	4.39E-01		2.99E-02	JUN,PIK3C2B	
Growth Hormone Signaling	4.48E-01		3.03E-02	PIK3C2B,STAT3	
IL-17A Signaling in Gastric Cells	4.48E-01		4.35E-02	JUN	
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	4.48E-01		4.35E-02	GPAT3	
Hepatic Cholestasis	4.49E-01		2.52E-02	IL1R1,IL6,IRAK2,JUN	
Crosstalk between Dendritic Cells and Natural Killer Cells	4.56E-01		3.08E-02	HLA-E,IL6	
CXCR4 Signaling	4.59E-01	-1.0	2.55E-02	JUN,PAK2,PIK3C2B,RRAS2	
Cholecystokinin/Gastrin-mediated Signaling	4.6E-01		2.73E-02	JUN,PTGS2,RRAS2	
IL-22 Signaling	4.64E-01		4.55E-02	STAT3	
Glioblastoma Multiforme Signaling	4.65E-01	-2.0	2.56E-02	LEF1,PDIA3,PIK3C2B,RRAS2	
GP6 Signaling Pathway	4.67E-01		2.75E-02	COL4A1,LAMC2,PIK3C2B	
AMPK Signaling	4.67E-01	-1.3416407864998738	2.46E-02	CCNA2,EP300,PIK3C2B,RAB1A,RAB27A	
Role of NFAT in Regulation of the Immune Response	4.7E-01	-1.0	2.58E-02	JUN,NFATC3,PIK3C2B,RRAS2	
CDP-diacylglycerol Biosynthesis I	4.8E-01		4.76E-02	GPAT3	
Glutathione-mediated Detoxification	4.8E-01		4.76E-02	GSTO1	
Polyamine Regulation in Colon Cancer	4.8E-01		4.76E-02	OAZ1	
TCA Cycle II (Eukaryotic)	4.8E-01		4.76E-02	IDH3A	
Fc Epsilon RI Signaling	4.94E-01		2.86E-02	PIK3C2B,RRAS2,SYNJ2	
Bupropion Degradation	4.97E-01		5.00E-02	CYP1B1	
Endoplasmic Reticulum Stress Pathway	4.97E-01		5.00E-02	CASP7	
Communication between Innate and Adaptive Immune Cells	5.02E-01		3.33E-02	HLA-E,IL6	
Oxidative Phosphorylation	5.16E-01		2.94E-02	MT-CO2,MT-ND4,NDUFV2	
Erythropoietin Signaling Pathway	5.23E-01	0.0	2.74E-02	IL6,JUN,PIK3C2B,RRAS2	
Telomerase Signaling	5.23E-01		2.97E-02	ETS2,PIK3C2B,RRAS2	
PCP pathway	5.32E-01		3.51E-02	JUN,PRICKLE1	
1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)	5.35E-01		5.56E-02	SYNJ2	
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis	5.35E-01		5.56E-02	SYNJ2	
eNOS Signaling	5.42E-01		2.80E-02	CCNA2,FLT1,PGF,PIK3C2B	
Semaphorin Signaling in Neurons	5.42E-01		3.57E-02	ITGB1,PAK2	
Wnt/Ca+ pathway	5.42E-01		3.57E-02	NFATC3,PDIA3	
FAT10 Signaling Pathway	5.56E-01		5.88E-02	UBE2Z	
Fatty Acid α-oxidation	5.56E-01		5.88E-02	PTGS2	
Lipid Antigen Presentation by CD1	5.56E-01		5.88E-02	PDIA3	
Apoptosis Signaling	5.62E-01		3.12E-02	CASP2,CASP7,RRAS2	
Unfolded protein response	5.75E-01		3.77E-02	CEBPB,SEL1L	
Huntington's Disease Signaling	5.77E-01	1.3416407864998738	2.63E-02	CASP1,CASP2,CASP7,EP300,JUN,PIK3C2B	
Phospholipase C Signaling	5.82E-01	-1.3416407864998738	2.64E-02	EP300,ITGA2,ITGA6,ITGB1,NFATC3,RRAS2	
UVC-Induced MAPK Signaling	5.99E-01		3.92E-02	JUN,RRAS2	
Dermatan Sulfate Degradation (Metazoa)	6.03E-01		6.67E-02	CEMIP2	
Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F	6.03E-01		6.67E-02	IL6	
RAN Signaling	6.03E-01		6.67E-02	KPNA5	
Adrenomedullin signaling pathway	6.04E-01	-2.0	2.81E-02	CEBPB,MYLK,PDIA3,PIK3C2B,RRAS2	
Melanocyte Development and Pigmentation Signaling	6.05E-01		3.30E-02	EP300,PIK3C2B,RRAS2	
Superpathway of Inositol Phosphate Compounds	6.1E-01	-1.3416407864998738	2.82E-02	MTMR9,PIK3C2B,PPIP5K2,SYNJ2,TNS3	
PKCθ Signaling in T Lymphocytes	6.1E-01	-1.0	3.01E-02	JUN,NFATC3,PIK3C2B,RRAS2	
IL-1 Signaling	6.14E-01		3.33E-02	IL1R1,IRAK2,JUN	
Insulin Receptor Signaling	6.18E-01	-1.0	3.03E-02	PIK3C2B,RAPGEF1,RRAS2,SYNJ2	
LPS/IL-1 Mediated Inhibition of RXR Function	6.23E-01		2.86E-02	ABCG1,ACSL5,GSTO1,IL1R1,JUN	
Apelin Cardiomyocyte Signaling Pathway	6.23E-01		3.37E-02	MYLK,PDIA3,PIK3C2B	
Nitric Oxide Signaling in the Cardiovascular System	6.23E-01		3.37E-02	FLT1,PGF,PIK3C2B	
PD-1, PD-L1 cancer immunotherapy pathway	6.23E-01		3.37E-02	HLA-E,LATS2,PIK3C2B	
Maturity Onset Diabetes of Young (MODY) Signaling	6.24E-01		4.08E-02	APOL3,EP300	
Melanoma Signaling	6.24E-01		4.08E-02	PIK3C2B,RRAS2	
Necroptosis Signaling Pathway	6.25E-01	-2.0	3.05E-02	CASP1,CFLAR,FKBP1A,TNFRSF10B	
Chondroitin Sulfate Degradation (Metazoa)	6.29E-01		7.14E-02	CEMIP2	
Mitochondrial L-carnitine Shuttle Pathway	6.29E-01		7.14E-02	ACSL5	
γ-linolenate Biosynthesis II (Animals)	6.29E-01		7.14E-02	ACSL5	
Prostate Cancer Signaling	6.32E-01		3.41E-02	LEF1,PIK3C2B,RRAS2	
Activation of IRF by Cytosolic Pattern Recognition Receptors	6.37E-01		4.17E-02	IL6,JUN	
UVB-Induced MAPK Signaling	6.37E-01		4.17E-02	JUN,PIK3C2B	
Antioxidant Action of Vitamin C	6.42E-01		3.45E-02	GSTO1,PDIA3,TXNRD1	
CREB Signaling in Neurons	6.57E-01	-1.7320508075688774	2.42E-02	ADGRF5,ADGRL4,CNR1,EDNRB,EP300,FLT1,GPR17,GPR19,GPR4,PDIA3,PIK3C2B,RRAS2,TGFBR2	
Cholesterol Biosynthesis I	6.57E-01		7.69E-02	NSDHL	
Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol)	6.57E-01		7.69E-02	NSDHL	
Cholesterol Biosynthesis III (via Desmosterol)	6.57E-01		7.69E-02	NSDHL	
Protein Kinase A Signaling	6.6E-01	-1.1338934190276817	2.58E-02	ATF1,DUSP3,LEF1,MYLK,NFATC3,PDIA3,PTGS2,PTPRE,TGFBR2	
Bladder Cancer Signaling	6.61E-01		3.53E-02	MMP1,PGF,RRAS2	
Ceramide Signaling	6.61E-01		3.53E-02	JUN,PIK3C2B,RRAS2	
iNOS Signaling	6.78E-01		4.44E-02	IRAK2,JUN	
Gαi Signaling	6.8E-01	0.0	3.23E-02	CNR1,GPR17,RRAS2,STAT3	
Granzyme A Signaling	6.88E-01		8.33E-02	EP300	
Wnt/β-catenin Signaling	6.9E-01	1.0	3.03E-02	CDH5,EP300,JUN,LEF1,TGFBR2	
HIPPO signaling	6.92E-01		3.66E-02	LATS2,MOB1A,WWTR1	
OX40 Signaling Pathway	6.93E-01		4.55E-02	HLA-E,JUN	
Breast Cancer Regulation by Stathmin1	6.95E-01	-0.2773500981126146	2.47E-02	ADGRF5,ADGRL4,CNR1,EDNRB,GPR17,GPR19,GPR4,JUN,PGF,PIK3C2B,RRAS2,STAT3,STMN1	
B Cell Receptor Signaling	7.04E-01	-0.4472135954999579	3.07E-02	JUN,NFATC3,PIK3C2B,RRAS2,SYNJ2	
Gα12/13 Signaling	7.05E-01	0.0	3.31E-02	CDH5,JUN,PIK3C2B,RRAS2	
P2Y Purigenic Receptor Signaling Pathway	7.13E-01	-1.0	3.33E-02	JUN,PDIA3,PIK3C2B,RRAS2	
UDP-N-acetyl-D-galactosamine Biosynthesis II	7.22E-01		9.09E-02	PGM3	
Retinoic acid Mediated Apoptosis Signaling	7.24E-01		4.76E-02	CFLAR,TNFRSF10B	
Protein Ubiquitination Pathway	7.28E-01		2.85E-02	HLA-E,PSMB4,UBE2H,UBE2J1,UBE2K,UBE2Z,USP53	
FLT3 Signaling in Hematopoietic Progenitor Cells	7.35E-01		3.85E-02	PIK3C2B,RRAS2,STAT3	
IL-23 Signaling Pathway	7.4E-01		4.88E-02	PIK3C2B,STAT3	
14-3-3-mediated Signaling	7.4E-01	-1.0	3.42E-02	JUN,PDIA3,PIK3C2B,RRAS2	
Tight Junction Signaling	7.49E-01		3.18E-02	CLDN5,JUN,MAGI2,MYLK,TGFBR2	
B Cell Activating Factor Signaling	7.56E-01		5.00E-02	JUN,NFATC3	
Extrinsic Prothrombin Activation Pathway	7.59E-01		1.00E-01	TFPI	
Fatty Acid Activation	7.59E-01		1.00E-01	ACSL5	
Glycogen Degradation III	7.59E-01		1.00E-01	PGM3	
Prostanoid Biosynthesis	7.59E-01		1.00E-01	PTGS2	
Macropinocytosis Signaling	7.7E-01		4.00E-02	ITGB1,PIK3C2B,RRAS2	
April Mediated Signaling	7.73E-01		5.13E-02	JUN,NFATC3	
CCR3 Signaling in Eosinophils	7.77E-01		3.54E-02	MYLK,PAK2,PIK3C2B,RRAS2	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	7.77E-01	-2.0	3.54E-02	IL6ST,PIK3C2B,RRAS2,STAT3	
Th2 Pathway	7.77E-01		3.54E-02	ICAM1,JUN,PIK3C2B,TGFBR2	
GDNF Family Ligand-Receptor Interactions	7.82E-01		4.05E-02	JUN,PIK3C2B,RRAS2	
Neurotrophin/TRK Signaling	7.82E-01		4.05E-02	JUN,PIK3C2B,RRAS2	
Endocannabinoid Developing Neuron Pathway	7.87E-01	-1.0	3.57E-02	CNR1,PIK3C2B,RRAS2,STAT3	
Glycogen Degradation II	8.01E-01		1.11E-01	PGM3	
Angiopoietin Signaling	8.06E-01		4.17E-02	PAK2,PIK3C2B,RRAS2	
IL-15 Signaling	8.06E-01		4.17E-02	PIK3C2B,RRAS2,STAT3	
Xenobiotic Metabolism Signaling	8.1E-01		3.00E-02	CYP1B1,EP300,FTL,GSTO1,IL6,PIK3C2B,RRAS2	
Role of PKR in Interferon Induction and Antiviral Response	8.27E-01	-1.0	3.70E-02	CASP1,IFNAR2,JUN,STAT3	
MIF Regulation of Innate Immunity	8.28E-01		5.56E-02	JUN,PTGS2	
IL-12 Signaling and Production in Macrophages	8.47E-01		3.77E-02	CEBPB,EP300,JUN,PIK3C2B	
Glucose and Glucose-1-phosphate Degradation	8.48E-01		1.25E-01	PGM3	
γ-glutamyl Cycle	8.48E-01		1.25E-01	GCLM	
Estrogen-Dependent Breast Cancer Signaling	8.59E-01		4.41E-02	JUN,PIK3C2B,RRAS2	
GM-CSF Signaling	8.59E-01		4.41E-02	PIK3C2B,RRAS2,STAT3	
Leptin Signaling in Obesity	8.59E-01		4.41E-02	PDIA3,PIK3C2B,STAT3	
Regulation of the Epithelial-Mesenchymal Transition Pathway	8.62E-01		3.26E-02	ADAM17,LEF1,PIK3C2B,RRAS2,STAT3,TGFBR2	
CDK5 Signaling	8.69E-01		3.85E-02	ITGA2,ITGA6,ITGB1,RRAS2	
Cardiac Hypertrophy Signaling	8.86E-01	-1.1338934190276817	3.15E-02	EP300,IL6,JUN,PDIA3,PIK3C2B,RRAS2,TGFBR2	
Role of JAK1 and JAK3 in γc Cytokine Signaling	8.87E-01		4.55E-02	PIK3C2B,RRAS2,STAT3	
ErbB4 Signaling	9.01E-01		4.62E-02	ADAM17,PIK3C2B,RRAS2	
GDP-glucose Biosynthesis	9.02E-01		1.43E-01	PGM3	
Glycoaminoglycan-protein Linkage Region Biosynthesis	9.02E-01		1.43E-01	XYLT2	
Inositol Pyrophosphates Biosynthesis	9.02E-01		1.43E-01	PPIP5K2	
Dendritic Cell Maturation	9.04E-01	-2.0	3.60E-02	HLA-E,ICAM1,IL6,PDIA3,PIK3C2B	
IL-9 Signaling	9.11E-01		6.25E-02	PIK3C2B,STAT3	
Inhibition of Angiogenesis by TSP1	9.11E-01		6.25E-02	JUN,TGFBR2	
Chronic Myeloid Leukemia Signaling	9.14E-01		4.00E-02	MECOM,PIK3C2B,RRAS2,TGFBR2	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	9.31E-01		4.76E-02	IL6,JUN,PTGS2	
Antiproliferative Role of TOB in T Cell Signaling	9.34E-01		6.45E-02	CCNA2,TGFBR2	
Inhibition of Matrix Metalloproteases	9.34E-01		6.45E-02	ADAM17,MMP1	
Synaptogenesis Signaling Pathway	9.35E-01	-2.3333333333333335	3.01E-02	ACTR2,ACTR3,ARPC1B,ARPC3,CDH5,EIF4EBP2,PIK3C2B,RAPGEF1,RRAS2	
Antigen Presentation Pathway	9.58E-01		6.67E-02	HLA-E,PDIA3	
Graft-versus-Host Disease Signaling	9.58E-01		6.67E-02	HLA-E,IL6	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	9.61E-01	-1.0	4.17E-02	ATP6V0E1,JUN,PTGS2,RRAS2	
Ovarian Cancer Signaling	9.63E-01		3.76E-02	LEF1,PGF,PIK3C2B,PTGS2,RRAS2	
Ceramide Biosynthesis	9.65E-01		1.67E-01	KDSR	
Thioredoxin Pathway	9.65E-01		1.67E-01	TXNRD1	
Zymosterol Biosynthesis	9.65E-01		1.67E-01	NSDHL	
SAPK/JNK Signaling	9.73E-01	0.0	4.21E-02	JUN,NFATC3,PIK3C2B,RRAS2	
VEGF Signaling	9.73E-01	-2.0	4.21E-02	FLT1,PGF,PIK3C2B,RRAS2	
IL-2 Signaling	9.78E-01		5.00E-02	JUN,PIK3C2B,RRAS2	
Endometrial Cancer Signaling	9.95E-01		5.08E-02	LEF1,PIK3C2B,RRAS2	
Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza	9.95E-01		5.08E-02	LEF1,NCOA3,SIAH1	
Amyotrophic Lateral Sclerosis Signaling	1.01E00	-2.0	4.35E-02	CASP1,CASP7,PGF,PIK3C2B	
UVA-Induced MAPK Signaling	1.01E00		4.35E-02	JUN,PDIA3,PIK3C2B,RRAS2	
Cancer Drug Resistance By Drug Efflux	1.01E00		5.17E-02	ABCG2,PTGS2,RRAS2	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	1.01E00		5.17E-02	CASP1,IFNAR2,IL6	
Death Receptor Signaling	1.02E00	-1.0	4.40E-02	CASP2,CASP7,CFLAR,TNFRSF10B	
LXR/RXR Activation	1.02E00	2.0	4.40E-02	ABCG1,IL1R1,IL6,PTGS2	
T Cell Receptor Signaling	1.02E00		4.40E-02	JUN,NFATC3,PIK3C2B,RRAS2	
IL-17A Signaling in Airway Cells	1.03E00		5.26E-02	IL6,PIK3C2B,STAT3	
PI3K Signaling in B Lymphocytes	1.04E00	-0.4472135954999579	3.97E-02	ATF1,JUN,NFATC3,PDIA3,RRAS2	
ErbB Signaling	1.04E00	-1.0	4.44E-02	JUN,PAK2,PIK3C2B,RRAS2	
Glycogen Biosynthesis II (from UDP-D-Glucose)	1.04E00		2.00E-01	GBE1	
Myo-inositol Biosynthesis	1.04E00		2.00E-01	BPNT2	
Pentose Phosphate Pathway (Non-oxidative Branch)	1.04E00		2.00E-01	RPE	
UDP-N-acetyl-D-glucosamine Biosynthesis II	1.04E00		2.00E-01	PGM3	
Role of NFAT in Cardiac Hypertrophy	1.04E00	-1.889822365046136	3.47E-02	EP300,IL6,IL6ST,PDIA3,PIK3C2B,RRAS2,TGFBR2	
Natural Killer Cell Signaling	1.05E00	-1.6329931618554523	3.70E-02	HLA-E,ITGB1,NFATC3,PAK2,PIK3C2B,RRAS2	
Iron homeostasis signaling pathway	1.06E00		4.03E-02	ATP6V0E1,FTL,IL6,IREB2,STAT3	
Coagulation System	1.06E00		7.69E-02	SERPINE1,TFPI	
Acute Myeloid Leukemia Signaling	1.08E00	-2.0	4.60E-02	LEF1,PIK3C2B,RRAS2,STAT3	
EGF Signaling	1.08E00		5.56E-02	JUN,PIK3C2B,STAT3	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	1.09E00		8.00E-02	CASP7,HLA-E	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	1.12E00		4.76E-02	JUN,NFATC3,RRAS2,TGFBR2	
Arsenate Detoxification I (Glutaredoxin)	1.13E00		2.50E-01	GSTO1	
Pentose Phosphate Pathway (Oxidative Branch)	1.13E00		2.50E-01	PGD	
Role of IL-17A in Arthritis	1.14E00		5.88E-02	MMP1,PIK3C2B,PTGS2	
LPS-stimulated MAPK Signaling	1.15E00	0.0	4.88E-02	ATF1,JUN,PIK3C2B,RRAS2	
Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism	1.16E00		8.70E-02	BPNT2,SYNJ2	
Xenobiotic Metabolism General Signaling Pathway	1.16E00	-1.3416407864998738	4.31E-02	EP300,FTL,GSTO1,PIK3C2B,RRAS2	
Insulin Secretion Signaling Pathway	1.16E00	-1.414213562373095	3.51E-02	EIF4EBP2,EIF4G2,PDIA3,PIK3C2B,SEC11A,SPCS2,SSR1,STAT3	
Lymphotoxin β Receptor Signaling	1.16E00		6.00E-02	EP300,PIK3C2B,VCAM1	
Renin-Angiotensin Signaling	1.18E00	-1.0	4.39E-02	JUN,PAK2,PIK3C2B,RRAS2,STAT3	
Myc Mediated Apoptosis Signaling	1.18E00		6.12E-02	CASP2,CFLAR,PMAIP1	
PEDF Signaling	1.18E00	-1.0	5.00E-02	CASP7,CFLAR,PIK3C2B,RRAS2	
TR/RXR Activation	1.18E00		5.00E-02	EP300,NCOA3,PIK3C2B,THRA	
Apelin Cardiac Fibroblast Signaling Pathway	1.19E00		9.09E-02	IL6,SERPINE1	
Apelin Endothelial Signaling Pathway	1.21E00	-1.3416407864998738	4.46E-02	ICAM1,JUN,PIK3C2B,RRAS2,VCAM1	
Estrogen Receptor Signaling	1.23E00	-1.2649110640673518	3.34E-02	CCNC,EP300,HES1,JUN,MMP1,NCOA3,PDIA3,PGF,PIK3C2B,RRAS2	
IL-4 Signaling	1.23E00		5.19E-02	NFATC3,PIK3C2B,RRAS2,SYNJ2	
FAT10 Cancer Signaling Pathway	1.25E00		6.52E-02	IL6,STAT3,TGFBR2	
Thyroid Cancer Signaling	1.25E00	-1.0	5.26E-02	JUN,LEF1,PIK3C2B,RRAS2	
Glutathione Biosynthesis	1.25E00		3.33E-01	GCLM	
HOTAIR Regulatory Pathway	1.26E00	-1.6329931618554523	4.20E-02	EP300,ICAM1,LEF1,MMP1,PIK3C2B,STAT3	
Role of Tissue Factor in Cancer	1.29E00		4.72E-02	ITGA6,ITGB1,MMP1,PIK3C2B,RRAS2	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	1.31E00		1.05E-01	IFNAR2,STAT3	
Pancreatic Adenocarcinoma Signaling	1.31E00	-2.0	4.76E-02	PGF,PIK3C2B,PTGS2,STAT3,TGFBR2	
Sphingosine-1-phosphate Signaling	1.31E00	0.4472135954999579	4.76E-02	CASP1,CASP2,CASP7,PDIA3,PIK3C2B	
Sertoli Cell-Sertoli Cell Junction Signaling	1.32E00		4.02E-02	CLDN5,ITGA2,ITGA6,ITGB1,JUN,MAGI2,RRAS2	
Vitamin-C Transport	1.35E00		1.11E-01	GSTO1,TXNRD1	
IGF-1 Signaling	1.35E00	-1.0	4.90E-02	IGFBP7,JUN,PIK3C2B,RRAS2,STAT3	
p38 MAPK Signaling	1.35E00	-1.3416407864998738	4.90E-02	ATF1,IL1R1,IRAK2,TGFBR2,TIFA	
Mouse Embryonic Stem Cell Pluripotency	1.38E00	-2.23606797749979	5.00E-02	IL6ST,LEF1,PIK3C2B,RRAS2,STAT3	
Neuregulin Signaling	1.38E00		5.00E-02	ADAM17,ITGA2,ITGA6,ITGB1,RRAS2	
EIF2 Signaling	1.39E00		3.92E-02	EIF3I,EIF4G2,PIK3C2B,RPL37,RPS16,RPS21,RPS3,RRAS2	
D-myo-inositol (1,4,5)-trisphosphate Degradation	1.39E00		1.18E-01	BPNT2,SYNJ2	
Inflammasome pathway	1.39E00		1.18E-01	CASP1,PANX1	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	1.41E00		3.96E-02	ADAM17,IL1R1,IL6,JUN,LEF1,MMP1,NFATC3,PIK3C2B	
Ascorbate Recycling (Cytosolic)	1.43E00		5.00E-01	GSTO1	
Atherosclerosis Signaling	1.43E00		5.15E-02	ICAM1,IL6,MMP1,SELE,VCAM1	
PPAR Signaling	1.43E00	1.3416407864998738	5.15E-02	EP300,IL1R1,JUN,PTGS2,RRAS2	
NF-κB Signaling	1.45E00	-1.1338934190276817	4.29E-02	AZI2,EP300,FLT1,IL1R1,PIK3C2B,RRAS2,TGFBR2	
p53 Signaling	1.45E00	-0.4472135954999579	5.21E-02	EP300,JUN,PIK3C2B,PMAIP1,TNFRSF10B	
STAT3 Pathway	1.45E00	-2.0	4.69E-02	FLT1,IL1R1,IL6ST,RRAS2,STAT3,TGFBR2	
Semaphorin Neuronal Repulsive Signaling Pathway	1.47E00	0.8164965809277261	4.72E-02	ITGA2,ITGA6,ITGB1,NRP2,PAK2,PIK3C2B	
MSP-RON Signaling In Macrophages Pathway	1.48E00	-0.4472135954999579	5.32E-02	JUN,PIK3C2B,PTGS2,RRAS2,STAT3	
TGF-β Signaling	1.51E00	-0.4472135954999579	5.43E-02	EP300,JUN,RRAS2,SERPINE1,TGFBR2	
Notch Signaling	1.52E00		8.33E-02	ADAM17,HES1,HES5	
Systemic Lupus Erythematosus In B Cell Signaling Pathway	1.52E00	-1.6666666666666667	3.95E-02	IFNAR2,IL6,IL6ST,JUN,NFATC3,PIK3C2B,RRAS2,STAT3,SYNJ2	
ErbB2-ErbB3 Signaling	1.52E00		6.45E-02	JUN,PIK3C2B,RRAS2,STAT3	
IL-10 Signaling	1.52E00		6.45E-02	IL1R1,IL6,JUN,STAT3	
Thrombopoietin Signaling	1.52E00	-1.0	6.45E-02	JUN,PIK3C2B,RRAS2,STAT3	
Tec Kinase Signaling	1.56E00	-2.4494897427831783	4.55E-02	ITGA2,ITGA6,ITGB1,PAK2,PIK3C2B,STAT3,TNFRSF10B	
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	1.59E00	-2.23606797749979	5.68E-02	ACTR2,ACTR3,ARPC1B,ARPC3,EZR	
T Helper Cell Differentiation	1.62E00		6.90E-02	IL6,IL6ST,STAT3,TGFBR2	
Senescence Pathway	1.62E00	-1.8973665961010275	3.92E-02	CEBPB,EP300,ETS2,IL6,JUN,NFATC3,PIK3C2B,RRAS2,SERPINE1,TGFBR2	
SPINK1 General Cancer Pathway	1.64E00	-2.0	7.02E-02	IL6,PIK3C2B,RRAS2,STAT3	
PDGF Signaling	1.68E00	-1.3416407864998738	6.02E-02	JUN,PIK3C2B,RRAS2,STAT3,SYNJ2	
CNTF Signaling	1.69E00	-2.0	7.27E-02	IL6ST,PIK3C2B,RRAS2,STAT3	
ILK Signaling	1.71E00	-1.414213562373095	4.52E-02	FN1,ITGB1,JUN,LEF1,NACA,PGF,PIK3C2B,PTGS2	
Clathrin-mediated Endocytosis Signaling	1.73E00		4.57E-02	ACTR2,ACTR3,ARPC1B,ARPC3,DAB2,ITGB1,PGF,PIK3C2B	
PPARα/RXRα Activation	1.73E00	1.1338934190276817	4.57E-02	EP300,IL1R1,IL6,JUN,NCOA3,PDIA3,RRAS2,TGFBR2	
PI3K/AKT Signaling	1.77E00	-1.3416407864998738	4.65E-02	IL1R1,IL6ST,ITGA2,ITGA6,ITGB1,PTGS2,RRAS2,SYNJ2	
Endocannabinoid Cancer Inhibition Pathway	1.81E00	0.3779644730092272	5.11E-02	CASP1,CASP2,CASP7,CNR1,LEF1,PGF,PIK3C2B	
VEGF Family Ligand-Receptor Interactions	1.81E00	-2.0	6.49E-02	FLT1,NRP2,PGF,PIK3C2B,RRAS2	
Phagosome Formation	1.83E00		5.71E-02	FN1,ITGA2,ITGA6,ITGB1,PDIA3,PIK3C2B	
BEX2 Signaling Pathway	1.84E00	-1.3416407864998738	6.58E-02	JUN,LEF1,PGF,STAT3,SWAP70	
IL-3 Signaling	1.86E00	-1.3416407864998738	6.67E-02	JUN,PIK3C2B,RAPGEF1,RRAS2,STAT3	
NF-κB Activation by Viruses	1.86E00	-2.23606797749979	6.67E-02	ITGA2,ITGA6,ITGB1,PIK3C2B,RRAS2	
TNFR1 Signaling	1.86E00	-1.0	8.16E-02	CASP2,CASP7,JUN,PAK2	
Paxillin Signaling	1.87E00	-2.23606797749979	5.83E-02	ITGA2,ITGA6,ITGB1,PAK2,PIK3C2B,RRAS2	
Aryl Hydrocarbon Receptor Signaling	1.89E00	0.4472135954999579	5.30E-02	CCNA2,CYP1B1,EP300,GSTO1,IL6,JUN,NCOA3	
mTOR Signaling	1.91E00		4.62E-02	EIF3I,EIF4G2,FKBP1A,PGF,PIK3C2B,RPS16,RPS21,RPS3,RRAS2	
Pentose Phosphate Pathway	1.93E00		2.22E-01	PGD,RPE	
Cardiac Hypertrophy Signaling (Enhanced)	1.93E00	-3.2071349029490928	3.57E-02	EDNRB,EP300,IL1R1,IL6,IL6ST,ITGA2,ITGA6,ITGB1,JUN,NFATC3,PDIA3,PIK3C2B,PTGS2,RRAS2,STAT3,TGFBR2	
FAK Signaling	1.95E00		6.06E-02	ITGA2,ITGA6,ITGB1,PAK2,PIK3C2B,RRAS2	
Virus Entry via Endocytic Pathways	1.95E00		6.06E-02	CD55,HLA-E,ITGA2,ITGB1,PIK3C2B,RRAS2	
Th1 Pathway	1.97E00	-1.0	6.12E-02	ICAM1,IL6,NFATC3,NFIL3,PIK3C2B,STAT3	
Caveolar-mediated Endocytosis Signaling	1.98E00		7.14E-02	CD55,HLA-E,ITGA2,ITGA6,ITGB1	
Germ Cell-Sertoli Cell Junction Signaling	1.99E00		5.10E-02	IQGAP1,ITGA2,ITGA6,ITGB1,PAK2,PIK3C2B,RRAS2,TGFBR2	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.99E00		1.25E-01	IL6,IL6ST,STAT3	
Xenobiotic Metabolism AHR Signaling Pathway	2.03E00	-1.3416407864998738	7.35E-02	ABCG2,CYP1B1,EP300,GSTO1,IL6	
Systemic Lupus Erythematosus Signaling	2.06E00		5.23E-02	HLA-E,HNRNPC,IL6,JUN,LSM12,NFATC3,PIK3C2B,RRAS2	
Agrin Interactions at Neuromuscular Junction	2.06E00	-1.0	7.46E-02	ITGB1,JUN,PAK2,RRAS2,UTRN	
HER-2 Signaling in Breast Cancer	2.1E00	-1.0	4.95E-02	CASP7,ETS2,ITGB1,JUN,MT-CO2,PIK3C2B,PTGS2,RRAS2,STAT3	
Oncostatin M Signaling	2.13E00	-2.0	9.76E-02	IL6ST,MMP1,RRAS2,STAT3	
Tumoricidal Function of Hepatic Natural Killer Cells	2.16E00		1.43E-01	CASP7,ICAM1,SRGN	
Regulation Of The Epithelial Mesenchymal Transition By Growth Factors Pathway	2.16E00	-1.6666666666666667	5.06E-02	IL6,JUN,LATS2,MMP1,PIK3C2B,RRAS2,STAT3,TGFBR2,WWTR1	
Remodeling of Epithelial Adherens Junctions	2.17E00	-2.23606797749979	7.94E-02	ACTR2,ACTR3,ARPC1B,ARPC3,IQGAP1	
Molecular Mechanisms of Cancer	2.23E00		3.96E-02	CASP7,CDK16,CFLAR,EP300,ITGA2,ITGA6,ITGB1,JUN,LEF1,PAK2,PIK3C2B,PMAIP1,RAPGEF1,RRAS2,TGFBR2	
fMLP Signaling in Neutrophils	2.24E00	-2.6457513110645903	6.19E-02	ACTR2,ACTR3,ARPC1B,ARPC3,NFATC3,PIK3C2B,RRAS2	
Th1 and Th2 Activation Pathway	2.24E00		5.63E-02	ICAM1,IL6,JUN,NFATC3,NFIL3,PIK3C2B,STAT3,TGFBR2	
TREM1 Signaling	2.26E00	-2.23606797749979	8.33E-02	CASP1,ICAM1,IL6,ITGB1,STAT3	
Systemic Lupus Erythematosus In T Cell Signaling Pathway	2.34E00	-0.6324555320336759	5.05E-02	CASP1,CASP2,CASP7,EZR,HLA-E,IL6,JUN,PIK3C2B,RRAS2,STAT3	
Axonal Guidance Signaling	2.35E00		3.86E-02	ACTR2,ACTR3,ADAM17,ADAM19,ARPC1B,ARPC3,ITGA2,ITGA6,ITGB1,MMP1,NFATC3,NRP2,PAK2,PDIA3,PGF,PIK3C2B,RRAS2	
IL-17 Signaling	2.38E00	-2.1213203435596424	5.93E-02	CEBPB,IL6,JUN,PGF,PIK3C2B,PTGS2,RRAS2,SRSF1	
Prolactin Signaling	2.39E00	-1.0	7.50E-02	CEBPB,EP300,JUN,PIK3C2B,RRAS2,STAT3	
Endothelin-1 Signaling	2.39E00	-2.3333333333333335	5.49E-02	CASP1,CASP2,CASP7,EDNRB,JUN,PDIA3,PIK3C2B,PTGS2,RRAS2	
Th17 Activation Pathway	2.42E00	-2.23606797749979	9.09E-02	IL1R1,IL6,IRAK2,NFATC3,STAT3	
IL-17A Signaling in Fibroblasts	2.43E00		1.18E-01	CEBPB,IL6,JUN,MMP1	
PTEN Signaling	2.44E00	1.1338934190276817	6.06E-02	FLT1,ITGA2,ITGA6,ITGB1,MAGI2,RRAS2,SYNJ2,TGFBR2	
JAK/Stat Signaling	2.44E00	-1.6329931618554523	7.69E-02	CEBPB,IL6,JUN,PIK3C2B,RRAS2,STAT3	
Renal Cell Carcinoma Signaling	2.47E00	-1.3416407864998738	7.79E-02	EP300,JUN,PAK2,PIK3C2B,RAPGEF1,RRAS2	
CD28 Signaling in T Helper Cells	2.49E00	-1.889822365046136	6.86E-02	ACTR2,ACTR3,ARPC1B,ARPC3,JUN,NFATC3,PIK3C2B	
HIF1α Signaling	2.5E00	-1.8973665961010275	5.32E-02	EP300,FLT1,IL6,JUN,MMP1,PGF,PIK3C2B,RRAS2,SERPINE1,STAT3	
PAK Signaling	2.54E00	-1.6329931618554523	7.00E-02	ITGA2,ITGA6,ITGB1,MYLK,PAK2,PIK3C2B,RRAS2	
VDR/RXR Activation	2.56E00	0.0	8.11E-02	CCNC,CEBPB,EP300,HES1,NCOA3,SERPINB1	
ERK/MAPK Signaling	2.57E00	-2.3333333333333335	5.43E-02	ATF1,ETS2,ITGA2,ITGA6,ITGB1,PAK2,PIK3C2B,RAPGEF1,RRAS2,STAT3	
Hypoxia Signaling in the Cardiovascular System	2.65E00		8.45E-02	EP300,JUN,UBE2H,UBE2J1,UBE2K,UBE2Z	
Glutathione Redox Reactions II	2.68E00		5.00E-01	PDIA3,TXNDC12	
Regulation of Cellular Mechanics by Calpain Protease	2.68E00	-2.0	8.57E-02	CCNA2,EZR,ITGA2,ITGA6,ITGB1,RRAS2	
IL-6 Signaling	2.71E00	-2.1213203435596424	6.72E-02	CEBPB,IL1R1,IL6,IL6ST,JUN,PIK3C2B,RRAS2,STAT3	
NRF2-mediated Oxidative Stress Response	2.74E00	-1.414213562373095	5.75E-02	EP300,FTL,GCLM,GSTO1,JUN,PIK3C2B,PRDX1,RRAS2,TXNRD1,UBE2K	
Colorectal Cancer Metastasis Signaling	2.76E00	-2.7136021011998728	5.13E-02	IL6,IL6ST,JUN,LEF1,MMP1,PGF,PIK3C2B,PTGS2,RRAS2,SIAH1,STAT3,TGFBR2	
HMGB1 Signaling	2.77E00	-1.414213562373095	6.25E-02	ICAM1,IL1R1,IL6,JUN,PIK3C2B,RRAS2,SELE,SERPINE1,VCAM1	
Reelin Signaling in Neurons	2.79E00	-2.1213203435596424	6.90E-02	ACTR2,ACTR3,ARPC1B,ARPC3,CNR1,ITGB1,PIK3C2B,RAPGEF1	
Neuroinflammation Signaling Pathway	2.82E00	-1.7320508075688774	4.96E-02	CASP1,CFLAR,HLA-E,ICAM1,IL1R1,IL6,IRAK2,JUN,NFATC3,PIK3C2B,PTGS2,TGFBR2,VCAM1	
CD40 Signaling	2.92E00	-0.4472135954999579	9.52E-02	ATF1,ICAM1,JUN,PIK3C2B,PTGS2,STAT3	
T Cell Exhaustion Signaling Pathway	2.92E00	-1.889822365046136	6.57E-02	HLA-E,IFNAR2,IL6,JUN,NFATC3,PIK3C2B,RRAS2,STAT3,TGFBR2	
Glucocorticoid Receptor Signaling	2.98E00		4.44E-02	EP300,ICAM1,IL1R1,IL6,IL6ST,JUN,MMP1,NCOA3,NFATC3,PIK3C2B,PTGS2,RRAS2,SELE,SERPINE1,STAT3,TGFBR2,VCAM1	
Acute Phase Response Signaling	3.15E00	-2.5298221281347035	6.49E-02	CEBPB,FN1,FTL,IL1R1,IL6,IL6ST,JUN,RRAS2,SERPINE1,STAT3	
MSP-RON Signaling In Cancer Cells Pathway	3.23E00	-1.6666666666666667	7.26E-02	ETS2,ITGA6,ITGB1,JUN,LEF1,PGF,PIK3C2B,RRAS2,STAT3	
RhoGDI Signaling	3.31E00	3.162277660168379	6.32E-02	ACTR2,ACTR3,ARPC1B,ARPC3,CDH5,EP300,EZR,ITGA2,ITGA6,ITGB1,PAK2	
Leukocyte Extravasation Signaling	3.37E00	-2.3333333333333335	6.43E-02	CD99,CDH5,CLDN5,EZR,ICAM1,ITGA2,ITGB1,MMP1,PECAM1,PIK3C2B,VCAM1	
Integrin Signaling	3.41E00	-3.464101615137755	6.09E-02	ACTR2,ACTR3,ARPC1B,ARPC3,ITGA2,ITGA6,ITGB1,MYLK,PAK2,PIK3C2B,RAPGEF1,RRAS2	
Epithelial Adherens Junction Signaling	3.45E00		7.09E-02	ACTR2,ACTR3,ARPC1B,ARPC3,IQGAP1,LEF1,MAGI2,RAPGEF1,RRAS2,TGFBR2	
RhoA Signaling	3.53E00	-2.1213203435596424	7.96E-02	ACTR2,ACTR3,ARPC1B,ARPC3,CDC42EP3,EZR,MYLK,NRP2,SEPTIN11	
IL-8 Signaling	3.54E00	-2.886751345948129	6.28E-02	CSTB,FLT1,ICAM1,IQGAP1,IRAK2,JUN,PAK2,PGF,PIK3C2B,PTGS2,RRAS2,VCAM1	
Ephrin Receptor Signaling	3.71E00	-3.162277660168379	6.56E-02	ACTR2,ACTR3,ARPC1B,ARPC3,ITGA2,ITGA6,ITGB1,PAK2,PGF,RAPGEF1,RRAS2,STAT3	
Regulation of eIF4 and p70S6K Signaling	3.74E00	-2.0	7.10E-02	EIF3I,EIF4EBP2,EIF4G2,ITGA2,ITGA6,ITGB1,PIK3C2B,RPS16,RPS21,RPS3,RRAS2	
Actin Nucleation by ARP-WASP Complex	3.99E00	-2.6457513110645903	1.04E-01	ACTR2,ACTR3,ARPC1B,ARPC3,ITGA2,ITGA6,ITGB1,RRAS2	
Ferroptosis Signaling Pathway	4.08E00	-1.2649110640673518	8.47E-02	EMP1,FTL,IREB2,MACROH2A1,RRAS2,SLC39A8,SLC7A11,STAT3,TXNRD1,WWTR1	
Regulation of Actin-based Motility by Rho	4.21E00	-2.1213203435596424	9.78E-02	ACTR2,ACTR3,ARPC1B,ARPC3,ITGA2,ITGA6,ITGB1,MYLK,PAK2	
Tumor Microenvironment Pathway	4.29E00	-2.3094010767585034	7.55E-02	CFLAR,FN1,HLA-E,ICAM1,IL6,JUN,MMP1,PGF,PIK3C2B,PTGS2,RRAS2,STAT3	
Actin Cytoskeleton Signaling	4.31E00	-2.886751345948129	6.67E-02	ACTR2,ACTR3,ARPC1B,ARPC3,EZR,FN1,IQGAP1,ITGA2,ITGA6,ITGB1,MYLK,PAK2,PIK3C2B,RRAS2	
HGF Signaling	4.97E00	-2.1213203435596424	9.65E-02	ETS2,IL6,ITGA2,ITGA6,ITGB1,JUN,PIK3C2B,PTGS2,RAPGEF1,RRAS2,STAT3	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	5.17E00		6.43E-02	CEBPB,FN1,ICAM1,IL1R1,IL6,IL6ST,IRAK2,JUN,LEF1,MMP1,NFATC3,PDIA3,PGF,PIK3C2B,RRAS2,SELE,STAT3,VCAM1	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	5.32E00		8.19E-02	BAMBI,COL4A1,EDNRB,FLT1,FN1,ICAM1,IFNAR2,IL1R1,IL6,MMP1,PGF,SERPINE1,TGFBR2,VCAM1	
Granulocyte Adhesion and Diapedesis	5.35E00		9.60E-02	CD99,CDH5,CLDN5,CXCL2,EZR,ICAM1,IL1R1,ITGB1,MMP1,PECAM1,SELE,VCAM1	
Cdc42 Signaling	5.42E00	-1.8973665961010275	9.76E-02	ACTR2,ACTR3,ARPC1B,ARPC3,HLA-E,IQGAP1,ITGA2,ITGA6,ITGB1,JUN,MYLK,PAK2	
Signaling by Rho Family GTPases	5.55E00	-3.0	7.17E-02	ACTR2,ACTR3,ARPC1B,ARPC3,CDC42EP3,CDH5,EZR,IQGAP1,ITGA2,ITGA6,ITGB1,JUN,MYLK,PAK2,PIK3C2B,SEPTIN11,STMN1	
Rac Signaling	5.61E00	-2.7136021011998728	1.02E-01	ACTR2,ACTR3,ARPC1B,ARPC3,IQGAP1,ITGA2,ITGA6,ITGB1,JUN,PAK2,PIK3C2B,RRAS2	
Coronavirus Pathogenesis Pathway	5.76E00	-0.2773500981126146	9.63E-02	ADAM17,CASP1,EP300,IFNAR2,IL6,JUN,PTGS2,RPS16,RPS21,RPS3,SERPINE1,STAT3,TGFBR2	
Hepatic Fibrosis Signaling Pathway	5.89E00	-3.2732683535398857	6.16E-02	BAMBI,CEBPB,CNR1,FLT1,FTL,ICAM1,IL1R1,IRAK2,ITGA2,ITGA6,ITGB1,JUN,LEF1,MMP1,MYLK,PGF,PIK3C2B,RRAS2,SERPINE1,STAT3,TGFBR2,VCAM1	
Osteoarthritis Pathway	6.64E00	-3.3565855667130946	8.59E-02	ACVRL1,CASP1,CASP2,CASP7,CEBPB,FN1,HES1,IL1R1,ITGA2,ITGA6,ITGB1,LEF1,MMP1,PGF,PTGS2,SLC39A8,TGFBR2	
Agranulocyte Adhesion and Diapedesis	8.02E00		1.14E-01	CD99,CDH5,CLDN5,CXCL2,EZR,FN1,ICAM1,IL1R1,ITGA2,ITGA6,ITGB1,MMP1,PECAM1,PODXL,SELE,VCAM1	

Upstream Regulators for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Analysis	ID	Upstream Regulator	Expr Log Ratio	Molecule Type	Predicted Activation State	Activation z-score	Notes	Bias Term	Bias-corrected z-score	p-value of overlap	Target molecules in dataset	Mechanistic Network	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TNF	 	cytokine	Inhibited	-3.524	bias	-0.363	-2.244	4.12E-07	CASP1,CEBPB,CFLAR,CXCL2,ICAM1,IL1R1,IL6,ITGB1,MT-CO2,PTGS2,SERPINE1,STAT3,VCAM1	IKBKB,IL6,IL6R,RELA,TNF	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IFNG	 	cytokine	Inhibited	-3.351	 	-0.231	-2.397	3.28E-06	CNR1,CXCL2,EDNRB,GPR19,HLA-E,ICAM1,IFI16,IL6,KCTD12,LAMC2,PANX1,PTGS2,SAMHD1,SLC7A11,STAT3,TGFBR2,TNFRSF10B,VCAM1	IFNG,IL6,RELA	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL1B	 	cytokine	Inhibited	-2.957	bias	-0.383	-1.823	5.84E-06	CEBPB,CXCL2,HLA-E,ICAM1,IL1R1,IL6,MT-CO2,PTGS2,SELE,SLC7A11,VCAM1	IL1B,IL6,RELA	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	mir-21	 	microrna	Inhibited	-2.190	 	-0.123	-1.921	9.15E-06	CDH5,CXCL2,IL6,PECAM1,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	LIF	 	cytokine	 	-0.747	 	-0.235	-0.188	9.18E-06	CDH5,CXCL2,FOXF1,IL6,JUN,MT-CO2,MT-ND4,PECAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TGFB1	 	growth factor	 	-1.229	 	-0.123	-0.774	9.28E-06	CXCL2,EDNRB,FN1,GPR19,HES1,IER3,IL6,IRAK2,ITGB1,PTGS2,SAMHD1,SERPINE1,STAT3,TGFBR2,TIA1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	Meg3	 	other	 	 	 	 	 	2.74E-05	FLT1,HES1,IQGAP1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CHI3L1	 	enzyme	 	 	 	 	 	3.94E-05	CALD1,EMP1,SERPINB1,SERPINE1,TGFBR2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL6R	 	transmembrane receptor	 	 	 	 	 	6.76E-05	IL6,PTGS2,VCAM1	IL6,IL6R,RELA	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PARP1	 	enzyme	 	-1.980	bias	-0.491	-1.007	8.23E-05	ICAM1,IL6,PTGS2,VCAM1	PARP1,RELA	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL6	-1.905	cytokine	 	-1.517	bias	-0.347	-0.871	1.04E-04	ICAM1,IL6,PTGS2,STAT3,TAL1,VCAM1	IL6,IL6R,PARP1,RELA	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	SOD1	 	enzyme	 	 	 	 	 	1.23E-04	ATF1,CASP1,CCNC,CNR1,ETS2,EZR,GCLM,JUN,MT-ND4,NFIL3,PTGS2,STMN1,TGFBR2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	EGFR	 	kinase	 	-1.588	bias	-0.402	-0.699	1.58E-04	JUN,LEF1,MMP1,PTGS2,SLC7A11,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PDCD4	 	other	 	 	 	 	 	2.30E-04	IL6,JUN,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	FAT1	 	other	 	 	 	 	 	3.63E-04	IL6,JUN,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	KLKB1	 	peptidase	 	 	 	 	 	3.66E-04	ICAM1,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MAP3K12	 	kinase	 	 	 	 	 	3.66E-04	JUN,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	EGF	 	growth factor	 	-1.149	bias	-0.388	-0.380	5.01E-04	JUN,PTGS2,SERPINE1,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IKBKB	 	kinase	 	-1.561	 	0.211	-1.889	7.35E-04	CFLAR,CXCL2,IL6,PTGS2	IKBKB,RELA	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	EDN1	 	cytokine	 	 	 	 	 	1.02E-03	EDNRB,MMP1,SERPINE1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	Ca2+	 	chemical - endogenous mammalian	 	 	 	 	 	1.04E-03	CEBPB,JUN,PTGS2,SERPINE1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	ANXA1	 	enzyme	 	 	 	 	 	1.08E-03	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CD40LG	 	cytokine	 	 	 	 	 	1.08E-03	ICAM1,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	GABPA	 	transcription regulator	 	 	 	 	 	1.08E-03	GCLM,SLC7A11	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	RELA	 	transcription regulator	 	 	 	 	 	1.21E-03	ICAM1,IL6,PTGS2,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	F2	 	peptidase	 	 	 	 	 	1.35E-03	IL6,JUN,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	GFAP	 	other	 	 	 	 	 	1.35E-03	ITGA2,ITGA6,ITGB1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	NPC1	 	transporter	 	 	 	 	 	1.35E-03	ABCG1,PTGS2,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PSEN1	 	peptidase	 	 	 	 	 	1.46E-03	ABCG1,ABCG2,CXCL2,EMP1,FKBP1A,H2AJ,HES5,HLA-E,MFSD14A,PMAIP1,PTGS2,STMN1,TGFBR2,TNFRSF10B,TPM3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PLCE1	 	enzyme	 	 	 	 	 	2.14E-03	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PTGS1	 	enzyme	 	 	 	 	 	2.14E-03	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	RCAN1	 	other	 	 	 	 	 	2.14E-03	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	STK38	 	kinase	 	 	 	 	 	2.14E-03	CXCL2,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	APP	 	other	 	-0.269	 	-0.162	0.340	2.24E-03	ABCG1,ABCG2,CLDN5,CXCL2,FKBP1A,H2AJ,HES1,IFI16,IL6,JUN,LEF1,MMP1,MT-CO2,MT-ND4,PMAIP1,PRNP,PTGS2,SERPINE1,SLC7A11,STAT3,STMN1,TNFRSF10B,TPM3,UBE2K	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MAPT	 	other	 	 	 	 	 	2.76E-03	ABCG1,ABCG2,B4GALT1,CEBPB,CXCL2,ELOVL7,FKBP1A,H2AJ,IFI16,MT-CO2,NDUFV2,PRNP,RPS16,SERPINE1,STMN1,TM4SF1,TPM3,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TAZ	 	enzyme	 	 	 	 	 	2.85E-03	CYP1B1,FN1,IFI16,PMAIP1,SERPINE1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TGFB2	 	growth factor	 	 	 	 	 	3.52E-03	CDH5,PECAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TLR8	 	transmembrane receptor	 	 	 	 	 	3.52E-03	CXCL2,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TTYH1	 	ion channel	 	 	 	 	 	3.52E-03	HES1,HES5	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	ethanol	 	chemical - endogenous mammalian	 	-1.653	 	-0.233	-1.093	3.80E-03	ABCG1,CNR1,IL6,JUN,PTGS2,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL12B	 	cytokine	 	 	 	 	 	4.59E-03	ICAM1,STAT3,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL1R1	-1.562	transmembrane receptor	 	 	 	 	 	4.59E-03	CXCL2,IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CEBPB	-1.180	transcription regulator	 	-1.951	bias	-0.463	-1.049	4.79E-03	CXCL2,DAB2,PTGS2,TM4SF1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	beta-estradiol	 	chemical - endogenous mammalian	 	-1.252	 	-0.092	-0.878	4.84E-03	ADGRF5,ANKRD12,BGN,BPNT2,CRIM1,DAB2,EZR,HLA-E,IL1R1,IL6,IQGAP1,MGP,NCOA3,PODXL,PTGS2,SERPINB1,TBC1D9,TRAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	KITLG	 	growth factor	 	 	 	 	 	5.21E-03	IL6,TAL1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TRAF3IP2	 	enzyme	 	 	 	 	 	5.21E-03	CXCL2,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	L-glutamic acid	 	chemical - endogenous mammalian	 	1.126	 	-0.093	1.303	5.30E-03	CLDN5,JUN,NFIL3,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TNFRSF1A	 	transmembrane receptor	 	 	 	 	 	6.23E-03	CEBPB,CFLAR,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CREB1	 	transcription regulator	 	-0.845	 	-0.120	-0.398	7.19E-03	BCAP29,CRIM1,FN1,GPR19,IER3,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CAV1	 	transmembrane receptor	 	 	 	 	 	7.21E-03	ICAM1,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MALAT1	 	other	 	 	 	 	 	7.21E-03	IL6,SELE	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	HTT	 	transcription regulator	 	 	 	 	 	8.72E-03	ATP6V0E1,CASP1,CASP2,CEBPB,CNR1,COL4A1,EDNRB,IFI16,ITGB1,JUN,MGP,NFIL3,STMN1,THRA,TM4SF1,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	AGT	 	growth factor	 	 	 	 	 	9.05E-03	CXCL2,IL6,PTGS2,SERPINE1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CTTN	 	other	 	 	 	 	 	9.49E-03	CXCL2,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL3	 	cytokine	 	 	 	 	 	9.49E-03	ICAM1,TAL1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	VEGFA	 	growth factor	 	 	 	 	 	9.49E-03	ICAM1,TAL1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	SRF	 	transcription regulator	 	-1.982	bias	-0.382	-1.225	1.08E-02	AZI2,CLDN5,FLT1,ITGB1,PTGR1,RBBP6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL1A	 	cytokine	 	 	 	 	 	1.17E-02	IL6,PTGS2,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CCL2	 	cytokine	 	 	 	 	 	1.20E-02	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CXCL2	-1.235	cytokine	 	 	 	 	 	1.20E-02	CXCL2,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	EP300	0.623	transcription regulator	 	 	 	 	 	1.20E-02	EP300,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	EPO	 	cytokine	 	 	 	 	 	1.20E-02	IL6,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	LAMA2	 	other	 	 	 	 	 	1.20E-02	CDH5,CLDN5	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	LRPAP1	 	other	 	 	 	 	 	1.20E-02	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PRKCE	 	kinase	 	 	 	 	 	1.20E-02	PTGS2,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TENM1	 	transmembrane receptor	 	 	 	 	 	1.20E-02	EDNRB,MGP	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TARDBP	0.941	transcription regulator	 	 	 	 	 	1.45E-02	HLA-E,IL6,TARDBP	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	B4GALT6	 	enzyme	 	 	 	 	 	1.49E-02	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CCL5	 	cytokine	 	 	 	 	 	1.49E-02	CXCL2,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	POU5F1	 	transcription regulator	 	0.816	 	-0.167	1.226	1.62E-02	BNIP2,CARD6,CASP1,CASP2,CASP7,TNFRSF10B	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CTNNB1	 	transcription regulator	 	1.387	 	-0.158	1.738	1.69E-02	HES1,JUN,LEF1,PECAM1,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	E2F1	 	transcription regulator	 	 	 	 	 	1.78E-02	ACSL5,ACTR3,CCNA2,NCOA3,TXNRD1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MAP2K4	 	kinase	 	 	 	 	 	1.79E-02	JUN,PAK2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	ABCC4	 	transporter	 	 	 	 	 	1.92E-02	ABCG2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	BDKRB2	 	g-protein coupled receptor	 	 	 	 	 	1.92E-02	PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	Becn2	 	other	 	 	 	 	 	1.92E-02	CNR1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CACNA1C	 	ion channel	 	 	 	 	 	1.92E-02	PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	DANCR	 	other	 	 	 	 	 	1.92E-02	RAB1A	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	EFEMP1	 	enzyme	 	 	 	 	 	1.92E-02	ADAM17	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	FRAT1	 	other	 	 	 	 	 	1.92E-02	JUN	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	Fendrr	 	other	 	 	 	 	 	1.92E-02	FOXF1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	GBP1	 	enzyme	 	 	 	 	 	1.92E-02	MMP1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	GPRASP1	 	transporter	 	 	 	 	 	1.92E-02	CNR1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	HMGB1	 	transcription regulator	 	 	 	 	 	1.92E-02	IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	HYOU1	 	other	 	 	 	 	 	1.92E-02	PECAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IL9R	 	transmembrane receptor	 	 	 	 	 	1.92E-02	IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	KNG1	 	other	 	 	 	 	 	1.92E-02	PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MAP3K1	 	kinase	 	 	 	 	 	1.92E-02	JUN	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MIB1	 	enzyme	 	 	 	 	 	1.92E-02	HES5	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	Map3k7	 	kinase	 	 	 	 	 	1.92E-02	PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PDIA3	-0.665	peptidase	 	 	 	 	 	1.92E-02	PRNP	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PLD1	 	enzyme	 	 	 	 	 	1.92E-02	PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PRKDC	 	kinase	 	 	 	 	 	1.92E-02	VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	RHBDF1	 	other	 	 	 	 	 	1.92E-02	ADAM17	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	RHBDF2	 	other	 	 	 	 	 	1.92E-02	ADAM17	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	SDC1	 	enzyme	 	 	 	 	 	1.92E-02	IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	STK38L	 	kinase	 	 	 	 	 	1.92E-02	ITGB1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TLN1	 	other	 	 	 	 	 	1.92E-02	ITGB1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TNFSF11	 	cytokine	 	 	 	 	 	1.92E-02	PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	UBQLN2	 	other	 	 	 	 	 	1.92E-02	TARDBP	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	VPS18	 	transporter	 	 	 	 	 	1.92E-02	ITGB1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	mir-150	 	microrna	 	 	 	 	 	1.92E-02	CLDN5	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	mir-183	 	microrna	 	 	 	 	 	1.92E-02	SEL1L	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MOG	 	other	 	 	 	 	 	1.93E-02	CXCL2,IL6,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TGFBR2	-1.727	kinase	 	 	 	 	 	1.93E-02	FN1,SERPINE1,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	STAT1	 	transcription regulator	 	-1.000	bias	-0.491	-0.017	1.97E-02	ICAM1,IFI16,KCTD12,SAMHD1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	KDM1A	 	enzyme	 	 	 	 	 	2.10E-02	B4GALT1,CEBPB,ELOVL7,IFI16,PRNP,TM4SF1,VCAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IGFBP2	 	other	 	 	 	 	 	2.10E-02	FN1,ITGA6,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	FAS	 	transmembrane receptor	 	 	 	 	 	2.48E-02	ICAM1,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	RBL1	 	transcription regulator	 	 	 	 	 	2.48E-02	CCNA2,HES1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	inosine	 	chemical - endogenous mammalian	 	 	 	 	 	2.48E-02	ARPC1B,FTL,SERPINB1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	levodopa	 	chemical - endogenous mammalian	 	0.351	 	-0.058	0.602	2.64E-02	CDC42EP3,CLDN5,CNR1,COL4A1,EDNRB,EIF4EBP2,EIF4G2,ETS2,FNIP1,FTL,IER3,IFNAR2,IQGAP1,KDM4B,NFATC3,PRICKLE1,TMEM70,VMP1,WWTR1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	FGF1	 	growth factor	 	 	 	 	 	2.86E-02	GCLM,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MAP2K1	 	kinase	 	 	 	 	 	3.26E-02	CDH5,PECAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	JUN	0.991	transcription regulator	 	 	 	 	 	3.35E-02	IL6,JUN,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CNR1	1.783	g-protein coupled receptor	 	 	 	 	 	3.58E-02	CNR1,PTGS2,STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TREM2	 	transmembrane receptor	 	 	 	 	 	3.68E-02	BAMBI,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	CBS/CBSL	 	enzyme	 	 	 	 	 	3.79E-02	CLDN5	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	DRP2	 	other	 	 	 	 	 	3.79E-02	UTRN	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	EIF4EBP1	 	translation regulator	 	 	 	 	 	3.79E-02	CFLAR	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	GRP	 	growth factor	 	 	 	 	 	3.79E-02	JUN	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	IFIH1	 	enzyme	 	 	 	 	 	3.79E-02	CXCL2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	KPNB1	 	transporter	 	 	 	 	 	3.79E-02	PMAIP1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MAPK10	 	kinase	 	 	 	 	 	3.79E-02	ADAM17	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	NMB	 	other	 	 	 	 	 	3.79E-02	JUN	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	OLIG2	 	transcription regulator	 	 	 	 	 	3.79E-02	GPR17	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PECAM1	-1.951	other	 	 	 	 	 	3.79E-02	CDH5	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PLG	 	peptidase	 	 	 	 	 	3.79E-02	SERPINE1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PROC	 	peptidase	 	 	 	 	 	3.79E-02	ICAM1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	PTGDR	 	g-protein coupled receptor	 	 	 	 	 	3.79E-02	IFI16	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	STAT6	 	transcription regulator	 	 	 	 	 	3.79E-02	PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TDGF1	 	growth factor	 	 	 	 	 	3.79E-02	STAT3	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	SNCA	 	enzyme	 	-1.673	 	-0.057	-1.535	3.81E-02	CDC42EP3,EP300,EZR,HES1,HES5,IL6,SERPINB1,SERPINE1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	RGS10	 	enzyme	 	 	 	 	 	3.83E-02	CASP1,CXCL2,IL6ST	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	TLR3	 	transmembrane receptor	 	 	 	 	 	4.12E-02	IL6,PTGS2	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	FGF2	 	growth factor	 	 	 	 	 	4.35E-02	HES1,JUN,LEF1	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	C3	 	peptidase	 	 	 	 	 	4.57E-02	CXCL2,IL6	 	
WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	 	MYD88	 	other	 	 	 	 	 	4.57E-02	CXCL2,IL6	 	

Causal Networks for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Master Regulator	Molecule Type	Expr Log Ratio	Depth	Predicted Activation State	Notes	Activation z-score	p-value of overlap	Network bias-corrected p-value	Participating regulators	Target molecules in dataset	Causal network	Target-connected regulators	Relationships Between Master Regulators(Increases/Downstream)	Relationships Between Master Regulators(Decreases/Downstream)	Relationships Between Master Regulators(Affects/Downstream)	Relationships Between Master Regulators(Increases/Upstream)	Relationships Between Master Regulators(Decreases/Upstream)	Relationships Between Master Regulators(Affects/Upstream)	Relationships Between Master Regulators(Increases/Both)	Relationships Between Master Regulators(Decreases/Both)	Relationships Between Master Regulators(Affects/Both)	
TGFB1	growth factor	 	3	 	 	-1.540	3.55E-09	2.40E-03	AKT1,APP,CDK5,CEBPB,CREB1,DCX,FOXO1,HTT,MAPK1,MAPK10,MTOR,PARP1,RB1,RPS6KB1,SMAD3,STAT3,TGFB1,TP53,TRPV1	ABCG2,ACTR3,ADAM17,BCAP29,CASP1,CDH5,CFLAR,CLDN5,CNR1,COL4A1,CRIM1,CXCL2,DAB2,EDNRB,FN1,FOXF1,GPR17,GPR19,HES1,HES5,ICAM1,IER3,IFI16,IL6,IRAK2,JUN,LEF1,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PMAIP1,PRNP,PTGS2,RRAS2,SAMHD1,SERPINB1,SERPINE1,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,TGFBR2,TIA1,TM4SF1,TNFRSF10B,UBE2K,VCAM1	51 (19)	15	 	beta-estradiol,ethanol,SNAI1	 	APP,CAV1,CDK5,LIF,MAPK1,TNF,VEGFA	Ca2+,CXCL12,GFAP	 	 	 	 	
APP	other	 	3	 	 	-0.962	2.60E-08	8.60E-03	AKT1,APP,CDK5,CREB1,DCX,EIF2S1,ELK1,FMR1,FOXO1,FYN,GLI1,GRIN1,HTT,MAP2,MAPK10,MTOR,NTRK1,NTRK2,PARP1,PDPK1,PTEN,RB1,RBL1,RELA,RPS6KB1,RPTOR,SRF,STAT3,TP53,TREM2,TRPM2,TSC2	ABCG2,ACTR3,ADAM17,BAMBI,BCAP29,CASP1,CCNA2,CDH5,CEBPB,CFLAR,CLDN5,CNR1,COL4A1,CRIM1,CXCL2,CYP1B1,FLT1,GPR17,GPR19,HES1,HES5,IER3,IFI16,IGFBP7,IL6,ITGB1,JUN,LEF1,MGP,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,NSDHL,PDIA3,PMAIP1,PRNP,PTGR1,PTGS2,RRAS2,SERPINB1,SERPINE1,SLC7A11,SSBP2,ST3GAL6,STAT3,STC1,STMN1,SYNJ2,TNFRSF10B,UBE2K,VCAM1	53 (32)	23	ROCK2,TGFB1	beta-estradiol	 	EDN1,EIF2AK2,FGF2,GFAP,IFNG,IGFBP2,IL15,LIF,MAPK1,PARP1	CXCL12,HGF,PDCD4,TENM1	 	 	 	 	
EGFR	kinase	 	3	 	 	-1.461	4.36E-08	1.70E-03	AXL,Cdc42,CEBPB,CREB1,CTNNB1,EGFR,GSK3B,MAPK1,NIBAN2,PARP1,RAC1,STAT3	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,HES1,HES5,ICAM1,IER3,IL6,JUN,LEF1,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PECAM1,PTGS2,RRAS2,SERPINE1,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	30 (12)	8	EGF,FGF2,HGF,IGFBP2,PRKCD,RHBDF1,RHBDF2,TAC1	beta-estradiol,PRKN	 	Ca2+,GBP1,MAPK1,VEGFA	 	 	 	 	 	
EDN1	cytokine	 	3	Inhibited	 	-3.182	6.03E-08	2.10E-03	CAV1,CEBPB,CREB1,DUSP1,EDN1,EGFR,ELK1,MAPK1,MAPK10,MAPK14,MMP9,PARP1,RAC1,SERPINE1,SRC,SRF,STAT3	ADAM17,BCAP29,CLDN5,CRIM1,CXCL2,DAB2,EDNRB,FLT1,FN1,GPR19,HES5,ICAM1,IER3,IL6,ITGB1,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PTGR1,PTGS2,RRAS2,SERPINE1,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	32 (17)	12	APP,TNF	 	 	Ca2+,MAPK1	 	 	 	 	 	
IFNG	cytokine	 	3	Inhibited	 	-2.714	1.31E-07	1.36E-02	AKT1,APP,CEBPB,CREB1,EIF2S1,FOXO1,GSK3B,IFNG,MAPK1,PDPK1,RPS6KB1,STAT3	BCAP29,CEBPB,CFLAR,CLDN5,CNR1,CRIM1,CXCL2,DAB2,EDNRB,GPR17,GPR19,HES5,HLA-E,ICAM1,IER3,IFI16,IL6,JUN,KCTD12,LAMC2,LEF1,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PANX1,PMAIP1,PRNP,PTGS2,RRAS2,SAMHD1,SERPINE1,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,TGFBR2,TM4SF1,TNFRSF10B,UBE2K,VCAM1	44 (12)	10	APP	 	 	CXCL12,FGF2,GFAP,MAPK1,TNF,VEGFA	CAV1,CNR1	 	 	 	 	
TNF	cytokine	 	1	Inhibited	biased	-3.606	2.75E-07	2.50E-03	TNF	CASP1,CEBPB,CFLAR,CXCL2,ICAM1,IL1R1,IL6,ITGB1,MT-CO2,PTGS2,SERPINE1,STAT3,VCAM1	13 (1)	1	CXCL12,ethanol,IFNG,IL23A,mir-21,PARP1,PRKCD,TGFB1	ADCYAP1,beta-estradiol	 	EDN1,GFAP,ITGB1,MAPK1	 	 	 	 	 	
Ca2+	chemical - endogenous mammalian	 	3	 	 	-1.342	3.44E-07	2.01E-02	APP,Ca2+,CEBPB,CEBPD,CREB1,FMR1,FOXO1,HIF1A,IKBKB,ITGB1,MAPK14,PIP5K1C,PRKCE,PTGS2,RBL1,RPS6KB1,STAT3,TP53,TREM2,TRPM2,TSC2	ABCG2,ADAM17,ADAM19,BAMBI,BCAP29,CEBPB,CLDN5,CRIM1,CXCL2,CYP1B1,DAB2,FLT1,FN1,GPR17,GPR19,HES1,HES5,IER3,IFI16,IL6,JUN,LEF1,MGP,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,NSDHL,PDIA3,PMAIP1,PRNP,PTGS2,RRAS2,SERPINE1,SLC7A11,SSBP2,ST3GAL6,STC1,STMN1,SYNJ2,TM4SF1,TNFRSF10B,UBE2K,VCAM1	45 (21)	18	CXCL12,EDN1,EGF,EGFR,GRM5,MAG	beta-estradiol,ethanol,HYOU1,TGFB1	 	MAPK1	 	 	 	 	 	
LIF	cytokine	 	3	 	 	-1.961	3.90E-07	2.00E-03	CEBPB,CREB1,LIF,MAPK1,PARP1,STAT3	BCAP29,CDH5,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,JUN,MT-CO2,MT-ND4,NFIL3,NRP2,PECAM1,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	26 (6)	5	APP,TGFB1	SNAI1	 	GFAP,MAPK1,TAC1	 	 	 	 	 	
beta-estradiol	chemical - endogenous mammalian	 	3	Inhibited	 	-2.405	4.72E-07	3.34E-02	AKT1,APP,ARRB1,beta-estradiol,CAV1,CEBPB,CREB1,CTNNB1,DRD2,EIF2S1,EIF4E,GSK3B,MAPK1,MAPK9,MMP9,NANOG,PARP1,SRC,STAT3,TCF7L2,TP53	ABCG2,ADGRF5,ANKRD12,BCAP29,BGN,BPNT2,CEBPB,CEMIP2,CFLAR,CLDN5,CRIM1,DAB2,EZR,FKBP1A,FN1,FOXF1,GCLM,GPR19,HES1,HES5,HLA-E,IER3,IFI16,IL1R1,IL6,IQGAP1,ITGB1,JUN,LEF1,MGP,MT-CO2,MT-ND4,NCOA3,NFIL3,NRP2,PECAM1,PMAIP1,PRICKLE1,PRNP,PRRC2C,PTGS2,RRAS2,SERPINB1,SERPINE1,SNAP23,SSBP2,STC1,STMN1,SYNJ2,TBC1D9,TGFBR2,TM4SF1,TNFRSF10B,TRAM1,UBE2K,VCAM1	56 (21)	17	 	 	 	EGF,IGFBP2,LAMA2,MAPK1,TAC1	APP,Ca2+,CAV1,EGFR,GRM5,TGFB1,TGFB2,TNF	 	 	 	 	
TAC1	other	 	3	Inhibited	 	-2.353	5.98E-07	2.70E-03	CEBPB,CREB1,EGFR,MAPK1,PARP1,STAT3,TAC1	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,JUN,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	26 (7)	6	beta-estradiol,FGF2,levodopa,LIF	 	 	EGFR,GFAP,MAPK1	 	 	 	 	 	
IFNG	cytokine	 	2	Inhibited	 	-3.128	6.27E-07	1.17E-02	EIF2S1,GSK3B,IFNG,STAT3	CEBPB,CNR1,CXCL2,EDNRB,GPR19,HES5,HLA-E,ICAM1,IFI16,IL6,KCTD12,LAMC2,MT-CO2,MT-ND4,PANX1,PTGS2,SAMHD1,SERPINE1,SLC7A11,STAT3,TGFBR2,TNFRSF10B,VCAM1	23 (4)	4	APP	 	 	CXCL12,FGF2,GFAP,MAPK1,TNF,VEGFA	CAV1,CNR1	 	 	 	 	
VEGFA	growth factor	 	3	Inhibited	 	-2.191	7.89E-07	6.60E-03	AKT1,CAV1,CEBPB,CREB1,EIF2S1,EIF4E,MAPK1,MMP9,MTOR,NTRK2,PARP1,STAT3,VEGFA	BCAP29,CCNA2,CEBPB,CFLAR,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IFI16,IL6,ITGB1,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SERPINB1,SSBP2,STAT3,STC1,STMN1,SYNJ2,TAL1,TM4SF1,VCAM1	30 (13)	12	EGF,EGFR,FGF2,HRAS,IFNG,TGFB1	Meg3	 	CAV1,MAPK1	 	 	 	 	 	
beta-estradiol	chemical - endogenous mammalian	 	2	Inhibited	 	-2.271	1.07E-06	1.83E-02	AKT1,beta-estradiol,CREB1,CTNNB1,GSK3B,MMP9,STAT3	ADGRF5,ANKRD12,BCAP29,BGN,BPNT2,CFLAR,CRIM1,DAB2,EZR,FN1,GPR19,HES1,HES5,HLA-E,IER3,IL1R1,IL6,IQGAP1,ITGB1,JUN,LEF1,MGP,MT-CO2,MT-ND4,NCOA3,NFIL3,NRP2,PECAM1,PTGS2,RRAS2,SERPINB1,SERPINE1,SSBP2,STC1,STMN1,SYNJ2,TBC1D9,TRAM1	38 (7)	7	 	 	 	EGF,IGFBP2,LAMA2,MAPK1,TAC1	APP,Ca2+,CAV1,EGFR,GRM5,TGFB1,TGFB2,TNF	 	 	 	 	
adenosine	chemical - endogenous mammalian	 	3	Inhibited	 	-2.121	1.70E-06	1.65E-02	adenosine,ADORA2A,CASP1,Cdc42,CREB1,dopamine,DRD2,EGFR,GSK3B,IL1B,NTRK1,NTRK2,PRKCE,STAT3	BCAP29,CCNA2,CCT5,CEBPB,CNR1,CRIM1,CXCL2,FN1,GPR19,HES5,HLA-E,ICAM1,IER3,IL1R1,IL6,JUN,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SERPINE1,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,TGFBR2,VCAM1	32 (14)	10	ethanol	 	 	 	 	 	 	 	 	
IL15	cytokine	 	3	Inhibited	 	-2.353	2.00E-06	9.10E-03	CEBPB,CREB1,IL15,MAPK1,PARP1,STAT1,STAT3	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IFI16,IL6,KCTD12,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SAMHD1,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	26 (7)	6	APP	 	 	CXCL12,MAPK1	 	 	 	 	 	
MAPK1	kinase	 	3	Inhibited	 	-2.858	2.37E-06	4.20E-03	CEBPB,CREB1,ELK1,MAPK1,PARP1,SRF	BCAP29,CLDN5,CRIM1,CXCL2,DAB2,FLT1,FN1,GPR19,ICAM1,IER3,IL6,ITGB1,NFIL3,NRP2,PTGR1,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	24 (6)	4	ADCYAP1,APP,beta-estradiol,Ca2+,CNR1,CXCL12,EDN1,EGF,EGFR,GRM5,HRAS,IFNG,IL15,levodopa,LIF,palmitic acid,RAPGEF3,TAC1,TGFB1,TNF,VEGFA	arachidonic acid,CAV1	 	PARP1	 	 	 	 	 	
CDK5	kinase	 	3	 	 	-0.822	2.45E-06	4.99E-02	AKT1,APP,CDK5,DCX,EIF2S1,FMR1,FOXO1,HTT,ITGB1,MAPK10,MTOR,PARP1,PIP5K1C,RBL1,RELA,RPS6KB1,STAT3,TREM2,TRPM2,TRPV1,TSC2	ACTR3,ADAM17,ADAM19,BAMBI,CASP1,CEBPB,CFLAR,CLDN5,CNR1,COL4A1,CXCL2,CYP1B1,FN1,GPR17,HES1,HES5,IFI16,IL6,JUN,LEF1,MGP,MMP1,MT-CO2,MT-ND4,NSDHL,PDIA3,PMAIP1,PRNP,PTGS2,SERPINB1,SERPINE1,SLC7A11,ST3GAL6,STAT3,TNFRSF10B,UBE2K,VCAM1	37 (21)	19	TGFB1	 	 	 	 	 	 	 	 	
IFNG	cytokine	 	1	Inhibited	 	-3.300	2.64E-06	1.24E-02	IFNG	CNR1,CXCL2,EDNRB,GPR19,HLA-E,ICAM1,IFI16,IL6,KCTD12,LAMC2,PANX1,PTGS2,SAMHD1,SLC7A11,STAT3,TGFBR2,TNFRSF10B,VCAM1	18 (1)	1	APP	 	 	CXCL12,FGF2,GFAP,MAPK1,TNF,VEGFA	CAV1,CNR1	 	 	 	 	
IL23A	cytokine	 	3	 	biased	-1.897	3.22E-06	3.30E-03	EGFR,IL23A,PRKCD,STAT3	HES5,IL6,JUN,MMP1,MT-CO2,MT-ND4,PTGS2,SERPINE1,SLC7A11,STAT3	10 (4)	4	 	ADCYAP1	 	TNF	 	 	 	 	 	
RHBDF1	other	 	2	 	biased	-1.633	3.60E-06	5.00E-04	EGFR,RHBDF1	ADAM17,JUN,MMP1,PTGS2,SLC7A11,STAT3	6 (2)	2	 	 	 	EGFR	 	 	 	 	 	
RHBDF2	other	 	2	 	biased	-1.633	3.60E-06	5.00E-04	EGFR,RHBDF2	ADAM17,JUN,MMP1,PTGS2,SLC7A11,STAT3	6 (2)	2	 	 	 	EGFR	 	 	 	 	 	
HGF	growth factor	 	3	Inhibited	biased	-2.000	4.00E-06	1.52E-02	EGFR,HGF,NTRK2,PRKCD,PTPN11,RAC1,RELA,STAT1,STAT3	CASP1,CCNA2,HES5,ICAM1,IFI16,JUN,KCTD12,MMP1,MT-CO2,MT-ND4,PTGS2,SAMHD1,SERPINE1,SLC7A11,STAT3,VCAM1	16 (9)	8	 	APP	 	EGFR,PRKCD	 	 	 	 	 	
ethanol	chemical - endogenous mammalian	 	3	 	 	-1.976	5.39E-06	3.12E-02	ADORA2A,CDK5,CREB1,DRD2,EGFR,EIF2AK2,EIF2S1,ethanol,FYN,GRIN2B,GSK3B,NTRK2,RAC1,RELA,STAT1	ABCG1,BCAP29,CCNA2,CCT5,CEBPB,CNR1,CRIM1,CXCL2,FN1,GPR19,ICAM1,IER3,IFI16,IL6,JUN,KCTD12,MMP1,NFIL3,NRP2,PTGS2,RRAS2,SAMHD1,SERPINE1,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,TGFBR2,VCAM1	31 (15)	12	 	 	 	adenosine,CNR1,EIF2AK2,FGF2,GFAP,HRAS,TNF	Ca2+,mir-29,TGFB1	 	 	 	 	
PRKN	enzyme	 	2	 	 	0.632	5.59E-06	2.10E-03	AKT1,EGFR,GSK3B,PRKN,RELA	CFLAR,JUN,LEF1,MMP1,PRDX1,PTGS2,SERPINE1,SLC7A11,STAT3,VCAM1	10 (5)	5	 	 	 	 	EGFR	 	 	 	 	
RAPGEF3	other	 	3	 	 	-1.877	5.94E-06	8.90E-03	CEBPB,CREB1,MAP3K2,MAPK1,PARP1,RAP1B,RAPGEF3,STAT3	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	23 (8)	5	 	 	 	MAPK1	 	 	 	 	 	
palmitic acid	chemical - endogenous mammalian	 	3	Inhibited	 	-2.041	6.54E-06	1.43E-02	CEBPB,CREB1,MAPK1,NTRK2,palmitic acid,PARP1,PTPN1,STAT3	BCAP29,CCNA2,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	24 (8)	6	 	 	 	MAPK1	 	 	 	 	 	
CAV1	transmembrane receptor	 	3	 	 	0.200	8.99E-06	2.00E-02	CAV1,CEBPB,CREB1,EGFR,FOS,MAPK1,NTRK2,PARP1,SRC,STAT3	BCAP29,CCNA2,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,RRAS2,SERPINE1,SLC7A11,SSBP2,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	25 (10)	8	TGFB1,VEGFA	beta-estradiol,IFNG	 	 	MAPK1	 	 	 	 	
mir-21	microRNA	 	1	Inhibited	 	-2.236	9.15E-06	1.90E-03	mir-21	CDH5,CXCL2,IL6,PECAM1,STAT3	5 (1)	1	 	 	 	GFAP,TNF	 	 	 	 	 	
IGFBP2	other	 	2	 	biased	-1.897	1.13E-05	2.10E-03	EGFR,IGFBP2,STAT3	FN1,HES5,ITGA6,JUN,MMP1,MT-CO2,MT-ND4,PTGS2,SLC7A11,STAT3	10 (3)	3	APP,beta-estradiol	levodopa	 	EFEMP1,EGFR	 	 	 	 	 	
PRKCD	kinase	 	2	 	biased	-1.667	1.42E-05	7.10E-03	EGFR,PRKCD,STAT3	HES5,JUN,MMP1,MT-CO2,MT-ND4,PTGS2,SERPINE1,SLC7A11,STAT3	9 (3)	3	EGF,HGF	 	 	EGFR,GFAP,TNF	 	 	 	 	 	
EGF	growth factor	 	2	 	 	-1.877	1.52E-05	1.89E-02	AKT1,CREB1,EGF,EGFR,RPS6KB1,STAT3	BCAP29,CFLAR,CRIM1,FN1,GPR19,HES5,IER3,JUN,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SERPINE1,SLC7A11,SSBP2,STAT3,STC1,STMN1,SYNJ2,VCAM1	23 (6)	6	beta-estradiol,CNR1	 	 	Ca2+,EGFR,FGF2,MAPK1,PRKCD,VEGFA	GFAP	 	 	 	 	
MAG	other	 	3	 	 	-0.816	1.61E-05	3.48E-02	CREB1,MAG,NTRK2,PARP1,PRKCA,RAC1,STAT1,STAT3	BCAP29,CCNA2,CRIM1,FN1,GPR19,HES5,IER3,IFI16,IL6,KCTD12,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SAMHD1,SERPINE1,SSBP2,STAT3,STC1,STMN1,SYNJ2,VCAM1	24 (8)	6	 	 	 	Ca2+,PARP1	 	 	 	 	 	
levodopa	chemical - endogenous mammalian	 	3	 	 	-1.441	1.68E-05	1.67E-02	CEBPB,CREB1,FAAH,GSK3B,levodopa,MAPK1,MAPT,PARP1,PPARG	BCAP29,CDC42EP3,CLDN5,CNR1,COL4A1,CRIM1,CXCL2,DAB2,EDNRB,EIF4EBP2,EIF4G2,ETS2,FN1,FNIP1,FTL,GPR19,ICAM1,IER3,IFNAR2,IL6,IQGAP1,KDM4B,NFATC3,NFIL3,NRP2,PRICKLE1,PTGS2,RRAS2,SERPINE1,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,TMEM70,VCAM1,VMP1,WWTR1	39 (9)	6	 	 	 	HRAS,MAPK1,TAC1,TTYH1	CNR1,CXCL12,GFAP,IGFBP2,PDCD4	 	 	 	 	
ADCYAP1	other	 	3	Inhibited	 	-2.117	1.69E-05	3.50E-02	ADCYAP1,CEBPB,CREB1,DIO2,GSK3B,MAPK1,MAPT,NTRK2,PARP1,STAT3	BCAP29,CCNA2,CRIM1,CXCL2,CYP1B1,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SERPINB1,SERPINE1,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	27 (10)	8	 	 	 	GFAP,MAPK1,TTYH1	IL23A,TNF	 	 	 	 	
GRM5	G-protein coupled receptor	 	3	 	 	-1.460	1.70E-05	2.27E-02	CEBPB,CNR1,CREB1,GRM5,MAPK1,PARP1,STAT3	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	23 (7)	5	 	beta-estradiol	 	Ca2+,CNR1,MAPK1	 	 	 	 	 	
CNR1	G-protein coupled receptor	1.783	3	 	 	-1.460	2.02E-05	2.92E-02	CEBPB,CNR1,CREB1,MAPK1,PARP1,STAT3	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,HES5,ICAM1,IER3,IL6,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	23 (6)	5	ethanol,GRM5	Becn2,GPRASP1,IFNG,levodopa	 	EGF,FGF2,MAPK1	 	 	 	 	 	
HRAS	enzyme	 	3	 	 	-1.964	2.03E-05	1.72E-02	CEBPB,CREB1,GRIN2B,GSK3B,HRAS,MAPK1,PARP1	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,ICAM1,IER3,IL6,NFIL3,NRP2,PTGS2,RRAS2,SERPINE1,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	21 (7)	4	ethanol,levodopa	 	 	MAPK1,VEGFA	 	 	 	 	 	
VEGFA	growth factor	 	2	 	 	-1.528	2.11E-05	1.66E-02	CAV1,CREB1,MMP9,STAT3,VEGFA	BCAP29,CRIM1,FN1,GPR19,HES5,ICAM1,IER3,ITGB1,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TAL1,VCAM1	21 (5)	5	EGF,EGFR,FGF2,HRAS,IFNG,TGFB1	Meg3	 	CAV1,MAPK1	 	 	 	 	 	
TGFB1	growth factor	 	1	 	 	-1.069	2.27E-05	2.16E-02	TGFB1	CXCL2,EDNRB,FN1,GPR19,HES1,IER3,IL6,IRAK2,PTGS2,SAMHD1,SERPINE1,STAT3,TGFBR2,TIA1	14 (1)	1	 	beta-estradiol,ethanol,SNAI1	 	APP,CAV1,CDK5,LIF,MAPK1,TNF,VEGFA	Ca2+,CXCL12,GFAP	 	 	 	 	
CXCL12	cytokine	 	3	Inhibited	 	-2.400	2.36E-05	1.99E-02	CEBPB,CREB1,CXCL12,MAPK1,MAPK14,PARP1	ADAM17,BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,ICAM1,IER3,IL6,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	21 (6)	5	IFNG,IL15	APP,levodopa,TGFB1	 	Ca2+,MAPK1,TNF	 	 	 	 	 	
PARP1	enzyme	 	3	Inhibited	 	-2.400	2.36E-05	1.77E-02	CREB1,ELK1,PARP1,SRF	BCAP29,CLDN5,CRIM1,FLT1,FN1,GPR19,ICAM1,IER3,IL6,ITGB1,NFIL3,NRP2,PTGR1,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,VCAM1	21 (4)	3	APP,MAG,MAPK1	 	 	TNF	 	 	 	 	 	
FGF2	growth factor	 	2	 	 	-0.626	2.41E-05	2.58E-02	CREB1,EIF4EBP1,FGF2,GSK3B,RAC1,STAT1	BCAP29,CFLAR,CRIM1,FN1,GPR19,HES1,ICAM1,IER3,IFI16,JUN,KCTD12,LEF1,NFIL3,NRP2,PTGS2,RRAS2,SAMHD1,SERPINE1,SSBP2,STAT3,STC1,STMN1,SYNJ2	23 (6)	6	APP,CNR1,EGF,ethanol,IFNG	 	 	EGFR,TAC1,VEGFA	 	 	 	 	 	
HGF	growth factor	 	2	 	biased	-1.414	2.56E-05	1.10E-02	EGFR,HGF,PRKCD,RAC1	CASP1,ICAM1,JUN,MMP1,PTGS2,SERPINE1,SLC7A11,STAT3	8 (4)	4	 	APP	 	EGFR,PRKCD	 	 	 	 	 	
Meg3	other	 	1	 	biased	0.577	2.74E-05	4.00E-04	Meg3	FLT1,HES1,IQGAP1	3 (1)	1	 	 	 	 	VEGFA	 	 	 	 	
EDN1	cytokine	 	2	 	 	-1.964	2.84E-05	2.15E-02	CREB1,EDN1,MAPK14,STAT3	BCAP29,CRIM1,EDNRB,FN1,GPR19,HES5,IER3,IL6,MMP1,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SERPINE1,SSBP2,STAT3,STC1,STMN1,SYNJ2	21 (4)	4	APP,TNF	 	 	Ca2+,MAPK1	 	 	 	 	 	
arachidonic acid	chemical - endogenous mammalian	 	3	Activated	 	2.400	2.95E-05	2.08E-02	arachidonic acid,CEBPB,CREB1,GSK3B,MAPK1,MAPT,PARP1	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,ICAM1,IER3,IL6,NFIL3,NRP2,PTGS2,RRAS2,SERPINE1,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	21 (7)	4	 	 	 	 	MAPK1	 	 	 	 	
LIF	cytokine	 	2	 	 	-1.091	3.17E-05	1.92E-02	CREB1,LIF,STAT3	BCAP29,CDH5,CRIM1,CXCL2,FN1,GPR19,HES5,IER3,JUN,MT-CO2,MT-ND4,NFIL3,NRP2,PECAM1,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2	21 (3)	3	APP,TGFB1	SNAI1	 	GFAP,MAPK1,TAC1	 	 	 	 	 	
MAPK1	kinase	 	2	Inhibited	 	-2.236	3.66E-05	1.92E-02	CEBPB,CREB1,MAPK1,PARP1	BCAP29,CRIM1,CXCL2,DAB2,FN1,GPR19,ICAM1,IER3,IL6,NFIL3,NRP2,PTGS2,RRAS2,SSBP2,STAT3,STC1,STMN1,SYNJ2,TM4SF1,VCAM1	20 (4)	3	ADCYAP1,APP,beta-estradiol,Ca2+,CNR1,CXCL12,EDN1,EGF,EGFR,GRM5,HRAS,IFNG,IL15,levodopa,LIF,palmitic acid,RAPGEF3,TAC1,TGFB1,TNF,VEGFA	arachidonic acid,CAV1	 	PARP1	 	 	 	 	 	
EGFR	kinase	 	1	 	biased	-1.342	5.02E-05	1.80E-03	EGFR	JUN,MMP1,PTGS2,SLC7A11,STAT3	5 (1)	1	EGF,FGF2,HGF,IGFBP2,PRKCD,RHBDF1,RHBDF2,TAC1	beta-estradiol,PRKN	 	Ca2+,GBP1,MAPK1,VEGFA	 	 	 	 	 	
ROCK2	kinase	 	3	 	 	1.706	5.59E-05	4.21E-02	BACE1,CREB1,RAC1,RELA,ROCK2,STAT1,STAT3	BCAP29,CRIM1,FN1,GPR19,HES5,ICAM1,IER3,IFI16,KCTD12,MT-CO2,MT-ND4,NFIL3,NRP2,PTGS2,RRAS2,SAMHD1,SSBP2,STAT3,STC1,STMN1,SYNJ2,VCAM1	22 (7)	5	 	 	 	APP	 	 	 	 	 	
PARP1	enzyme	 	1	Inhibited	biased	-2.000	5.78E-05	7.80E-03	PARP1	ICAM1,IL6,PTGS2,VCAM1	4 (1)	1	APP,MAG,MAPK1	 	 	TNF	 	 	 	 	 	
IL6R	transmembrane receptor	 	1	 	biased	-0.577	6.76E-05	9.20E-03	IL6R	IL6,PTGS2,VCAM1	3 (1)	1	 	 	 	 	 	 	 	 	 	
PDCD4	other	 	1	 	biased	0.577	2.30E-04	1.95E-02	PDCD4	IL6,JUN,PTGS2	3 (1)	1	 	APP,FAT1,levodopa	 	 	 	 	 	 	 	
LIF	cytokine	 	1	 	 	-0.816	2.31E-04	1.72E-02	LIF	CDH5,CXCL2,JUN,MT-CO2,MT-ND4,PECAM1	6 (1)	1	APP,TGFB1	SNAI1	 	GFAP,MAPK1,TAC1	 	 	 	 	 	
FAT1	other	 	1	 	biased	-0.577	3.63E-04	2.41E-02	FAT1	IL6,JUN,PTGS2	3 (1)	1	 	 	 	 	PDCD4	 	 	 	 	
KLKB1	peptidase	 	1	 	biased	-1.414	3.66E-04	2.30E-03	KLKB1	ICAM1,VCAM1	2 (1)	1	 	 	 	 	 	 	 	 	 	
MAP3K12	kinase	 	1	 	biased	0.000	3.66E-04	3.30E-03	MAP3K12	JUN,STAT3	2 (1)	1	 	 	 	 	 	 	 	 	 	
EIF2AK2	kinase	 	3	 	 	-0.707	3.81E-04	2.52E-02	EIF2AK2,EIF2S1,STAT1,STAT3	CEBPB,HES5,ICAM1,IFI16,KCTD12,MT-CO2,MT-ND4,SAMHD1	8 (4)	3	APP,ethanol	mir-29	 	 	 	 	 	 	 	
EGF	growth factor	 	1	 	biased	-1.000	4.07E-04	2.33E-02	EGF	JUN,PTGS2,SERPINE1,VCAM1	4 (1)	1	beta-estradiol,CNR1	 	 	Ca2+,EGFR,FGF2,MAPK1,PRKCD,VEGFA	GFAP	 	 	 	 	
ITGB1	transmembrane receptor	-1.541	2	 	 	-0.707	8.65E-04	2.89E-02	ITGB1,LAMA2,STAT3	ADAM17,ADAM19,CDH5,CLDN5,FN1,HES5,MT-CO2,MT-ND4	8 (3)	3	STK38L,TLN1,TNF	VPS18	 	LAMA2	 	 	 	 	 	
EDN1	cytokine	 	1	 	 	-1.732	1.02E-03	3.38E-02	EDN1	EDNRB,MMP1,SERPINE1	3 (1)	1	APP,TNF	 	 	Ca2+,MAPK1	 	 	 	 	 	
CD40LG	cytokine	 	1	 	biased	-1.414	1.08E-03	7.30E-03	CD40LG	ICAM1,VCAM1	2 (1)	1	 	 	 	 	 	 	 	 	 	
mir-29	microRNA	 	3	 	biased	0.816	1.50E-03	3.10E-02	EIF2AK2,EIF2S1,mir-29,PMP22,STAT1	CEBPB,ICAM1,IFI16,JUN,KCTD12,SAMHD1	6 (5)	3	 	ethanol	 	 	EIF2AK2	 	 	 	 	
SNAI1	transcription regulator	 	3	 	 	0.447	1.80E-03	4.37E-02	AKT1,ATM,SNAI1,TAZ,YAP1	CFLAR,FN1,JUN,SERPINE1,TGFBR2	5 (5)	4	 	 	 	GFAP,TAZ	LIF,TGFB1	 	 	 	 	
EIF2AK2	kinase	 	2	 	biased	-1.342	2.18E-03	2.73E-02	EIF2AK2,EIF2S1,STAT1	CEBPB,ICAM1,IFI16,KCTD12,SAMHD1	5 (3)	2	APP,ethanol	mir-29	 	 	 	 	 	 	 	
TGFB2	growth factor	 	1	 	biased	-1.414	3.52E-03	1.54E-02	TGFB2	CDH5,PECAM1	2 (1)	1	 	beta-estradiol	 	 	 	 	 	 	 	
TTYH1	ion channel	 	1	 	biased	1.414	3.52E-03	1.46E-02	TTYH1	HES1,HES5	2 (1)	1	ADCYAP1,levodopa	 	 	 	 	 	 	 	 	
CAV1	transmembrane receptor	 	1	 	biased	-1.414	7.21E-03	4.11E-02	CAV1	ICAM1,VCAM1	2 (1)	1	TGFB1,VEGFA	beta-estradiol,IFNG	 	 	MAPK1	 	 	 	 	
VEGFA	growth factor	 	1	 	biased	-1.414	7.21E-03	4.51E-02	VEGFA	ICAM1,TAL1	2 (1)	1	EGF,EGFR,FGF2,HRAS,IFNG,TGFB1	Meg3	 	CAV1,MAPK1	 	 	 	 	 	
GFAP	other	 	1	 	 	1.414	9.49E-03	2.42E-02	GFAP	ITGA2,ITGA6	2 (1)	1	ADCYAP1,APP,ethanol,IFNG,LIF,mir-21,PRKCD,SNAI1,TAC1,TNF	EGF,levodopa,TGFB1	 	 	 	 	 	 	 	
LAMA2	other	 	1	 	 	-1.414	9.49E-03	4.01E-02	LAMA2	CDH5,CLDN5	2 (1)	1	beta-estradiol,ITGB1	 	 	 	 	 	 	 	 	
TENM1	transmembrane receptor	 	1	 	biased	-1.414	1.20E-02	3.32E-02	TENM1	EDNRB,MGP	2 (1)	1	 	APP	 	 	 	 	 	 	 	
ABCC4	transporter	 	1	 	biased	1.000	1.92E-02	3.40E-02	ABCC4	ABCG2	1 (1)	1	 	 	 	 	 	 	 	 	 	
Becn2	other	 	1	 	biased	-1.000	1.92E-02	4.96E-02	Becn2	CNR1	1 (1)	1	 	 	 	 	CNR1	 	 	 	 	
DANCR	other	 	1	 	biased	-1.000	1.92E-02	1.57E-02	DANCR	RAB1A	1 (1)	1	 	 	 	 	 	 	 	 	 	
EFEMP1	enzyme	 	1	 	biased	-1.000	1.92E-02	3.33E-02	EFEMP1	ADAM17	1 (1)	1	IGFBP2	 	 	 	 	 	 	 	 	
Fendrr	other	 	1	 	biased	-1.000	1.92E-02	2.88E-02	Fendrr	FOXF1	1 (1)	1	 	 	 	 	 	 	 	 	 	
GBP1	enzyme	 	1	 	biased	-1.000	1.92E-02	3.35E-02	GBP1	MMP1	1 (1)	1	EGFR	 	 	 	 	 	 	 	 	
GPRASP1	transporter	 	1	 	biased	-1.000	1.92E-02	4.96E-02	GPRASP1	CNR1	1 (1)	1	 	 	 	 	CNR1	 	 	 	 	
HYOU1	other	 	1	 	biased	-1.000	1.92E-02	3.51E-02	HYOU1	PECAM1	1 (1)	1	 	 	 	 	Ca2+	 	 	 	 	
MIB1	enzyme	 	1	 	biased	1.000	1.92E-02	4.96E-02	MIB1	HES5	1 (1)	1	 	 	 	 	 	 	 	 	 	
PDIA3	peptidase	-0.665	1	 	biased	1.000	1.92E-02	3.22E-02	PDIA3	PRNP	1 (1)	1	 	 	 	 	 	 	 	 	 	
PRKDC	kinase	 	1	 	biased	-1.000	1.92E-02	4.99E-02	PRKDC	VCAM1	1 (1)	1	 	 	 	 	 	 	 	 	 	
RHBDF1	other	 	1	 	biased	-1.000	1.92E-02	3.33E-02	RHBDF1	ADAM17	1 (1)	1	 	 	 	EGFR	 	 	 	 	 	
RHBDF2	other	 	1	 	biased	-1.000	1.92E-02	3.33E-02	RHBDF2	ADAM17	1 (1)	1	 	 	 	EGFR	 	 	 	 	 	
STK38L	kinase	 	1	 	biased	-1.000	1.92E-02	4.85E-02	STK38L	ITGB1	1 (1)	1	 	 	 	ITGB1	 	 	 	 	 	
TAZ	enzyme	 	1	 	biased	-1.000	1.92E-02	4.88E-02	TAZ	FN1	1 (1)	1	SNAI1	 	 	 	 	 	 	 	 	
TLN1	other	 	1	 	biased	-1.000	1.92E-02	4.85E-02	TLN1	ITGB1	1 (1)	1	 	 	 	ITGB1	 	 	 	 	 	
VPS18	transporter	 	1	 	biased	1.000	1.92E-02	4.85E-02	VPS18	ITGB1	1 (1)	1	 	 	 	 	ITGB1	 	 	 	 	
mir-183	microRNA	 	1	 	biased	1.000	1.92E-02	1.55E-02	mir-183	SEL1L	1 (1)	1	 	 	 	 	 	 	 	 	 	
DRP2	other	 	1	 	biased	1.000	3.79E-02	3.65E-02	DRP2	UTRN	1 (1)	1	 	 	 	 	 	 	 	 	 	

Diseases and Bio Functions for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Cellular Compromise	degeneration	Degeneration of cells	1.16E-07	 	1.579	 	0.515	JUN,CNR1,EP300,EDNRB,CASP1,IL6,IL6ST,STMN1,IREB2,ETS2,TGFBR2,STAT3,PRNP,PTGS2,FLT1,RAB1A,PARL,SERPINE1,ZPR1,NFIL3,TARDBP,USP53	22	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	degeneration	Degeneration of neurons	3.74E-07	 	1.381	bias	0.328	JUN,CNR1,EP300,EDNRB,CASP1,IL6,STMN1,IREB2,ETS2,TGFBR2,STAT3,PRNP,PTGS2,FLT1,RAB1A,PARL,SERPINE1,ZPR1,NFIL3,TARDBP,USP53	21	
Neurological Disease	degeneration	Degeneration of nervous system	7.25E-07	 	1.355	bias	0.222	JUN,EP300,CNR1,EDNRB,CASP1,IL6,STMN1,IREB2,IL6ST,ETS2,TGFBR2,SLC7A11,STAT3,PRNP,PTGS2,FLT1,RAB1A,PARL,SERPINE1,ZPR1,NFIL3,USP53,TARDBP	23	
Neurological Disease	neurodegeneration	Neurodegeneration	3.57E-06	 	1.160	 	0.081	JUN,EP300,CNR1,EDNRB,CASP1,IL6,STMN1,IREB2,ETS2,TGFBR2,SLC7A11,STAT3,PRNP,PTGS2,FLT1,RAB1A,PARL,SERPINE1,ZPR1,NFIL3,USP53,TARDBP	22	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	activation	Activation of astrocytes	2.99E-05	 	-1.942	bias	-1.172	PRNP,IL1R1,PTGS2,CEBPB,CASP1,SERPINE1,IL6,TARDBP	8	
Cell Death and Survival	necrosis	Necrosis	3.01E-05	 	0.321	 	0.057	JUN,INSM1,ITGA2,CNR1,FKBP1A,SEL1L,IL6,TNFRSF10B,ETS2,ADAM17,CFLAR,STAT3,FN1,IL1R1,ITGB1,PARL,CASP2,NFIL3,CASP7,TARDBP,RRAS2,GBE1,EP300,CASP1,WWTR1,ACVRL1,IL6ST,SIAH1,RPS3,SLC7A11,PRNP,PANX1,PTGS2,CEBPB,PDIA3,UBE2K,SERPINE1,C9orf72,GCLM,MMP1,USP53	41	
Cell Death and Survival	cell death	Neuronal cell death	5.30E-05	 	-0.112	 	-0.326	JUN,INSM1,ITGA2,CNR1,FKBP1A,SEL1L,IL6,ETS2,ADAM17,CFLAR,STAT3,FN1,IL1R1,ITGB1,PARL,CASP2,NFIL3,CASP7,TARDBP,RRAS2,GBE1,EP300,CASP1,ACVRL1,SIAH1,RPS3,PRNP,PANX1,PTGS2,CEBPB,PDIA3,UBE2K,SERPINE1,C9orf72,GCLM,MMP1,USP53	37	
Organismal Injury and Abnormalities	degeneration	Organ Degeneration	1.49E-04	 	0.545	bias	-0.430	JUN,CNR1,EDNRB,CASP1,IL6,IREB2,ETS2,TGFBR2,SLC7A11,PRNP,PTGS2,NFIL3,USP53	13	
Neurological Disease, Organismal Injury and Abnormalities	degeneration	Degeneration of brain	1.92E-04	 	0.220	bias	-0.572	JUN,TGFBR2,SLC7A11,PRNP,PTGS2,CNR1,CASP1,IL6,NFIL3,IREB2,ETS2	11	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	cerebral degeneration	Cerebral degeneration	1.92E-04	 	 	 	 	EP300,C9orf72,IL6,NFIL3,TARDBP,ETS2	6	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	activation	Activation of neuroglia	2.22E-04	Decreased	-2.378	 	-2.021	PRNP,FN1,IL1R1,CEBPB,PTGS2,CASP1,SERPINE1,ABHD12,IL6,TARDBP	10	
Cell Cycle	cleavage	Cleavage of cells	2.28E-04	 	 	 	 	LEF1,TIAL1,WWTR1,HES1,NCOA3	5	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	2.68E-04	 	 	 	 	C9orf72,IL6,NFIL3,TARDBP,ETS2	5	
Cell Morphology, Cellular Movement	cell spreading	Cell spreading	3.13E-04	 	 	 	 	STAT3,FN1,ITGA6,EDNRB	4	
Nervous System Development and Function	activation	Activation of neuronal layer	3.58E-04	 	 	 	 	THRA,CNR1	2	
Cell-To-Cell Signaling and Interaction	transduction	Transduction of multilineage progenitor cells	3.58E-04	 	 	 	 	FN1,IL6	2	
Organismal Injury and Abnormalities	edema	Edema	5.50E-04	 	1.342	 	1.200	PRNP,FLT1,CD93,SERPINE1,IL6	5	
Cell Death and Survival	apoptosis	Apoptosis of sympathetic neuron	7.10E-04	 	0.478	 	0.591	JUN,ADAM17,CASP1,CASP2,SIAH1	5	
Cell Death and Survival	apoptosis	Apoptosis	7.76E-04	 	0.950	 	0.348	JUN,INSM1,ITGA2,CNR1,SEL1L,TNFRSF10B,ADAM17,CFLAR,STAT3,FN1,ITGB1,PARL,CASP2,CASP7,GBE1,EP300,CASP1,WWTR1,IL6ST,SIAH1,RPS3,PRNP,PANX1,PTGS2,CEBPB,CCNA2,HES1,GCLM,USP53	29	
Neurological Disease, Organismal Injury and Abnormalities	progressive encephalopathy	Progressive encephalopathy	8.21E-04	 	 	 	 	JUN,FTL,CNR1,IL6,PRDX1,ABCG2,STMN1,ETS2,TGFBR2,STAT3,PRNP,PTGS2,C9orf72,ICAM1,NFIL3,TARDBP	16	
Cell Cycle	cell division	Cell division of stem cells	8.42E-04	 	 	 	 	TIAL1,WWTR1,HES1,NCOA3	4	
Nervous System Development and Function	neuroprotection	Neuroprotection of cerebral cortex cells	8.42E-04	 	0.287	bias	0.779	STAT3,PRNP,PTGS2,CNR1	4	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	cell death	Cell death of cortical neurons	9.46E-04	 	0.546	 	0.695	JUN,CFLAR,PRNP,IL1R1,PTGS2,EP300,SERPINE1,GCLM,CASP2,NFIL3,TARDBP,ETS2	12	
Nervous System Development and Function	neuroprotection	Neuroprotection of CA1 neuron	1.06E-03	 	 	 	 	STAT3,PTGS2	2	
Neurological Disease	neurological disorder	Progressive neurological disorder	1.08E-03	 	 	 	 	JUN,FTL,CNR1,IL6,PRDX1,ABCG2,STMN1,ETS2,TGFBR2,STAT3,PRNP,PTGS2,PDIA3,C9orf72,ICAM1,NFIL3,TARDBP	17	
Cell Morphology, Cellular Movement	cell spreading	Cell spreading of tumor cell lines	1.31E-03	 	 	 	 	STAT3,FN1,EDNRB	3	
Cellular Development	differentiation	Differentiation of stem cells	1.33E-03	 	-0.557	 	0.192	JUN,THRA,PGF,WWTR1,IL6,IL6ST,NCOA3,EIF4G2,ZFP36L2,STAT3,FN1,HES5,ITGB1,FLT1,HES1,TAL1	16	
Neurological Disease	damage	Damage of nervous system	1.50E-03	 	0.525	 	0.150	JUN,TGFBR2,CFLAR,PRNP,IL1R1,PTGS2,CNR1,FKBP1A,CASP1,IL6,GPR17,NFIL3	12	
Neurological Disease	progressive motor neuropathy	Progressive motor neuropathy	2.04E-03	 	 	 	 	PRNP,FTL,CNR1,PDIA3,C9orf72,IL6,NFIL3,STMN1,ETS2,TARDBP	10	
Cell Death and Survival, Cell Morphology, Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	loss	Loss of CA1 neuron	2.09E-03	 	 	 	 	PRNP,CEBPB	2	
Cardiovascular System Development and Function, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Organismal Development, Tissue Development	proliferation	Proliferation of microvascular endothelial cells	2.09E-03	 	 	 	 	IL6,PECAM1	2	
Cell Signaling, Molecular Transport, Nucleic Acid Metabolism, Small Molecule Biochemistry	accumulation	Accumulation of cyclic AMP	2.10E-03	 	 	 	 	PRNP,CNR1,ICAM1	3	
Nervous System Development and Function	neuroprotection	Neuroprotection of hippocampus	2.10E-03	 	 	 	 	STAT3,PRNP,PTGS2	3	
Neurological Disease, Organismal Injury and Abnormalities	abnormality	Abnormality of cerebral cortex	2.23E-03	 	-0.570	 	-1.002	EIF4EBP2,LEF1,ITGA6,CNR1,EP300,IREB2,ETS2,SLC7A11,CFLAR,PRNP,CEBPB,PTGS2,NFIL3,TARDBP	14	
Cellular Development, Embryonic Development, Organismal Development	differentiation	Differentiation of embryonic stem cells	2.26E-03	 	-0.180	bias	0.530	JUN,STAT3,FN1,THRA,FLT1,WWTR1,IL6,EIF4G2	8	
Metabolic Disease, Organismal Injury and Abnormalities	amyloidosis	Amyloidosis	2.29E-03	 	 	 	 	JUN,TGFBR2,STAT3,PRNP,PTGS2,CNR1,IL6,PRDX1,ICAM1,ABCG2,BGN,ETS2	12	
Inflammatory Response	inflammatory response	Inflammatory response	2.31E-03	Decreased	-2.433	 	-2.113	STAT3,PRNP,FN1,PTGS2,CEBPB,ABHD12,IL6	7	
Cell Death and Survival	cell death	Cell death of tumor cell lines	2.41E-03	 	-0.368	 	-0.527	JUN,STAT3,SLC7A11,CFLAR,PTGS2,CNR1,CASP1,WWTR1,NFIL3,TNFRSF10B	10	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	outgrowth	Outgrowth of neurons	2.46E-03	 	-1.735	bias	-0.733	ITGA6,EZR,CNR1,IL6,HDGFL3,IL6ST,VCAM1,EIF4G2,NFATC3,CFLAR,ADAM17,STAT3,PRNP,FN1,ITGB1,PDIA3,SERPINE1	17	
Cellular Development, Nervous System Development and Function	differentiation	Differentiation of astrocytes	2.96E-03	 	-1.231	 	-1.046	STAT3,HES5,ITGB1,HES1,ACTR3,IL6ST	6	
Cellular Development	differentiation	Differentiation of central nervous system cells	3.06E-03	 	-0.342	 	0.146	STAT3,PRNP,FN1,HES5,ITGB1,CNR1,HES1,ACTR3,IL6ST	9	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	growth	Growth of neurites	3.14E-03	 	-1.962	 	-0.985	MTMR9,EP300,EZR,CNR1,IL6,HDGFL3,IL6ST,VCAM1,EIF4G2,NFATC3,CFLAR,ADAM17,STAT3,PRNP,FN1,ITGB1,FLT1,PDIA3,SERPINE1,ZPR1	20	
Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation	assembly	Assembly of cells	3.14E-03	 	 	 	 	PANX1,IL6,PECAM1	3	
Drug Metabolism, Lipid Metabolism, Small Molecule Biochemistry	synthesis	Synthesis of prostaglandin E2	3.14E-03	 	 	 	 	PRNP,PTGS2,IL6	3	
Nervous System Development and Function	myelination	Myelination of nervous system	3.26E-03	 	-1.091	bias	-0.591	JUN,ITGB1,THRA,PTPRE,ADAM19,GPR17,IL6ST	7	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	neurodegeneration	Neurodegeneration of neurites	3.26E-03	 	0.391	 	-0.048	JUN,CASP1,SERPINE1,ZPR1,NFIL3,STMN1,TARDBP	7	
Cell Death and Survival, Cellular Function and Maintenance	self-renewal	Self-renewal of cells	3.38E-03	 	-1.664	bias	-0.979	STAT3,ITGB1,LEF1,WWTR1,SEL1L,HES1	6	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of phagocytes	3.45E-03	 	 	 	 	IL1R1,ITGB1	2	
Cell-To-Cell Signaling and Interaction, Embryonic Development	binding	Binding of mesenchymal cells	3.45E-03	 	 	 	 	ITGB1,VCAM1	2	
Cell-To-Cell Signaling and Interaction, Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities	damage	Damage of synapse	3.45E-03	 	 	 	 	PRNP,IL6	2	
Nervous System Development and Function, Tissue Morphology	quantity	Quantity of radial glial cells	3.45E-03	 	 	 	 	STAT3,ITGB1	2	
Nervous System Development and Function	myelination	Myelination	3.77E-03	 	0.277	 	0.725	JUN,FN1,ITGB1,THRA,PTPRE,ADAM19,GPR17,IL6ST,TARDBP	9	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	cell death	Cell death of cerebral cortex cells	4.11E-03	 	0.331	 	0.360	JUN,EP300,RPS3,ETS2,CFLAR,PRNP,IL1R1,PTGS2,SERPINE1,GCLM,CASP2,NFIL3,TARDBP	13	
Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities	damage	Damage of neurons	4.25E-03	 	-0.440	 	-0.884	TGFBR2,PRNP,PTGS2,FKBP1A,CNR1,IL6,NFIL3	7	
Cellular Movement	cell movement	Cell movement of stem cells	4.35E-03	Decreased	-2.186	bias	-1.457	ADAM17,ITGB1,PGF,FLT1,EDNRB,SELE	6	
Neurological Disease, Organismal Injury and Abnormalities	neurodegeneration	Neurodegeneration of brain	4.40E-03	 	-0.346	 	-1.032	SLC7A11,PRNP,PTGS2,CNR1,IL6,NFIL3,IREB2,ETS2	8	
Cell Death and Survival, Organismal Injury and Abnormalities	necrosis	Necrosis of epithelial tissue	4.62E-03	 	1.982	 	1.902	CFLAR,ITGB1,ITGA2,SEL1L	4	
Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Alzheimer disease	Alzheimer disease	4.67E-03	 	 	 	 	JUN,TGFBR2,STAT3,PRNP,PTGS2,CNR1,IL6,PRDX1,ICAM1,ABCG2,ETS2	11	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	outgrowth	Outgrowth of neurites	4.75E-03	Decreased	-2.040	bias	-1.044	EZR,CNR1,IL6,HDGFL3,IL6ST,VCAM1,EIF4G2,NFATC3,CFLAR,ADAM17,STAT3,PRNP,FN1,ITGB1,PDIA3,SERPINE1	16	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Inflammatory Response	binding	Binding of professional phagocytic cells	5.11E-03	 	 	 	 	IL1R1,ITGB1	2	
Cellular Development	commitment	Commitment of stem cells	5.11E-03	 	 	 	 	SEL1L,HES1	2	
Cell-mediated Immune Response, Lymphoid Tissue Structure and Development	frequency	Frequency of T lymphocytes	5.11E-03	 	 	 	 	SERPINB1,TGFBR2	2	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	Huntington disease	Huntington disease grade 3 Huntington disease	5.11E-03	 	 	 	 	CASP2,CASP7	2	
Neurological Disease	neurodegeneration	Neurodegeneration of peripheral nervous system	5.11E-03	 	 	 	 	JUN,EDNRB	2	
Auditory and Vestibular System Development and Function, Nervous System Development and Function, Organ Morphology, Tissue Morphology	quantity	Quantity of vestibular hair cells	5.11E-03	 	 	 	 	HES5,HES1	2	
Cellular Movement, Nervous System Development and Function	cell movement	Cell movement of Schwann cells	5.62E-03	 	 	 	 	FN1,RRAS2,ITGB1,ITGA6	4	
Cellular Development, Embryonic Development, Organismal Development, Tissue Development	differentiation	Differentiation of embryonic tissue	6.42E-03	 	-1.276	 	-0.611	JUN,STAT3,FN1,PRNP,HES5,FLT1,PGF,WWTR1,HES1,IL6	10	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Nervous System Development and Function	activation	Activation of microglia	6.51E-03	Decreased	-2.219	 	-1.997	FN1,PRNP,PTGS2,CEBPB,ABHD12,IL6	6	
Neurological Disease, Organismal Injury and Abnormalities	degeneration	Degeneration of forebrain	6.75E-03	 	1.000	bias	0.391	JUN,TGFBR2,CASP1,IL6	4	
Cardiovascular System Development and Function, Organismal Development	angiogenesis	Angiogenesis	6.78E-03	 	-1.214	 	-0.907	FN1,ITGB1,PGF,IL6,PECAM1	5	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking	adhesion	Adhesion of immune cells	6.96E-03	 	 	 	 	IL1R1,ITGB1,SELE	3	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	apoptosis	Apoptosis of cerebellar granule cell	6.96E-03	 	 	 	 	JUN,PRNP,EP300	3	
Cell-To-Cell Signaling and Interaction	binding	Binding of neuroglia	6.96E-03	 	 	 	 	FN1,ITGB1,ITGA6	3	
Cell Morphology, Nervous System Development and Function, Organ Morphology, Organismal Development	morphology	Morphology of hippocampal cells	6.96E-03	 	 	 	 	SYNCRIP,PRNP,CEBPB	3	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of epithelial cells	7.06E-03	 	 	 	 	FN1,ITGA6	2	
Cellular Compromise, Nervous System Development and Function, Neurological Disease	degeneration	Degeneration of myelin sheath	7.06E-03	 	 	 	 	IL6ST,TARDBP	2	
Endocrine System Disorders, Gastrointestinal Disease, Metabolic Disease, Organismal Injury and Abnormalities	diabetes mellitus	Diabetes mellitus	7.06E-03	 	 	 	 	STAT3,PTGS2	2	
Neurological Disease	neurological disorder	Early-onset neurological disorder	7.06E-03	 	 	 	 	PTGS2,EDNRB	2	
Neurological Disease, Organismal Injury and Abnormalities	gliosis	Gliosis of cerebellum	7.06E-03	 	 	 	 	PRNP,IL6	2	
Cellular Movement	homing	Homing of stem cells	7.06E-03	 	 	 	 	PGF,SELE	2	
Cell Death and Survival, Cellular Development, Cellular Function and Maintenance	self-renewal	Self-renewal of tumor cell lines	7.06E-03	 	 	 	 	LEF1,SEL1L	2	
Cardiovascular System Development and Function	development	Development of vasculature	7.25E-03	 	-1.214	 	-0.895	ADAM17,FN1,ITGB1,PGF,IL6,PECAM1	6	
Cell Death and Survival	cell death	Cell death of central nervous system cells	7.31E-03	 	0.476	 	0.419	JUN,EP300,SEL1L,IL6ST,RPS3,ETS2,CFLAR,PRNP,IL1R1,PTGS2,SERPINE1,CASP2,GCLM,NFIL3,TARDBP	15	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function	proliferation	Proliferation of oligodendrocytes	7.37E-03	 	 	 	 	PRNP,FN1,THRA,CXCL2	4	
Neurological Disease, Organismal Injury and Abnormalities	neurodegeneration	Neurodegeneration of cerebral cortex	7.72E-03	 	-1.172	 	-1.543	SLC7A11,PTGS2,CNR1,NFIL3,ETS2	5	
Infectious Diseases	infection	Viral Infection	7.72E-03	 	0.000	 	-0.043	SNAP23,SYNCRIP,STAT3,PRNP,IL1R1	5	
Cell Death and Survival	apoptosis	Apoptosis of neurons	7.83E-03	 	0.444	 	-0.106	JUN,INSM1,GBE1,EP300,CNR1,CASP1,SEL1L,SIAH1,RPS3,ADAM17,PRNP,FN1,PANX1,PTGS2,CEBPB,PARL,CASP2,GCLM,CASP7,USP53	20	
Cell-To-Cell Signaling and Interaction, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	recruitment	Recruitment of leukocytes	7.95E-03	 	 	 	 	IL1R1,CXCL2,VCAM1	3	
Cell-To-Cell Signaling and Interaction, Cellular Movement	recruitment	Recruitment of cells	8.03E-03	 	-1.732	 	-1.347	IL1R1,ITGB1,CXCL2,VCAM1	4	
Cellular Movement	migration	Migration of stem cells	8.23E-03	Decreased	-2.200	bias	-1.537	ADAM17,ITGB1,PGF,FLT1,EDNRB	5	
Cellular Movement	cell movement	Cell movement of neuroglia	8.47E-03	Decreased	-2.177	 	-1.671	STAT3,FN1,RRAS2,ITGB1,ITGA6,IL6	6	
Organismal Development	growth	Growth of organism	8.54E-03	 	-0.850	 	-0.102	INSM1,ITGA6,CNR1,SEL1L,IL6,ZIC2,STAT3,PRNP,FN1,ITGB1,PTGS2,TIAL1,HES1,RAPGEF1,TARDBP	15	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of lymphatic system cells	9.29E-03	 	 	 	 	SELE,VCAM1	2	
Cell-To-Cell Signaling and Interaction	attachment	Attachment of cells	9.29E-03	 	 	 	 	FN1,ITGA6	2	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	binding	Binding of Schwann cells	9.29E-03	 	 	 	 	ITGB1,ITGA6	2	
Cell Morphology, Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	abnormal morphology	Abnormal morphology of pyramidal neurons	9.46E-03	 	 	 	 	EIF4EBP2,PRNP,CEBPB,IREB2	4	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	quantity	Quantity of steroid	9.46E-03	 	0.000	 	0.140	STAT3,PRNP,PTGS2,IL6	4	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	brain damage	Brain damage	9.82E-03	 	0.493	 	0.192	JUN,CFLAR,IL1R1,CNR1,CASP1,IL6,GPR17,NFIL3	8	
Infectious Diseases	replication	Replication of virus	1.02E-02	 	 	 	 	SNAP23,STAT3,IL1R1	3	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Organismal Development, Tissue Development	proliferation	Proliferation of neural stem cells	1.05E-02	 	-1.000	 	-0.593	ITGB1,CNR1,SEL1L,IL6,HES1	5	
Embryonic Development, Organismal Development, Tissue Development	growth	Growth of embryonic tissue	1.08E-02	 	-0.847	 	-0.236	ZIC2,STAT3,PRNP,INSM1,ITGB1,PTGS2,ITGA6,CNR1,SEL1L,HES1,RAPGEF1,IL6	12	
Cell-To-Cell Signaling and Interaction	activation	Activation of cells	1.09E-02	Decreased	-2.576	 	-2.118	FN1,PRNP,IL1R1,PTGS2,CEBPB,CNR1,CASP1,SERPINE1,ABHD12,IL6,TARDBP	11	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	proliferation	Proliferation of neuronal cells	1.12E-02	 	-1.693	 	-0.714	MTMR9,EP300,ITGA6,EZR,CNR1,IL6,HDGFL3,IL6ST,VCAM1,EIF4G2,NFATC3,CFLAR,ADAM17,STAT3,PRNP,FN1,ITGB1,FLT1,PDIA3,SERPINE1,ZPR1	21	
Neurological Disease, Organismal Injury and Abnormalities	edema	Edema of brain	1.14E-02	 	 	 	 	FLT1,CD93,SERPINE1	3	
Nervous System Development and Function, Neurological Disease	abnormal morphology	Abnormal morphology of nervous system	1.18E-02	 	 	 	 	EIF4EBP2,JUN,CLN5,THRA,CNR1,MAGI2,IL6,FLI1,IREB2,B4GALT1,STAT3,HES5,ITGB1,ZPR1,CASP2,TARDBP,LEF1,MECOM,ITGA6,CSTB,ACVRL1,STMN1,IL6ST,TGFBR2,PRNP,LATS2,CEBPB,HES1,GCLM,UTRN	30	
Free Radical Scavenging, Molecular Transport	accumulation	Accumulation of reactive oxygen species	1.18E-02	 	 	 	 	SLC7A11,CNR1	2	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell rolling	Cell rolling of leukocytes	1.18E-02	 	 	 	 	SELE,VCAM1	2	
Neurological Disease	mechanical hypersensitivity	Mechanical hypersensitivity	1.18E-02	 	 	 	 	IL6,IL6ST	2	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	megakaryocytopoiesis	Megakaryocytopoiesis	1.18E-02	 	 	 	 	IL6,IL6ST	2	
Neurological Disease, Organismal Injury and Abnormalities	reactive gliosis	Reactive gliosis	1.18E-02	 	 	 	 	IL6,TARDBP	2	
Cell-To-Cell Signaling and Interaction	binding	Binding of tumor cell lines	1.27E-02	 	 	 	 	ADAM17,FN1,VCAM1	3	
Cardiovascular System Development and Function, Tissue Morphology	permeability	Permeability of vascular system	1.28E-02	 	1.982	 	2.136	SERPINE1,CXCL2,PECAM1,CYP1B1	4	
Neurological Disease	function	Abnormal function of nervous system	1.31E-02	 	 	 	 	CNR1,CSTB,PARL,IL6,UTRN	5	
Cell Death and Survival	cell death	Cell death of neuroglia	1.34E-02	 	0.478	 	0.325	JUN,STAT3,IL1R1,PTGS2,ITGB1,IL6ST,TARDBP	7	
Cellular Development, Nervous System Development and Function	differentiation	Differentiation of oligodendrocyte precursor cells	1.37E-02	 	 	 	 	FN1,HES5,THRA,GPR17	4	
Cell Morphology, Cellular Assembly and Organization, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Nervous System Development and Function, Organismal Development, Tissue Development	branching	Branching of neurons	1.44E-02	 	-1.269	 	-0.698	JUN,EIF4EBP2,NRP2,EZR,CNR1,MAGI2,IL6,ACTR3,STAT3,PRNP,IL1R1,SEPTIN11,ITGB1,PTGS2,PDIA3,CALD1	16	
Cell Death and Survival	cell death	Cell death of brain	1.44E-02	 	-0.055	 	-0.139	JUN,EP300,RPS3,ETS2,CFLAR,PRNP,IL1R1,PTGS2,SERPINE1,CASP2,GCLM,NFIL3,CASP7,TARDBP	14	
Neurological Disease, Organ Morphology, Organismal Injury and Abnormalities, Psychological Disorders	atrophy	Atrophy of hippocampus	1.46E-02	 	 	 	 	EP300,TARDBP	2	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	lesioning	Lesioning of brain	1.46E-02	 	 	 	 	CFLAR,CASP1	2	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities, Tissue Morphology	neurodegeneration	Neurodegeneration of cortical neurons	1.46E-02	 	 	 	 	NFIL3,ETS2	2	
Cardiovascular System Development and Function, Organismal Development	vasculogenesis	Vasculogenesis	1.47E-02	 	 	 	 	FN1,ITGB1,IL6,PECAM1	4	
Cell Death and Survival	apoptosis	Apoptosis of central nervous system cells	1.50E-02	 	0.521	 	0.459	JUN,PRNP,PTGS2,EP300,SEL1L,GCLM,CASP2,IL6ST,RPS3	9	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	synaptic transmission	Synaptic transmission of hippocampal CA1 region	1.56E-02	 	 	 	 	EIF4EBP2,SLC7A11,PRNP	3	
Cardiovascular Disease, Organismal Injury and Abnormalities	infarction	Infarction	1.56E-02	 	 	 	 	PRNP,FN1,IL1R1,PANX1,PTGS2,CNR1,IL6	7	
Embryonic Development, Organismal Development	growth	Growth of embryo	1.57E-02	 	-0.587	 	0.135	INSM1,ITGA6,CNR1,SEL1L,IL6,ZIC2,STAT3,PRNP,FN1,ITGB1,PTGS2,TIAL1,HES1,RAPGEF1	14	
Cellular Movement, Embryonic Development	migration	Migration of embryonic cells	1.57E-02	 	-0.728	bias	-0.207	PGF,FLT1,CNR1,EDNRB	4	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of neurons	1.61E-02	 	 	 	 	EIF4EBP2,IQGAP1,CLN5,NRP2,THRA,CNR1,MAGI2,IL6,IREB2,SYNCRIP,STAT3,HES5,SEPTIN11,ITGB1,ZPR1,CASP2,TARDBP,CSTB,ACVRL1,TPM3,TGFBR2,PRNP,CEBPB,HES1,UTRN	25	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of leukocytes	1.62E-02	 	-1.446	 	-0.985	TGFBR2,IL1R1,CXCL2,SELE,VCAM1	5	
Cellular Movement	homing	Homing of cells	1.68E-02	 	 	 	 	NRP2,PGF,SELE,IL6	4	
Nervous System Development and Function	morphology	Morphology of nervous system	1.69E-02	 	 	 	 	EIF4EBP2,JUN,IQGAP1,CLN5,AP4E1,NRP2,THRA,CNR1,MAGI2,IL6,FLI1,IREB2,B4GALT1,SYNCRIP,STAT3,HES5,SEPTIN11,ITGB1,ZPR1,CASP2,TARDBP,LEF1,MECOM,ITGA6,CSTB,ACVRL1,STMN1,IL6ST,TPM3,TGFBR2,PRNP,LATS2,CEBPB,HES1,GCLM,UTRN	36	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of cerebral cortex cells	1.71E-02	 	 	 	 	PRNP,EZR,CNR1	3	
Drug Metabolism, Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	concentration	Concentration of prostaglandin E2	1.76E-02	 	 	 	 	PRNP,PTGS2	2	
Neurological Disease, Organismal Injury and Abnormalities	memory deficits	Memory deficits	1.76E-02	 	 	 	 	CNR1,TARDBP	2	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of hippocampus region	1.90E-02	 	 	 	 	LEF1	1	
Hematological System Development and Function, Humoral Immune Response, Immune Cell Trafficking, Inflammatory Response, Tissue Development	accumulation	Accumulation of B lymphocytes	1.90E-02	 	 	 	 	CD99	1	
Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Tissue Development	accumulation	Accumulation of CD8+ T lymphocyte	1.90E-02	 	 	 	 	CD99	1	
Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Tissue Development	accumulation	Accumulation of dendritic cells	1.90E-02	 	 	 	 	CD99	1	
Endocrine System Development and Function, Nervous System Development and Function, Organ Development	activation	Activation of adenohypophysis	1.90E-02	 	 	 	 	IL6	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	activation	Activation of enteric neurons	1.90E-02	 	 	 	 	IL6	1	
Cardiovascular System Development and Function, Tissue Development	adhesion	Adhesion of endothelial tissue	1.90E-02	 	 	 	 	IL1R1	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of neutrophils	1.90E-02	 	 	 	 	IL1R1	1	
Cardiovascular System Development and Function, Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	angiogenesis	Angiogenesis of cerebellum	1.90E-02	 	 	 	 	IL6	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Nervous System Development and Function, Organismal Development, Tissue Development	arborization	Arborization of spinal nerve	1.90E-02	 	 	 	 	ITGB1	1	
Nervous System Development and Function, Organ Morphology, Organismal Development	area	Area of lateral cerebral ventricle	1.90E-02	 	 	 	 	AP4E1	1	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function	proliferation	Arrest in proliferation of oligodendrocyte precursor cells	1.90E-02	 	 	 	 	THRA	1	
Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation	assembly	Assembly of tumor cell lines	1.90E-02	 	 	 	 	PANX1	1	
Neurological Disease	axonopathy	Axonopathy of central nervous system	1.90E-02	 	 	 	 	STMN1	1	
Neurological Disease	axonopathy	Axonopathy of peripheral nervous system	1.90E-02	 	 	 	 	STMN1	1	
Cell-To-Cell Signaling and Interaction, Embryonic Development	binding	Binding of dental pulp stem cells	1.90E-02	 	 	 	 	ITGB1	1	
Cardiovascular Disease, Organismal Injury and Abnormalities	bleeding	Bleeding of vascular plexus	1.90E-02	 	 	 	 	FLI1	1	
Cell Death and Survival, Embryonic Development	cell death	Cell death of embryonic tissue	1.90E-02	 	 	 	 	HES1	1	
Cell Morphology, Nervous System Development and Function, Organ Morphology, Organismal Development	cellularity	Cellularity of cerebellum	1.90E-02	 	 	 	 	IL6	1	
Cellular Development	commitment	Commitment of neural stem cells	1.90E-02	 	 	 	 	SEL1L	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	compaction	Compaction of tumor cell lines	1.90E-02	 	 	 	 	PANX1	1	
Auditory Disease, Developmental Disorder, Neurological Disease, Organismal Injury and Abnormalities	congenital deafness	Congenital deafness	1.90E-02	 	 	 	 	EDNRB	1	
Infectious Diseases, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	Creutzfeldt-Jakob disease	Creutzfeldt-Jakob disease	1.90E-02	 	 	 	 	PRNP	1	
Cellular Assembly and Organization, Nervous System Development and Function	defasciculation	Defasciculation of sensory neurons	1.90E-02	 	 	 	 	NRP2	1	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	degeneration	Degeneration of cholinergic fibers	1.90E-02	 	 	 	 	JUN	1	
Cell Cycle	cell cycle progression	Delay in cell cycle progression of tumor cell lines	1.90E-02	 	 	 	 	CSTB	1	
Cellular Movement, Nervous System Development and Function	migration	Delay in migration of Schwann cells	1.90E-02	 	 	 	 	ITGB1	1	
Tissue Morphology	density	Density of neuronal progenitor cells	1.90E-02	 	 	 	 	HES1	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	depletion	Depletion of NADPH	1.90E-02	 	 	 	 	SLC7A11	1	
Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation, Nervous System Development and Function	depolarization-induced suppression of excitation	Depolarization-induced suppression of excitation of hippocampal neurons	1.90E-02	 	 	 	 	CNR1	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of habenulopeduncular tract	1.90E-02	 	 	 	 	NRP2	1	
Cellular Movement	distribution	Distribution of granule neuron progenitor cells	1.90E-02	 	 	 	 	VCAM1	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	excitation	Excitation of postsynaptic region	1.90E-02	 	 	 	 	PCDH8	1	
Neurological Disease	excitotoxic lesion	Excitotoxic lesion	1.90E-02	 	 	 	 	CNR1	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	extension	Extension of peripheral lamellae	1.90E-02	 	 	 	 	ITGB1	1	
Nervous System Development and Function	fasciculation	Fasciculation of spinal nerve	1.90E-02	 	 	 	 	NRP2	1	
Hereditary Disorder, Infectious Diseases, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	fatal familial insomnia	Fatal familial insomnia	1.90E-02	 	 	 	 	PRNP	1	
Cellular Assembly and Organization, Nervous System Development and Function	folding	Folding of postsynaptic membrane	1.90E-02	 	 	 	 	UTRN	1	
Tissue Development	formation	Formation of basement membrane	1.90E-02	 	 	 	 	ITGB1	1	
Organismal Development, Tissue Development	formation	Formation of blood vessel lumen	1.90E-02	 	 	 	 	ITGB1	1	
Embryonic Development, Organismal Development, Tissue Development	formation	Formation of epiblast	1.90E-02	 	 	 	 	ITGB1	1	
Cellular Assembly and Organization, Cellular Compromise	formation	Formation of ferritin inclusion body	1.90E-02	 	 	 	 	FTL	1	
Organismal Injury and Abnormalities, Renal and Urological Disease	formation	Formation of glomeruloid body	1.90E-02	 	 	 	 	TFPI	1	
Cellular Assembly and Organization	formation	Formation of mitochondrial cristae	1.90E-02	 	 	 	 	TARDBP	1	
Cardiovascular Disease, Organismal Injury and Abnormalities	formation	Formation of plaque	1.90E-02	 	 	 	 	PRNP	1	
Inflammatory Response	frequency	Frequency of neutrophils	1.90E-02	 	 	 	 	CXCL2	1	
Hereditary Disorder, Infectious Diseases, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	gerstmann-straussler-scheinker disease	Gerstmann-straussler-scheinker disease	1.90E-02	 	 	 	 	PRNP	1	
Tissue Development	growth	Growth of white matter	1.90E-02	 	 	 	 	IL6	1	
Endocrine System Development and Function, Small Molecule Biochemistry	hydroxylation	Hydroxylation of melatonin	1.90E-02	 	 	 	 	CYP1B1	1	
Hematological Disease	hyperemia	Hyperemia	1.90E-02	 	 	 	 	PTGS2	1	
Developmental Disorder, Neurological Disease	hypoplasia	Hypoplasia of superior cervical ganglion	1.90E-02	 	 	 	 	HES1	1	
Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	induction	Induction of neural stem cells	1.90E-02	 	 	 	 	HES5	1	
Dermatological Diseases and Conditions, Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	inflammatory hyperalgesia	Inflammatory hyperalgesia	1.90E-02	 	 	 	 	CNR1	1	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	necrosis	Initiation of necrosis of cortical neurons	1.90E-02	 	 	 	 	CASP2	1	
Cell Morphology, Cellular Movement, Nervous System Development and Function, Tissue Development	innervation	Innervation of olfactory glomeruli	1.90E-02	 	 	 	 	NRP2	1	
Endocrine System Disorders, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	insulin resistance	Insulin resistance of POMC neurons	1.90E-02	 	 	 	 	STAT3	1	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	lack	Lack of mesencephalic tract of the trigeminal nerve	1.90E-02	 	 	 	 	LEF1	1	
Endocrine System Disorders, Organismal Injury and Abnormalities	leptin resistance	Leptin resistance of POMC neurons	1.90E-02	 	 	 	 	STAT3	1	
Cell Death and Survival, Cell Morphology, Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	loss	Loss of CA3 neurons	1.90E-02	 	 	 	 	CEBPB	1	
Nervous System Development and Function, Organ Morphology, Tissue Morphology	mass	Mass of white matter	1.90E-02	 	 	 	 	PRNP	1	
Cellular Movement, Embryonic Development, Nervous System Development and Function	migration	Migration of enteric neuroblasts	1.90E-02	 	 	 	 	EDNRB	1	
Cellular Movement, Embryonic Development	migration	Migration of hemangioblasts	1.90E-02	 	 	 	 	FLT1	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	movement	Movement of recycling endosomes	1.90E-02	 	 	 	 	TARDBP	1	
Neurological Disease, Skeletal and Muscular Disorders	muscle spasticity	Muscle spasticity of hindlimb	1.90E-02	 	 	 	 	CNR1	1	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	neurodegeneration	Neurodegeneration of sympathetic neuron	1.90E-02	 	 	 	 	JUN	1	
Nervous System Development and Function	organization	Organization of cranial nerve	1.90E-02	 	 	 	 	NRP2	1	
Nervous System Development and Function	organization	Organization of spinal nerve	1.90E-02	 	 	 	 	NRP2	1	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	osteoarthritis	Osteoarthritis	1.90E-02	 	 	 	 	TGFBR2	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organismal Development, Tissue Development	outgrowth	Outgrowth of neuroblasts	1.90E-02	 	 	 	 	ITGA6	1	
Neurological Disease, Organismal Injury and Abnormalities	partial seizure	Partial seizure	1.90E-02	 	 	 	 	PRNP	1	
Nervous System Development and Function	pathfinding	Pathfinding of vomeronasal nerve	1.90E-02	 	 	 	 	NRP2	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	penetration	Penetration of imatinib	1.90E-02	 	 	 	 	ABCG2	1	
Cardiovascular Disease	prion plaque	Prion plaque	1.90E-02	 	 	 	 	PRNP	1	
Neurological Disease, Skeletal and Muscular Disorders	motor dysfunction	Progressive motor dysfunction	1.90E-02	 	 	 	 	TARDBP	1	
Neurological Disease, Skeletal and Muscular Disorders	paralysis	Progressive paralysis	1.90E-02	 	 	 	 	TARDBP	1	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function	proliferation	Proliferation of reactive astrocytes	1.90E-02	 	 	 	 	EDNRB	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	prostatic carcinoma	Prostatic carcinoma	1.90E-02	 	 	 	 	ITGA6	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Organismal Development, Tissue Morphology	quantity	Quantity of neuroectodermal progenitor cells	1.90E-02	 	 	 	 	STAT3	1	
Cellular Assembly and Organization, Nervous System Development and Function, Tissue Morphology	quantity	Quantity of postsynaptic membrane	1.90E-02	 	 	 	 	UTRN	1	
Developmental Disorder	runting	Runting	1.90E-02	 	 	 	 	IL6	1	
Infectious Diseases, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	scrapie	Scrapie	1.90E-02	 	 	 	 	PRNP	1	
Cellular Assembly and Organization, Cellular Movement, Nervous System Development and Function	segregation	Segregation of sensory axons	1.90E-02	 	 	 	 	ITGB1	1	
Cell Death and Survival, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Organismal Development	self-renewal	Self-renewal of multilineage progenitor cells	1.90E-02	 	 	 	 	HES1	1	
Cellular Response to Therapeutics	sensitivity	Sensitivity of primary afferent neuron	1.90E-02	 	 	 	 	IL6ST	1	
Nervous System Development and Function	size	Size of cerebrospinal fluid compartment	1.90E-02	 	 	 	 	PRNP	1	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	size	Size of motor axons	1.90E-02	 	 	 	 	TARDBP	1	
Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Alzheimer disease	Stage I Alzheimer disease	1.90E-02	 	 	 	 	PTGS2	1	
Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Alzheimer disease	Stage V Alzheimer disease	1.90E-02	 	 	 	 	PTGS2	1	
Amino Acid Metabolism, Lipid Metabolism, Small Molecule Biochemistry	suppression	Suppression of GABA	1.90E-02	 	 	 	 	CNR1	1	
Cell Death and Survival, Cellular Compromise	toxicity	Toxicity of cerebellar granule cell	1.90E-02	 	 	 	 	GCLM	1	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	striatal degeneration	Striatal degeneration	2.05E-02	 	 	 	 	JUN,CASP1,IL6	3	
Cell Morphology, Nervous System Development and Function, Organ Morphology, Organismal Development	morphology	Morphology of cerebral cortex cells	2.07E-02	 	 	 	 	EIF4EBP2,SYNCRIP,PRNP,CEBPB,IREB2	5	
Cellular Development, Embryonic Development, Organismal Development	differentiation	Differentiation of embryonic cells	2.11E-02	 	-0.759	 	-0.062	JUN,STAT3,FN1,THRA,FLT1,PGF,WWTR1,IL6,EIF4G2	9	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function	proliferation	Proliferation of neuroglia	2.16E-02	 	-1.706	 	-1.412	PRNP,FN1,ITGB1,THRA,EDNRB,CXCL2,IL6,HES1	8	
Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities	neurodegeneration	Neurodegeneration of brain cells	2.16E-02	 	-0.251	bias	-0.850	PRNP,PTGS2,NFIL3,IREB2,ETS2	5	
Nervous System Development and Function	development	Sensory system development	2.16E-02	 	-1.949	 	-1.581	STAT3,HES5,ITGB1,HES1,IL6ST	5	
Cellular Development, Cellular Growth and Proliferation	proliferation	Proliferation of stem cells	2.18E-02	 	-1.442	 	-0.853	ZIC2,STAT3,FN1,ITGB1,PTGS2,CNR1,TIAL1,SEL1L,HES1,IL6,NCOA3	11	
Cellular Movement, Nervous System Development and Function	migration	Migration of Schwann cells	2.23E-02	 	 	 	 	FN1,RRAS2,ITGB1	3	
Organismal Injury and Abnormalities, Tissue Morphology	size	Size of lesion	2.28E-02	 	 	 	 	PRNP,PANX1,PTGS2,CNR1,CASP1,SERPINE1,IL6	7	
Cell Death and Survival, Organismal Injury and Abnormalities	apoptosis	Apoptosis of epithelial cells	2.43E-02	 	 	 	 	ITGB1,SEL1L	2	
Cell-To-Cell Signaling and Interaction	binding	Binding of stem cells	2.43E-02	 	 	 	 	ITGB1,VCAM1	2	
Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	damage	Damage of cortical neurons	2.43E-02	 	 	 	 	CNR1,NFIL3	2	
Cardiovascular System Development and Function	morphology	Morphology of cardiovascular system	2.43E-02	 	 	 	 	FN1,IL6	2	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of dendritic trees	2.43E-02	 	 	 	 	IQGAP1,ITGB1	2	
Molecular Transport	quantity	Quantity of heavy metal	2.43E-02	 	 	 	 	PRNP,FTL	2	
Nervous System Development and Function, Organ Morphology, Tissue Morphology	quantity	Quantity of inner hair cells	2.43E-02	 	 	 	 	HES5,HES1	2	
Infectious Diseases	replication	Replication of RNA virus	2.43E-02	 	 	 	 	STAT3,IL1R1	2	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance, Nervous System Development and Function	extension	Extension of neurites	2.56E-02	 	0.316	 	0.748	FN1,NRP2,ITGB1,EP300,SERPINE1,C9orf72,ACTR3,EIF4G2	8	
Neurological Disease	demyelination	Demyelination	2.58E-02	Decreased	-2.219	 	-2.548	PRNP,PTGS2,PTPRE,CXCL2,IL6,STMN1	6	
Cellular Movement	migration	Migration of cells	2.58E-02	Decreased	-2.686	 	-1.816	IQGAP1,RRAS2,NRP2,PGF,ITGA6,CNR1,EDNRB,SELE,CXCL2,STMN1,VCAM1,TGFBR2,ADAM17,STAT3,FN1,IL1R1,ITGB1,FLT1,ICAM1	19	
Organismal Injury and Abnormalities	bleeding	Bleeding	2.61E-02	 	 	 	 	TFPI,PARL,FLI1	3	
Cellular Compromise	injury	Injury of cells	2.61E-02	 	 	 	 	STAT3,CNR1,IL6	3	
Nervous System Development and Function	remyelination	Remyelination	2.61E-02	 	 	 	 	JUN,ADAM19,GPR17	3	
Cell Signaling, Small Molecule Biochemistry	synthesis	Synthesis of nitric oxide	2.61E-02	 	 	 	 	CEBPB,ITGB1,CNR1	3	
DNA Replication, Recombination, and Repair, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities	Down syndrome	Down syndrome	2.80E-02	 	 	 	 	ABCG1,ETS2	2	
Cellular Assembly and Organization	quantity	Quantity of mitochondria	2.80E-02	 	 	 	 	PARL,TARDBP	2	
Cell-To-Cell Signaling and Interaction, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	recruitment	Recruitment of phagocytes	2.80E-02	 	 	 	 	CXCL2,VCAM1	2	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function	proliferation	Proliferation of oligodendrocyte precursor cells	2.82E-02	 	 	 	 	FN1,THRA,CXCL2	3	
Cell Death and Survival	excitotoxicity	Susceptibility to excitotoxicity of neurons	2.82E-02	 	 	 	 	PTGS2,CNR1,GCLM	3	
Neurological Disease, Organismal Injury and Abnormalities	brain atrophy	Brain atrophy	3.04E-02	 	 	 	 	PRNP,EP300,TARDBP	3	
Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities	neurodegeneration	Neurodegeneration of cerebral cortex cells	3.04E-02	 	 	 	 	PTGS2,NFIL3,ETS2	3	
Cellular Movement	cell movement	Cell movement	3.17E-02	Decreased	-3.157	 	-2.187	IQGAP1,RRAS2,NRP2,PGF,ITGA6,CNR1,EDNRB,SELE,CXCL2,IL6,STMN1,VCAM1,TGFBR2,ADAM17,STAT3,FN1,IL1R1,ITGB1,FLT1,ICAM1	20	
Cell Morphology, Nervous System Development and Function, Neurological Disease, Tissue Morphology	abnormal morphology	Abnormal morphology of neurons	3.19E-02	 	 	 	 	EIF4EBP2,CLN5,THRA,CSTB,MAGI2,IL6,ACVRL1,IREB2,TGFBR2,STAT3,PRNP,HES5,ITGB1,CEBPB,ZPR1,HES1,CASP2,UTRN,TARDBP	19	
Cell Death and Survival	apoptosis	Apoptosis of dorsal root ganglion cells	3.19E-02	 	 	 	 	SEL1L,CASP2	2	
Endocrine System Development and Function, Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	concentration	Concentration of corticosterone	3.19E-02	 	 	 	 	STAT3,IL6	2	
Cell Death and Survival, Nervous System Development and Function	cell viability	Cell viability of hippocampal neurons	3.26E-02	 	 	 	 	JUN,STAT3,ITGB1	3	
Cardiovascular System Development and Function, Nervous System Development and Function, Organ Morphology, Tissue Morphology	permeability	Permeability of blood-brain barrier	3.26E-02	 	 	 	 	SERPINE1,CXCL2,CYP1B1	3	
Cellular Development, Nervous System Development and Function	differentiation	Differentiation of neuroglia	3.38E-02	 	-0.986	 	-0.602	STAT3,FN1,HES5,ITGB1,THRA,HES1,GPR17,ACTR3,IL6ST	9	
Cell Death and Survival	cell viability	Cell viability of tumor cell lines	3.47E-02	 	-0.712	 	-0.248	JUN,STAT3,ACSL5,SEL1L	4	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	apoptosis	Apoptosis of cerebral cortex cells	3.51E-02	 	0.342	 	0.387	JUN,PRNP,PTGS2,GCLM,CASP2,RPS3	6	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance, Nervous System Development and Function	extension	Extension of axons	3.51E-02	 	1.000	 	1.323	FN1,ITGB1,EP300,C9orf72,ACTR3,EIF4G2	6	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	neurodegeneration	Neurodegeneration of axons	3.58E-02	 	0.391	 	-0.059	SERPINE1,ZPR1,NFIL3,STMN1,TARDBP	5	
Cell Death and Survival, Organismal Injury and Abnormalities	apoptosis	Apoptosis of endothelial cells	3.61E-02	 	 	 	 	CFLAR,ITGA2	2	
Cellular Assembly and Organization, Nervous System Development and Function	complexity	Complexity of dendritic trees	3.61E-02	 	 	 	 	IQGAP1,ITGB1	2	
Cellular Development, Embryonic Development, Organismal Development	differentiation	Differentiation of embryoid body cells	3.61E-02	 	 	 	 	FN1,IL6	2	
Neurological Disease	dysmyelination	Dysmyelination of axons	3.61E-02	 	 	 	 	IL6,STMN1	2	
Cellular Movement	migration	Migration of neural stem cells	3.61E-02	 	 	 	 	ITGB1,EDNRB	2	
Nervous System Development and Function, Organ Morphology, Tissue Morphology	quantity	Quantity of granule cells	3.61E-02	 	 	 	 	PRNP,LEF1	2	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	release	Release of fatty acid	3.61E-02	 	 	 	 	IL1R1,CNR1	2	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	synaptic transmission	Synaptic transmission of CA1 neuron	3.61E-02	 	 	 	 	EIF4EBP2,PRNP	2	
Tissue Development	development	Development of epithelial tissue	3.73E-02	 	 	 	 	ITGB1,IL6,PECAM1	3	
Cellular Development, Embryonic Development, Nervous System Development and Function, Organismal Development, Tissue Development	differentiation	Differentiation of neural precursor cells	3.73E-02	 	 	 	 	STAT3,FN1,PRNP	3	
Protein Synthesis	synthesis	Synthesis of protein	3.73E-02	 	 	 	 	MKRN1,PRNP,EIF4G2	3	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of dorsal striatum	3.75E-02	 	 	 	 	IREB2	1	
Nervous System Development and Function, Neurological Disease	abnormal morphology	Abnormal morphology of superior ganglion of glossopharyngeal nerve	3.75E-02	 	 	 	 	MECOM	1	
Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Tissue Development	accumulation	Accumulation of CD4+ T-lymphocytes	3.75E-02	 	 	 	 	CD99	1	
Cell-To-Cell Signaling and Interaction, Embryonic Development	adhesion	Adhesion of bone marrow mesenchymal stem cells	3.75E-02	 	 	 	 	VCAM1	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of bone marrow-derived dendritic cells	3.75E-02	 	 	 	 	ITGB1	1	
Cell-To-Cell Signaling and Interaction	binding	Binding of leukemia cell lines	3.75E-02	 	 	 	 	VCAM1	1	
Neurological Disease, Organismal Injury and Abnormalities	bleeding	Bleeding of brainstem	3.75E-02	 	 	 	 	PARL	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organismal Development, Tissue Development	branching	Branching of basal dendrites	3.75E-02	 	 	 	 	CNR1	1	
Cell Cycle, Embryonic Development, Nervous System Development and Function	cell division	Cell division of neuroblasts	3.75E-02	 	 	 	 	LEF1	1	
Cellular Movement, Nervous System Development and Function	chemotaxis	Chemotaxis of cortical astrocytes	3.75E-02	 	 	 	 	IL6	1	
Cellular Movement, Embryonic Development	chemotaxis	Chemotaxis of mesenchymal stem cells	3.75E-02	 	 	 	 	PGF	1	
Developmental Disorder, Endocrine System Disorders, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	childhood adrenoleukodystrophy	Childhood adrenoleukodystrophy	3.75E-02	 	 	 	 	PTGS2	1	
DNA Replication, Recombination, and Repair	cleavage	Cleavage of DNA	3.75E-02	 	 	 	 	PRNP	1	
Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Alzheimer disease	Clinical dementia rating score 3 Alzheimer disease	3.75E-02	 	 	 	 	IL6	1	
Cellular Development, Nervous System Development and Function	commitment	Commitment of astrocytes	3.75E-02	 	 	 	 	SEL1L	1	
Cellular Development	commitment	Commitment of neuronal progenitor cells	3.75E-02	 	 	 	 	HES1	1	
Carbohydrate Metabolism, Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	concentration	Concentration of phosphatidylserine	3.75E-02	 	 	 	 	PTGS2	1	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	degeneration	Degeneration of myelin figure	3.75E-02	 	 	 	 	RAB1A	1	
Neurological Disease, Organismal Injury and Abnormalities	degeneration	Degeneration of nigrostriatum	3.75E-02	 	 	 	 	TGFBR2	1	
Cell Death and Survival	apoptosis	Delay in apoptosis of sympathetic neuron	3.75E-02	 	 	 	 	CASP2	1	
Neurological Disease	ataxia	Delay in ataxia of mice	3.75E-02	 	 	 	 	PRNP	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of cerebellar vermian lobule IX	3.75E-02	 	 	 	 	ZIC2	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of cerebellar vermian lobule VI	3.75E-02	 	 	 	 	ZIC2	1	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	development	Development of projection neurons	3.75E-02	 	 	 	 	NRP2	1	
Cellular Development, Embryonic Development, Organismal Development, Tissue Development	differentiation	Differentiation of neuroectodermal cells	3.75E-02	 	 	 	 	WWTR1	1	
Cellular Development, Embryonic Development, Organismal Development, Tissue Development	differentiation	Differentiation of pluripotent stem cell-derived mesodermal cells	3.75E-02	 	 	 	 	JUN	1	
Neurological Disease	distal peripheral neuropathy	Distal peripheral neuropathy	3.75E-02	 	 	 	 	FLT1	1	
Neurological Disease, Organismal Injury and Abnormalities	edema	Edema of lateral cerebral ventricle	3.75E-02	 	 	 	 	FLT1	1	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function	expansion	Expansion of satellite cells	3.75E-02	 	 	 	 	ITGB1	1	
Cardiovascular Disease, Organismal Injury and Abnormalities	failure	Failure of heart	3.75E-02	 	 	 	 	PTGS2	1	
Auditory and Vestibular System Development and Function, Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	formation	Formation of inner hair cells	3.75E-02	 	 	 	 	HES1	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Embryonic Development	fusion	Fusion of adipose mesenchymal stem cells	3.75E-02	 	 	 	 	VCAM1	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Skeletal and Muscular System Development and Function	fusion	Fusion of myotube	3.75E-02	 	 	 	 	VCAM1	1	
Cell Signaling, Small Molecule Biochemistry	generation	Generation of nitrite	3.75E-02	 	 	 	 	ITGB1	1	
Hematological Disease, Neurological Disease, Organismal Injury and Abnormalities, Respiratory Disease	hypoxia	Hypoxia of brain	3.75E-02	 	 	 	 	EDNRB	1	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	lesioning	Lesioning of cerebral cortex	3.75E-02	 	 	 	 	CFLAR	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long term synaptic depression	Long term synaptic depression of corticostriatal neurons	3.75E-02	 	 	 	 	CNR1	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long term synaptic depression	Long term synaptic depression of excitatory synapses	3.75E-02	 	 	 	 	CNR1	1	
Cellular Function and Maintenance	maintenance	Maintenance of embryonic stem cells	3.75E-02	 	 	 	 	FN1	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Nervous System Development and Function	modulation	Modulation of synapse	3.75E-02	 	 	 	 	PCDH8	1	
Cell Morphology, Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organ Development, Organ Morphology, Organismal Development, Tissue Development	morphogenesis	Morphogenesis of hippocampal neurons	3.75E-02	 	 	 	 	EZR	1	
Cell Death and Survival	necroptosis	Necroptosis of oligodendrocytes	3.75E-02	 	 	 	 	TARDBP	1	
Cell Cycle	neurite outgrowth stage	Neurite outgrowth stage of dorsal root ganglion cells	3.75E-02	 	 	 	 	ITGB1	1	
Auditory Disease, Cell Death and Survival, Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities, Tissue Morphology	neurodegeneration	Neurodegeneration of spiral ganglion cells	3.75E-02	 	 	 	 	EDNRB	1	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	neurodegeneration	Neurodegeneration of substantia nigra pars compacta	3.75E-02	 	 	 	 	SLC7A11	1	
Cellular Assembly and Organization, Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	outgrowth	Outgrowth of growth cone	3.75E-02	 	 	 	 	FN1	1	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	pain	Pain of hindpaw	3.75E-02	 	 	 	 	IL6ST	1	
Neurological Disease, Organismal Injury and Abnormalities	pathogenesis	Pathogenesis of medulla oblongata	3.75E-02	 	 	 	 	PRNP	1	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	pruritus	Pruritus	3.75E-02	 	 	 	 	STAT3	1	
Cell-To-Cell Signaling and Interaction, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	recruitment	Recruitment of M2 macrophages	3.75E-02	 	 	 	 	VCAM1	1	
Endocrine System Development and Function, Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	release	Release of corticosterone	3.75E-02	 	 	 	 	CNR1	1	
Cellular Function and Maintenance, Tissue Development	reorganization	Reorganization of growth cone	3.75E-02	 	 	 	 	CNR1	1	
Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Alzheimer disease	Stage II Alzheimer disease	3.75E-02	 	 	 	 	PTGS2	1	
Cell Morphology, Cellular Compromise, Organismal Injury and Abnormalities	swelling	Swelling of astrocyte endfeet	3.75E-02	 	 	 	 	IL6	1	
Tissue Morphology	thickening	Thickening of endothelial tissue	3.75E-02	 	 	 	 	FLT1	1	
Organismal Functions, Skeletal and Muscular Disorders	weakness	Weakness of hindlimb	3.75E-02	 	 	 	 	IL6	1	
Lipid Metabolism, Small Molecule Biochemistry	synthesis	Synthesis of lipid	4.00E-02	 	0.038	bias	0.774	PRNP,PTGS2,CNR1,IL6	4	
Cellular Movement	chemotaxis	Chemotaxis of central nervous system cells	4.04E-02	 	 	 	 	NRP2,IL6	2	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of hippocampal neurons	4.04E-02	 	 	 	 	PRNP,EZR	2	
Neurological Disease, Organismal Injury and Abnormalities	gliosis	Gliosis of cells	4.04E-02	 	 	 	 	PRNP,IL6	2	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	formation	Formation of brain cells	4.19E-02	 	 	 	 	PRNP,EZR,CNR1,HES1	4	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	neurogenesis	Neurogenesis of brain	4.19E-02	 	0.068	 	0.513	CNR1,CD93,IL6,HES1	4	
Cell-To-Cell Signaling and Interaction, Cellular Function and Maintenance, Nervous System Development and Function	paired-pulse facilitation	Paired-pulse facilitation of synapse	4.23E-02	 	 	 	 	NRP2,CNR1,SHISA9	3	
Cell Death and Survival	cell death	Cell death of stem cells	4.46E-02	 	0.447	 	0.244	TPM3,PRNP,SEL1L,CCNA2,HES1	5	
Cellular Development, Embryonic Development, Organismal Development, Tissue Development	differentiation	Differentiation of mesodermal cells	4.49E-02	 	 	 	 	JUN,FLT1	2	
Organismal Functions	energy expenditure	Energy expenditure	4.49E-02	 	 	 	 	CNR1,IL6	2	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cellular infiltration	Infiltration by neutrophils	4.49E-02	 	 	 	 	IL1R1,CXCL2	2	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	development	Development of oligodendrocytes	4.50E-02	 	 	 	 	TGFBR2,HES5,IL6ST	3	
Cell Death and Survival	apoptosis	Apoptosis of tumor cell lines	4.50E-02	 	0.103	 	0.048	JUN,STAT3,CFLAR,CASP1,WWTR1,TNFRSF10B	6	
Cellular Development, Nervous System Development and Function, Tissue Development	differentiation	Differentiation of neurons	4.50E-02	 	-1.330	 	-0.715	INSM1,THRA,SPAG9,BNIP2,CNR1,CHRDL1,IL6,ACTR3,STAT3,PRNP,FN1,HES5,ITGB1,CEBPB,HES1,TAL1	16	
Cell Morphology, Cellular Assembly and Organization, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organismal Development, Tissue Development	branching	Branching of neurites	4.61E-02	 	-1.021	 	-0.450	EIF4EBP2,NRP2,EZR,CNR1,MAGI2,IL6,ACTR3,STAT3,PRNP,SEPTIN11,ITGB1,PTGS2,PDIA3,CALD1	14	
Behavior	learning	Learning	4.62E-02	 	-0.391	 	-0.019	JUN,PTGS2,ITGB1,CNR1,TARDBP	5	
Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders	multiple sclerosis	Multiple Sclerosis	4.77E-02	 	 	 	 	CNR1,PDIA3,STMN1	3	
Nervous System Development and Function	myelination	Myelination of central nervous system	4.77E-02	 	 	 	 	THRA,GPR17,IL6ST	3	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	apoptosis	Apoptosis of brain cells	4.81E-02	 	0.100	 	0.107	JUN,PRNP,PTGS2,EP300,GCLM,CASP2,RPS3	7	
Tissue Morphology	quantity	Quantity of stem cells	4.94E-02	Decreased	-2.219	 	-1.720	STAT3,FN1,ITGB1,EDNRB,IL6	5	
Auditory and Vestibular System Development and Function, Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	formation	Formation of hair cells	4.95E-02	 	 	 	 	HES5,HES1	2	
Auditory and Vestibular System Development and Function, Nervous System Development and Function, Organ Morphology, Tissue Morphology	quantity	Quantity of outer hair cells	4.95E-02	 	 	 	 	HES5,HES1	2	

Tox Functions for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Heart Failure	failure	Failure of heart	3.75E-02	 	 	 	 	PTGS2	1	

Regulator Effects for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Consistency Score	Node Total	Regulator Total	Regulators	Target Total	Target Molecules in Dataset	Disease & Function Total	Diseases & Functions	Known Regulator-Disease/Function Relationships
2.449	8	1	TNF	6	CASP1,CEBPB,IL1R1,IL6,PTGS2,SERPINE1	1	Activation of cells	0% (0/1)	
Networks for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
ID	Analysis	Molecules in Network	Score	Focus Molecules	Top Diseases and Functions	
1	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ADAM17,ADAM19,CEBPB,CLDN5,CNR1,CXCL2,DAB2,DERL1,EIF4G2,EP300,EZR,HES1,HES5,HLA-E,ICAM1,IL1R1,IL6,IL6ST,ITGA2,ITGA6,ITGB1,JUN,MMP1,MT-CO2,MT-ND4,PDIA3,PRNP,PTGS2,SEL1L,STAT3,STMN1,TAL1,TARDBP,TM4SF1,VCAM1	57	35	Cancer, Cellular Movement, Organismal Injury and Abnormalities	
2	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ATF4,BAMBI,BCAP29,BMP7,CD14,CREB1,ELAVL1,FN1,GAL,GALP,GPR19,ICAM1,IER3,IL1B,IL1RN,LRPAP1,NFIL3,NPY2R,NRP2,PIK3CG,PLAU,POMC,RRAS2,SELE,SERPINE1,SLC7A11,SSBP2,ST6GALNAC5,STC1,SYNJ2,TGFBR2,TGIF1,TREM2,WWTR1,mir-15	18	17	Cardiovascular Disease, Organismal Injury and Abnormalities, Cellular Movement	
3	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ABCG2,BNIP2,CALU,CARD6,CCND1,CD55,CLTC,DNM1L,EMP1,FOXF1,FOXO3,GLI1,GNL3,IGFBP7,LATS2,MFSD14A,NANOG,NPNT,PIWIL2,PMAIP1,POU5F1,PRRC2C,PSEN1,PTEN,SART1,SOX17,ST8SIA1,TMEM127,TNFRSF10B,TP53,TP73,WWTR1,XRCC6,YY2,ZIC2	18	17	Cell Death and Survival, Cellular Development, Cellular Function and Maintenance	
4	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ACSL5,ACTR3,ADORA2A,APOD,APOE,ASCL1,B4GALT1,CASP1,CCNA2,CCT5,CDKN1C,CFLAR,CGA,CX3CL1,CX3CR1,E2F1,EID1,ELOVL7,ESR1,FKBP11,HELLS,IFITM3,INSM1,INSM2,IRAK2,MAPT,NDUFV2,PEA15,RPL37,RPS16,SERPINA3,TP73,TXNDC12,TXNRD1,melatonin	18	17	Neurological Disease, Skeletal and Muscular Disorders, Cell Death and Survival	
5	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	C9orf72,CCNYL1,CDC42EP3,COL4A1,CREB1,CTNNB1,EDN1,EDNRB,EIF4EBP2,ETS2,FLCN,FNIP1,FNIP2,GRIA1,GRIA2,HTT,IFNAR2,IQGAP1,KDM4B,MBP,PRICKLE1,RASIP1,REEP3,RHOA,SLC1A2,SNAP23,SOX17,SOX9,SYPL1,TCF7L2,TFE3,TMEM141,TMEM70,VMP1,levodopa	16	16	Cell Death and Survival, Nervous System Development and Function, Cellular Compromise	
6	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ADGRF5,ANKRD12,ANXA1,APOA4,BGN,BPNT2,CRIM1,CRY1,CRY2,DAB2,F2,FOS,GAL,GPR17,IFITM3,IL1R1,MAGI2,MGP,NCOA3,NR3C2,NSDHL,NTS,PAFAH1B1,PDK4,PGR,PLAGL1,PODXL,RHOA,S100B,SYNCRIP,TRAM1,TSC2,XAF1,beta-estradiol,progesterone	16	16	Psychological Disorders, Cellular Movement, Organismal Injury and Abnormalities	
7	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ATF1,ATG7,ATP1A1,BID,CASP1,CASP2,CASP7,CC2D1A,CCNC,CDK16,CDK5,EZR,FASLG,FMNL3,FTH1,FTL,GBA,GCLM,HSPA5,IREB2,NR4A2,Nefm,PIP5K1C,RAB1A,SERPINB1,SNAP25,SNCA,SOD1,SPAG9,SYN1,TIAL1,ULK1,ZFP36L2,glutathione,iron	16	16	Neurological Disease, Organismal Injury and Abnormalities, Cell Death and Survival	
8	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	APOA1,ARNTL,ARPC1B,ATP6V0E1,CALD1,CARTPT,CEMIP2,CLOCK,CYCS,FABP7,FGF1,GAST,HTT,IDH3A,MBNL1,MYB,MYLK,NACA,PAK2,PAX6,PDPK1,PKN2,PPARGC1A,PRKCD,PRKCG,RGS4,SEL1L,SOX2,ST8SIA1,TBC1D9,THRA,TIA1,TNS3,XRCC6,ZNF830	16	16	Embryonic Development, Organismal Development, Cell Cycle	
9	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	24-hydroxycholesterol,ABCB1,ABCG1,ABCG2,AP4E1,APP,CLTC,CX3CR1,DKK1,DLG4,DNM1L,EEF2,ERBB2,FKBP1A,GLUL,GNAO1,GRM5,H2AJ,HNRNPC,IFI16,IL18,NPC1,NSF,PRDX1,PRKCA,PRKCE,PRNP,RANBP9,RPS3,SEPTIN11,SIAH1,TNFRSF10B,TPM3,Tpm1,UBE2K	15	15	Cell Death and Survival, Nervous System Development and Function, Tissue Morphology	
10	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	APC,APLN,CASP8,CD274,CD93,CDH5,CTNNB1,CYP1B1,Ccl7,DAG1,DDX20,DKK1,DRP2,FMR1,GJB2,IFNG,KCTD12,LAMC2,LEF1,MAP2K1,MYCT1,PANX1,PCDH8,PECAM1,PLAU,PRX,S100A9,SAMHD1,SMAD3,SND1,ST3GAL6,TGFB2,TLR3,UTRN,mir-21	13	14	Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation	
11	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	A2M,APOE,APP,AZI2,BDNF,CASK,CRKL,Ca2+,DLG4,FLT1,FYN,GRIN1,GRIN2A,GRIN2B,GSK3B,ITGB1,LRP1,MAPT,MIB2,MMP9,NFATC3,PLAT,PSEN1,PTGR1,PTPRE,RAPGEF1,RBBP6,RELN,SHC1,SLK,SRF,TGFB1,WNT1,beta-estradiol,levodopa	8	10	Cell-To-Cell Signaling and Interaction, Nervous System Development and Function, Cell Morphology	
12	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	CHRDL1,HDAC4	1	1	Developmental Disorder, Ophthalmic Disease, Organismal Injury and Abnormalities	
13	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	EGR3,HEG1	1	1	Cardiovascular System Development and Function, Organ Development, Skeletal and Muscular System Development and Function	
14	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	CDC73,PHF6	1	1	Developmental Disorder, Hereditary Disorder, Neurological Disease	
15	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	HOXD10,TFPI	1	1	Carbohydrate Metabolism, Cellular Growth and Proliferation, Drug Metabolism	
16	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	PSMB4,PSMD8	1	1	Gene Expression, RNA Damage and Repair, RNA Post-Transcriptional Modification	
17	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ASPH,ZFYVE27	1	1	Cellular Assembly and Organization, Cellular Function and Maintenance, Hereditary Disorder	
18	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	ASF1A,HIRA	1	1	Infectious Diseases, Developmental Disorder, Embryonic Development	
19	WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM	COQ4,PARL,TTC19	1	1	Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	

My Lists for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
My Lists	 -log(p-value)	Ratio	Molecules 

Tox Lists for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
Ingenuity Toxicity Lists	 -log(p-value)	Ratio	Molecules 
Renal Necrosis/Cell Death	5.31E00	4.87E-02	UBE2J1,SEL1L,TNFRSF10B,SLK,STAT3,CFLAR,PTGR1,IER3,ITGB1,FLT1,CASP2,CASP7,CARD8,TARDBP,PAK2,EZR,CASP1,ABCG2,SIAH1,STMN1,PRNP,EMP1,CEBPB,PTGS2,PKN2,ICAM1,PMAIP1,BGN
Hepatic Fibrosis	5.19E00	6.19E-02	COL4A1,IFNAR2,ITGA6,CNR1,IL6,TBC1D9,ABCG2,TGFBR2,FN1,IGFBP7,SEC11A,CAMLG,PTPRE,CDC42EP3,GCLM,XYLT2,ICAM1,MMP1,BGN
Oxidative Stress	4.28E00	1.35E-01	JUN,STAT3,IL6,GCLM,PRDX1,ICAM1,VCAM1
Increases Liver Hepatitis	3.91E00	1.01E-01	JUN,STAT3,IL1R1,LATS2,CNR1,CASP1,SERPINE1,IL6
Increases Glomerular Injury	3.63E00	7.46E-02	JUN,SLK,ITGB1,CEBPB,PTGS2,FLT1,WWTR1,IL6,ICAM1,CYP1B1
Genes associated with Chronic Allograft Nephropathy (Human)	3.41E00	2.11E-01	COL4A1,FN1,ICAM1,VCAM1
Liver Proliferation	2.99E00	5.18E-02	JUN,ITGA6,CNR1,EDNRB,IL6,IL6ST,NFATC3,TGFBR2,CFLAR,ITGB1,CEBPB,PTGS2,FLT1
Cardiac Hypertrophy	2.72E00	4.32E-02	JUN,THRA,FKBP1A,EP300,IL6,IL6ST,NFATC3,ADAM17,STAT3,FN1,IER3,PTGS2,RAB1A,SERPINE1,FNIP1,MMP1
Increases Liver Hyperplasia/Hyperproliferation	2.71E00	6.72E-02	JUN,IQGAP1,TGFBR2,STAT3,PRNP,PTGS2,TXNRD1,IL6
Hypoxia-Inducible Factor Signaling	2.71E00	8.7E-02	UBE2J1,JUN,UBE2H,FLT1,EP300,ASPH
VDR/RXR Activation	2.56E00	8.11E-02	SERPINB1,CCNC,CEBPB,EP300,HES1,NCOA3
Acute Renal Failure Panel (Rat)	2.42E00	9.09E-02	JUN,FKBP1A,CXCL2,IL6,VCAM1
NRF2-mediated Oxidative Stress Response	2.28E00	4.95E-02	JUN,GSTO1,FTL,RRAS2,EP300,TXNRD1,PIK3C2B,UBE2K,GCLM,PRDX1
Increases Liver Damage	2.23E00	6.98E-02	STAT3,IL1R1,CASP1,SERPINE1,IL6,IL6ST
Persistent Renal Ischemia-Reperfusion Injury (Mouse)	1.94E00	1.2E-01	MGP,CXCL2,VCAM1
Increases Transmembrane Potential of Mitochondria and Mitochondrial Membrane	1.92E00	8.51E-02	CFLAR,IL6,ICAM1,CASP7
Liver Necrosis/Cell Death	1.91E00	4E-02	JUN,STAT3,CFLAR,LATS2,IER3,CEBPB,PTGS2,FKBP1A,SERPINE1,IL6,IL6ST,CASP7
Cardiac Fibrosis	1.8E00	4.18E-02	JUN,ADAM17,STAT3,FN1,ITGB1,PTGS2,FLT1,SERPINE1,UTRN,BGN
Primary Glomerulonephritis Biomarker Panel (Human)	1.75E00	1.82E-01	IER3,SERPINE1
Aryl Hydrocarbon Receptor Signaling	1.72E00	4.9E-02	JUN,GSTO1,EP300,CCNA2,IL6,CYP1B1,NCOA3
PPARα/RXRα Activation	1.71E00	4.52E-02	JUN,TGFBR2,RRAS2,IL1R1,EP300,PDIA3,IL6,NCOA3
Recovery from Ischemic Acute Renal Failure (Rat)	1.55E00	1.43E-01	COL4A1,MGP
TGF-β Signaling	1.46E00	5.26E-02	JUN,TGFBR2,RRAS2,EP300,SERPINE1
Pro-Apoptosis	1.46E00	7.89E-02	CASP2,CASP7,TNFRSF10B
p53 Signaling	1.43E00	5.15E-02	JUN,EP300,PIK3C2B,PMAIP1,TNFRSF10B
NF-κB Signaling	1.36E00	4.12E-02	TGFBR2,RRAS2,IL1R1,FLT1,EP300,PIK3C2B,AZI2
Increases Cardiac Proliferation	1.3E00	5.48E-02	STAT3,RAB1A,IL6,NACA
TR/RXR Activation	1.18E00	5E-02	THRA,EP300,PIK3C2B,NCOA3
Increases Renal Proliferation	1.16E00	3.95E-02	JUN,STAT3,ITGB1,CEBPB,PTGS2,IL6
Increases Renal Damage	1.08E00	4.6E-02	IL1R1,ITGB1,IL6,ICAM1
Mechanism of Gene Regulation by Peroxisome Proliferators via PPARα	1.01E00	4.35E-02	JUN,IL1R1,PTGS2,EP300
LXR/RXR Activation	9.99E-01	4.3E-02	IL1R1,PTGS2,ABCG1,IL6
Hepatic Stellate Cell Activation	8.68E-01	5.88E-02	TGFBR2,IL6
Increases Liver Steatosis	7.77E-01	3.54E-02	JUN,CNR1,CASP1,ABCG1
Cytochrome P450 Panel - Substrate is a Xenobiotic (Human)	6.88E-01	8.33E-02	CYP1B1
Cytochrome P450 Panel - Substrate is a Sterol (Human)	6.57E-01	7.69E-02	CYP1B1
Cytochrome P450 Panel - Substrate is a Sterol (Mouse)	6.57E-01	7.69E-02	CYP1B1
Cytochrome P450 Panel - Substrate is a Sterol (Rat)	6.57E-01	7.69E-02	CYP1B1
Cytochrome P450 Panel - Substrate is a Xenobiotic (Rat)	6.29E-01	7.14E-02	CYP1B1
Increases Depolarization of Mitochondria and Mitochondrial Membrane	6.29E-01	7.14E-02	PRNP
Glutathione Depletion - Phase II Reactions	6.29E-01	7.14E-02	GSTO1
Renal Glomerulus Panel (Human)	6.03E-01	6.67E-02	PODXL
Cytochrome P450 Panel - Substrate is a Xenobiotic (Mouse)	5.79E-01	6.25E-02	CYP1B1
Long-term Renal Injury Anti-oxidative Response Panel (Rat)	5.79E-01	6.25E-02	GCLM
Xenobiotic Metabolism Signaling	5.73E-01	2.55E-02	GSTO1,FTL,RRAS2,EP300,PIK3C2B,IL6,CYP1B1
Nongenotoxic Hepatocarcinogenicity Biomarker Panel	5.56E-01	5.88E-02	SEL1L
LPS/IL-1 Mediated Inhibition of RXR Function	5.23E-01	2.6E-02	JUN,GSTO1,IL1R1,ACSL5,ABCG1
Increases Heart Failure	4.97E-01	5E-02	CASP1
Positive Acute Phase Response Proteins	4.8E-01	4.76E-02	SERPINE1
Increases Cardiac Dysfunction	4.65E-01	3.12E-02	TGFBR2,EP300
Reversible Glomerulonephritis Biomarker Panel (Rat)	4.48E-01	4.35E-02	XYLT2
Hepatic Cholestasis	4.33E-01	2.47E-02	JUN,IL1R1,IRAK2,IL6
Decreases Transmembrane Potential of Mitochondria and Mitochondrial Membrane	4E-01	2.5E-02	CASP2,PMAIP1,TNFRSF10B
Anti-Apoptosis	3.94E-01	3.7E-02	BNIP2
Decreases Depolarization of Mitochondria and Mitochondrial Membrane	3.39E-01	3.12E-02	CSTB
Fatty Acid Metabolism	2.96E-01	2.25E-02	ACSL5,CYP1B1
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	2.1E-01	2E-02	EP300
PXR/RXR Activation	2E-01	1.92E-02	IL6
RAR Activation	0E00	1.69E-02	JUN,EP300,MMP1
Mitochondrial Dysfunction	0E00	1.86E-02	MT-CO2,NDUFV2,MT-ND4
Cardiac Necrosis/Cell Death	0E00	1.74E-02	IQGAP1,STAT3,CASP1,IL6,IL6ST
Increases Renal Nephritis	0E00	1.82E-02	IL6

My Pathways for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
My Pathways	 -log(p-value)	Ratio	Molecules 

Analysis Ready Molecules for My Projects->Adult_WM_vs_GM->WM_vs_GM_A2B5_Final - 2020-12-23 05:29 PM
ID	Symbol	Expr Log Ratio	Expr p-value
ABCG1	ABCG1	-1.05253018053821	0.0270256986832014
ABCG2	ABCG2	-1.68546775990703	0.0187596700101204
ABHD12	ABHD12	1.36452144579905	0.0187596700101204
ABRACL	ABRACL	-1.12468726225678	0.0349179730063875
ACSL5	ACSL5	-1.76303561648676	0.0141419772329685
ACTR2	ACTR2	-0.845350227953688	0.0328557339637858
ACTR3	ACTR3	-0.595222792260008	0.0328557339637858
ACVRL1	ACVRL1	-1.22875549844835	0.0403089567360536
ADAM17	ADAM17	-0.52812674715015	0.0439865832848236
ADAM19	ADAM19	-1.46053949897366	0.0227281038079047
ADGRF5	ADGRF5	-2.40980459934569	0.0144127255078825
ADGRL4	ADGRL4	-1.92923397737743	0.0221122158166994
ANKRD12	ANKRD12	0.650056069416953	0.0350379475442577
AP4E1	AP4E1	-0.74141949045211	0.043960582205754
APOL3	APOL3	-1.86005364037191	0.0401635932222916
ARFIP1	ARFIP1	-0.802548698632663	0.0249148554911986
ARHGEF26	ARHGEF26	-1.4970930907041	0.0227281038079047
ARL8B	ARL8B	-1.18177782912141	0.0373811399342775
ARPC1B	ARPC1B	-1.28182926608781	0.0230503153544118
ARPC3	ARPC3	-0.750167738242862	0.0257694049367069
ASF1A	ASF1A	-0.857073260425464	0.0303735168188736
ASPH	ASPH	-0.981217235625354	0.046722315663797
ATF1	ATF1	1.3595469439135	0.0227281038079047
ATP11C	ATP11C	-1.28931683861783	0.0187596700101204
ATP6V0E1	ATP6V0E1	-0.716794222844445	0.0404935502535451
AZI2	AZI2	0.975029043796934	0.0236063899320649
B4GALT1	B4GALT1	-1.38277034930365	0.0288286856769069
BAMBI	BAMBI	0.862260243229573	0.0262547684902737
BCAP29	BCAP29	-1.22134667763492	0.0170402076380964
BGN	BGN	0.9950116010753	0.0145571753713705
BNIP2	BNIP2	-0.662697047944029	0.0268626157760347
BOD1	BOD1	0.621875779155358	0.0245011004374221
IMPAD1	BPNT2	-0.85589007536629	0.0328557339637858
C1orf43	C1orf43	-1.02961914993849	0.0350761717546779
C1orf54	C1orf54	-1.24121191472366	0.0293715707427289
C2CD4B	C2CD4B	-1.88149722892656	0.0221122158166994
C9orf72	C9orf72	-0.919526084365655	0.0272737419413114
CALD1	CALD1	-0.771916550228742	0.0328557339637858
CALU	CALU	-0.714975389481339	0.0392738720328736
CAMLG	CAMLG	1.33012961449122	0.0380359896916828
CARD6	CARD6	-1.85951907494158	0.0483188158128482
CARD8	CARD8	-0.928311345024847	0.0419605530279645
CASP1	CASP1	-1.70544536456916	0.0240991496924312
CASP2	CASP2	-0.618948735153698	0.0497372205670895
CASP7	CASP7	-1.5851481247527	0.0328557339637858
CCDC69	CCDC69	-1.20933341373556	0.0471203204724716
CCNA2	CCNA2	0.727754284166118	0.0413316938419708
CCNC	CCNC	-0.555519021799596	0.0465366726844662
CCT5	CCT5	-0.828122138363886	0.0328557339637858
CD55	CD55	-1.26286816931243	0.0249148554911986
CD93	CD93	-1.55259151403473	0.0397348304628911
CD99	CD99	-1.50718075057982	0.0452549270438051
CDC42EP3	CDC42EP3	-1.66398507171556	0.0227281038079047
CDC73	CDC73	-1.36160634049238	0.0395425867850752
CDH5	CDH5	-1.04649781597574	0.0499871288747396
CDK16	CDK16	-0.761661414117942	0.0471203204724716
CEBPB	CEBPB	-1.18044737044716	0.0245011004374221
CEMIP2	CEMIP2	-1.35617069904426	0.0277495253827114
CEP19	CEP19	1.73884505935355	0.0473208712838411
CFLAR	CFLAR	-1.27407818054524	0.0395425867850752
CHRDL1	CHRDL1	2.88213172095738	0.00715445527776153
CLDN5	CLDN5	-1.16436246767137	0.0328557339637858
CLIC1	CLIC1	-1.36449489854149	0.020779253227259
CLN5	CLN5	0.878710948602922	0.046722315663797
CMTM6	CMTM6	-1.29221848927639	0.0221122158166994
CNR1	CNR1	1.78330224731201	0.00715445527776153
COBL	COBL	1.11440353125996	0.0237762011712414
COBLL1	COBLL1	-2.24757847943843	0.0145571753713705
COL4A1	COL4A1	-2.1717661871807	0.0145571753713705
COPS2	COPS2	0.932207946154168	0.0255862378722627
CRIM1	CRIM1	-1.16065070814883	0.0187596700101204
CRY1	CRY1	0.951614720668305	0.0187596700101204
CSTB	CSTB	-0.959103764000338	0.0452549270438051
CXCL2	CXCL2	-1.23514437931494	0.0328557339637858
CYP1B1	CYP1B1	-4.0172549922511	0.0153950617722225
DAB2	DAB2	-1.25736514580068	0.0245706402892712
DDX20	DDX20	1.09455508290659	0.0328557339637858
DENR	DENR	-0.639368013120222	0.046722315663797
DERL1	DERL1	-1.23116523378215	0.0459679564155506
DHX30	DHX30	1.24454468903161	0.0432467637631008
DUSP3	DUSP3	-0.98756863390587	0.0494197166556513
EDNRB	EDNRB	-1.19255181662504	0.0328557339637858
EID1	EID1	0.75018792126358	0.0428506592983698
EIF3I	EIF3I	-0.817078945065234	0.0328557339637858
EIF4EBP2	EIF4EBP2	-0.917176222052927	0.0413316938419708
EIF4G2	EIF4G2	1.53943274395241	0.0257694049367069
ELOVL7	ELOVL7	-1.56699140204574	0.0293715707427289
EMP1	EMP1	-2.02931303552254	0.0187596700101204
EP300	EP300	0.622960173255992	0.0328557339637858
ETS2	ETS2	-1.62476203858591	0.0203734557003546
EZR	EZR	-0.701087613072202	0.0286103173208486
FAM124B	FAM124B	-2.3398364367212	0.0245011004374221
FAM193A	FAM193A	0.50812221821154	0.0348726489917189
FGD5	FGD5	-1.23849333300162	0.0389622603872162
FGFBP3	FGFBP3	1.0463572911323	0.0252305064941191
FKBP1A	FKBP1A	-0.741613254349046	0.0471203204724716
FLI1	FLI1	-1.97369441839377	0.00332130656605315
FLT1	FLT1	-1.93867508674747	0.0249148554911986
FMNL3	FMNL3	-0.962592266970473	0.043739811038404
FN1	FN1	-1.43292469813059	0.0153950617722225
FNIP1	FNIP1	1.75529541391429	0.0419605530279645
FNIP2	FNIP2	-1.17574900295696	0.0227281038079047
FOXF1	FOXF1	-2.09253464076972	0.0287404321715241
FTL	FTL	-1.10381457050817	0.0446426369810432
GBE1	GBE1	-0.760769694171008	0.0272737419413114
GCLM	GCLM	-1.93694537377831	0.0328557339637858
GGCX	GGCX	1.01844296993059	0.0428506592983698
GIMAP6	GIMAP6	-1.48632784101521	0.0392738720328736
GLRX5	GLRX5	0.906407228037441	0.0272737419413114
GPAT3	GPAT3	-1.9195004656397	0.0180479915171529
GPR17	GPR17	1.62372327892227	0.0411788163589164
GPR19	GPR19	2.33766326691829	0.00490150682554391
GPR4	GPR4	-1.38923589948054	0.0350379475442577
GSTO1	GSTO1	-0.996249322810932	0.0272737419413114
H2AFJ	H2AJ	1.33913871254448	0.0328557339637858
HDGFL3	HDGFL3	-1.88553834614266	0.029809767011133
HEG1	HEG1	-0.770644392554283	0.0494582424667178
HES1	HES1	2.29851469131979	0.00332130656605315
HES5	HES5	3.3973747353265	1.88873614791308E-4
HLA-E	HLA-E	-1.48695375014326	0.0298636523838199
HNRNPC	HNRNPC	-0.697390287650078	0.0350379475442577
IAH1	IAH1	-0.577158604497491	0.0349179730063875
ICAM1	ICAM1	-1.7505801394952	0.0328557339637858
IDH3A	IDH3A	-1.03826722717012	0.0221122158166994
IER3	IER3	-1.40072669813258	0.0328557339637858
IFI16	IFI16	-1.28915626426158	0.0471316648419585
IFNAR2	IFNAR2	-1.01982165219058	0.0373811399342775
IGFBP7	IGFBP7	-0.864174278142777	0.0328557339637858
IL1R1	IL1R1	-1.56195420306056	0.0272737419413114
IL6	IL6	-1.90503259605583	0.0477502235504717
IL6ST	IL6ST	-0.756937989766332	0.0395425867850752
INSM1	INSM1	2.2229829397979	0.0200719595235403
INSM2	INSM2	2.36219792118774	0.029809767011133
IQGAP1	IQGAP1	-1.31417554391471	0.0419605530279645
IRAK2	IRAK2	-1.09598009830381	0.0328557339637858
IREB2	IREB2	-0.86277375574481	0.0413316938419708
ITGA2	ITGA2	-1.55485321577358	0.0453209685465658
ITGA6	ITGA6	-1.24251971694933	0.0227281038079047
ITGB1	ITGB1	-1.54087854372173	0.0450676070565125
JUN	JUN	0.991284807034106	0.0200719595235403
KCTD12	KCTD12	-1.85496760456408	0.0250001909326549
KDM4B	KDM4B	0.950829082737498	0.0453209685465658
KDSR	KDSR	1.15197777306105	0.0350379475442577
KPNA5	KPNA5	0.829572240085715	0.0475275091262434
LAMC2	LAMC2	-2.06561508489266	0.0484646365675499
LATS2	LATS2	-0.90090490874198	0.0327886906972507
LEF1	LEF1	-1.98287231452479	0.00737007836998988
LSM12	LSM12	-1.01285590639518	0.0443535523347545
LUZP1	LUZP1	-1.04329817002221	0.0328557339637858
H2AFY	MACROH2A1	-0.991967487549724	0.0453209685465658
MAGI2	MAGI2	0.882039468766676	0.0447853556410205
MBNL1	MBNL1	-0.745030242832955	0.0240991496924312
MECOM	MECOM	-1.7075197264348	0.0272737419413114
MEG3	MEG3	1.47263795988144	0.0328557339637858
MFSD14A	MFSD14A	0.594034133242634	0.0446210707694061
MGP	MGP	-3.0138665282298	0.0141419772329685
MIB2	MIB2	1.14854536706722	0.0348726489917189
MKRN1	MKRN1	1.63045393893397	0.0221122158166994
MMP1	MMP1	-4.46051182505947	0.0227281038079047
MOB1A	MOB1A	-1.06022032358652	0.0328557339637858
MPZL2	MPZL2	-2.16553701966891	0.0227281038079047
COX2	MT-CO2	-0.688731008669169	0.0428506592983698
ND4	MT-ND4	-0.819866166107346	0.0277495253827114
MTMR9	MTMR9	-0.706093399162642	0.0187596700101204
MYCT1	MYCT1	-1.41945733975741	0.0471203204724716
MYLK	MYLK	-0.794456742088575	0.0328557339637858
NACA	NACA	1.16977203295263	0.0411788163589164
NCOA3	NCOA3	-1.01861225330712	0.0446153674076169
NDUFV2	NDUFV2	-0.694238286562586	0.0272737419413114
NFATC3	NFATC3	-0.712395827396151	0.0480359051912688
NFIL3	NFIL3	0.975539719067971	0.0153950617722225
NKTR	NKTR	-0.792900031291062	0.0249148554911986
NPNT	NPNT	-2.67121917671763	0.0227281038079047
NRP2	NRP2	-1.70989024213191	0.046722315663797
NSDHL	NSDHL	1.17868813796647	0.0471203204724716
OAZ1	OAZ1	-0.97187493499044	0.0272737419413114
PAK2	PAK2	-0.774757455249847	0.0349179730063875
PANX1	PANX1	-1.87242381085487	0.0333615081375074
PARL	PARL	-0.772550113683605	0.0475275091262434
PCBP2	PCBP2	-0.612341237188852	0.0471203204724716
PCDH8	PCDH8	1.28551803888862	0.0187596700101204
PCIF1	PCIF1	1.05899754898934	0.029809767011133
PCMT1	PCMT1	0.605386907725492	0.0349179730063875
PDIA3	PDIA3	-0.664882356679156	0.0413316938419708
PECAM1	PECAM1	-1.95113660735262	0.0102781864061719
PGD	PGD	-1.49097486667352	0.0350379475442577
PGF	PGF	-1.27318358422366	0.043960582205754
PGM3	PGM3	-0.832410430395485	0.0404935502535451
PIK3C2B	PIK3C2B	-0.726834806933836	0.0471203204724716
PKN2	PKN2	-1.32484146443357	0.0153950617722225
PMAIP1	PMAIP1	-1.80124023237561	0.0187596700101204
PODXL	PODXL	-1.27713507795145	0.0245011004374221
PPIP5K2	PPIP5K2	-0.858798174592677	0.0245011004374221
PRDX1	PRDX1	-0.819063211561151	0.0125664296238713
PRICKLE1	PRICKLE1	1.60741823356525	0.0125664296238713
PRNP	PRNP	0.587443702429441	0.0419605530279645
PRRC2C	PRRC2C	-0.690966309107568	0.032735147680335
PSMB4	PSMB4	-0.848482082427452	0.0327886906972507
PTBP3	PTBP3	-1.2142193491502	0.0353759081275274
PTGR1	PTGR1	-1.16142023313689	0.0221122158166994
PTGS2	PTGS2	-2.80725034659302	0.0187596700101204
PTPRE	PTPRE	1.51315494131883	0.0250001909326549
RAB1A	RAB1A	-1.82250878423275	0.0125664296238713
RAB27A	RAB27A	-0.992254947003234	0.00737007836998988
RAI14	RAI14	-1.47286028191455	0.0227281038079047
RAPGEF1	RAPGEF1	-1.02666726178855	0.0413316938419708
RASIP1	RASIP1	-1.55572905863388	0.0446153674076169
RASSF3	RASSF3	-1.59253359499724	0.0141419772329685
RBBP6	RBBP6	1.43497460084439	0.0447853556410205
RBIS	RBIS	1.1264743284882	0.0452549270438051
RNF149	RNF149	-0.832240540282784	0.0187596700101204
RPE	RPE	-1.12324177718008	0.0274077826596038
RPL37	RPL37	1.26800013512563	0.0268626157760347
RPS16	RPS16	-0.819267726388823	0.0348726489917189
RPS21	RPS21	0.839177058305806	0.029809767011133
RPS3	RPS3	-0.568918802075762	0.0454003465537154
RRAS2	RRAS2	-1.42290801649443	0.0432467637631008
RREB1	RREB1	-1.24819360556443	0.0249148554911986
RSL1D1	RSL1D1	0.928526060297067	0.0328557339637858
SAMHD1	SAMHD1	1.27639027461563	0.00737007836998988
SEC11A	SEC11A	-0.6319765912999	0.0328557339637858
SEC23IP	SEC23IP	-0.727464759591419	0.0392738720328736
SEL1L	SEL1L	-0.664092380790954	0.0339220327580911
SELE	SELE	-2.80431125886432	0.0272737419413114
SEPTIN11	SEPTIN11	-1.11664951916283	0.0278759363257105
SERPINB1	SERPINB1	-1.17778928691612	0.0227281038079047
SERPINE1	SERPINE1	-1.71257629333523	0.0428506592983698
SHISA9	SHISA9	1.93987093687191	0.00341348409231925
SIAH1	SIAH1	0.855604719834915	0.033100415096871
SLC39A8	SLC39A8	-1.26945797616909	0.0221122158166994
SLC41A2	SLC41A2	1.31404824578224	0.0350379475442577
SLC49A4	SLC49A4	-0.847553464687895	0.0248231069074349
SLC7A11	SLC7A11	-2.42421358602434	0.0145571753713705
SLFN11	SLFN11	-1.3748429564702	0.0194344546935173
SLK	SLK	-0.675580610936809	0.0499871288747396
SMIM10L1	SMIM10L1	1.4460531133285	0.029809767011133
SNAP23	SNAP23	-0.71092707164798	0.0328557339637858
SPAG9	SPAG9	-0.571918319136989	0.0498008562805317
SPCS2	SPCS2	-0.713386850333497	0.029809767011133
SRGN	SRGN	-1.93550551207842	0.0250001909326549
SRSF1	SRSF1	0.780897604191291	0.0409845327849705
SSBP2	SSBP2	0.570812755334515	0.043960582205754
SSR1	SSR1	-0.977505292861922	0.0221122158166994
ST3GAL6	ST3GAL6	-0.994853351871631	0.0413207439805469
STAT3	STAT3	-0.802919282444559	0.0327886906972507
STC1	STC1	-2.12778230099545	0.0404935502535451
STMN1	STMN1	2.31488064437423	0.0389622603872162
SUSD6	SUSD6	-1.13398547741627	0.0303735168188736
SWAP70	SWAP70	-1.5029981350019	0.0145571753713705
SYNCRIP	SYNCRIP	1.55356339587753	0.0145571753713705
SYNJ2	SYNJ2	-1.48763149857277	0.0272737419413114
TAL1	TAL1	-2.07580721388872	0.00841676886368411
TARDBP	TARDBP	0.940836997562821	0.0447853556410205
TBC1D9	TBC1D9	-0.853712109819385	0.0399601908922046
TBCEL	TBCEL	-1.26094122137263	0.0328557339637858
TCAF1	TCAF1	1.2977940640441	0.0470975654461469
TES	TES	-1.80185937341328	0.00239884140391404
TFPI	TFPI	-2.14216801623055	0.0187596700101204
TGFBR2	TGFBR2	-1.72665539360144	0.0239826885786112
TGOLN2	TGOLN2	-1.11722274789453	0.012643529734487
THRA	THRA	0.836157530632054	0.0298076934255733
TIA1	TIA1	0.99569965885416	0.0200950649341783
TIAL1	TIAL1	0.962903099408854	0.0409090992862302
TIFA	TIFA	-1.04861490792801	0.0319055093596781
TM4SF1	TM4SF1	-1.49352981618536	0.0237762011712414
TMEM127	TMEM127	-0.861441955794566	0.0187596700101204
TMEM70	TMEM70	-1.24166197395596	0.0221122158166994
TMOD3	TMOD3	-1.39610233440353	0.018783420822631
TNFRSF10B	TNFRSF10B	-1.24157210378263	0.0145571753713705
TNS3	TNS3	1.05008924646094	0.0272737419413114
TPM3	TPM3	-0.770460590062102	0.0272737419413114
TRAM1	TRAM1	-0.929164668407273	0.0187596700101204
TXNDC12	TXNDC12	-0.855749948233286	0.0249148554911986
TXNRD1	TXNRD1	-1.09635795103865	0.029809767011133
U2SURP	U2SURP	-0.658752907877671	0.0397984643623711
UBE2H	UBE2H	-1.47889847504953	0.0465366726844662
UBE2J1	UBE2J1	-1.09193061464243	0.0221122158166994
UBE2K	UBE2K	-0.744794902545439	0.0380359896916828
UBE2Z	UBE2Z	-1.20876705699711	0.029809767011133
UFD1	UFD1	-0.768900015182707	0.0447853556410205
USP53	USP53	-1.33494994558454	0.0328557339637858
UTRN	UTRN	-1.52908673834591	0.00941371985664961
VCAM1	VCAM1	-1.8198291289514	0.0257694049367069
VMP1	VMP1	-1.81791767732418	0.0339220327580911
WWTR1	WWTR1	-1.73267407378485	0.0272737419413114
XYLT2	XYLT2	-0.867975048205341	0.0428506592983698
ZBTB2	ZBTB2	0.881051606744208	0.0411788163589164
ZFP36L2	ZFP36L2	0.834554947078374	0.0428506592983698
ZIC2	ZIC2	-1.18163151267188	0.0399601908922046
ZNF776	ZNF776	0.704190254066422	0.0286103173208486
ZNF830	ZNF830	1.27464447936867	0.0274077826596038
ZPR1	ZPR1	-0.86306900865317	0.0392738720328736

